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Abstract 
Introduction: Exercise-induced muscle damage (EIMD) is an accepted consequence of 
eccentric exercise. Sex differences in EIMD are attributed to tendon properties, fascicle 
lengthening and direct hormonal influences, however these remain unreported in vivo. 
Furthermore, the classical definition of eccentric contractions omits the role of the elastic 
tendon in determining eccentric fascicle lengthening and subsequent EIMD.  
Aim: The overall aims of the current thesis were, to investigate the role of the patella tendon 
during eccentric contractions, to investigate whether muscle and tendon properties are 
determinants of EIMD and investigate group differences (sex and oral contraceptive 
(OCP)use) in EIMD.  
Materials and method: In brief, vastus lateralis (VL) and patella tendon properties were 
measured in males, females and female OCP users, using a combination of ultrasonography, 
electromyography and dynamometry. During maximal voluntary eccentric knee extensions 
((MVEKE) 12 reps × 6 sets), VL fascicle lengthening and MVEKE torque was recorded every 10 
of knee joint angle (20 - 90). Maximal isometric voluntary knee extensor (MVCKE) torque 
loss, creatine kinase (CK) and muscle soreness were measured pre, post, 48, 96 and 168 hours 
post damage as markers of EIMD.  
Main findings: Patella tendon properties appear to act as a mechanical buffer on VL fascicle 
lengthening during MVEKE in vivo. Furthermore, due to significantly higher patella tendon 
stiffness, VL fascicle lengthening was significantly greater in males compared to females. 
Despite evidencing an attenuating role of the patella tendon on VL fascicle lengthening, 
patella tendon properties did not correlate with any indirect markers of EIMD, nor did they 
explain group differences in EIMD. Furthermore, MVEKE torque, MVEKE torque made relative 
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to estimated total quadriceps anatomical cross-sectional area and VL fascicle lengthening did 
not correlate with any functional indirect marker of EIMD, nor did they explain group 
differences in EIMD. Within the current thesis CK was the only indirect marker of EIMD to be 
significantly different between the groups (males > females < OCP users). Creatine kinase was 
consistently lower in the groups with lower circulating oestrogen levels. Therefore, it was 
concluded that the antioxidant and membrane stabilising role of oestrogen might explain the 
group differences in CK reported in the current thesis.  
Conclusion: In agreement with the historical definition, VL fascicles lengthen during MVEKE. 
Furthermore, it is evident from the current thesis that patella tendon properties determine 
the magnitude of VL fascicle lengthening during MVEKE, but do not appear to explain the 
variability or group differences in EIMD.  
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Chapter one: Thesis introduction and literature review 
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Thesis introduction 
Exercise-induced muscle damage (EIMD) is an established consequence of maximal voluntary 
eccentric contractions (MVEKE). Classically, eccentric contractions are defined as a 
combination of active and passive forces produced during the lengthening of the muscle 
tendon unit (MTU). It is apparent however, that based on ultrasonography applied in vivo 
during eccentric phases of gait that this classical definition may not fit the measured 
movement of the gastrocnemius muscle fascicles (Fukunaga et al., 2001). As the use of this 
method is limited during MVEKE, and is the main measurement outcome of the present thesis, 
there remains a need to describe the reliability of the ultrasound technique during MVEKE 
contractions (aim one).  
Exercise-induced muscle damage occurs from all forms of muscle contractions, 
however, eccentric exercise has been reported to result in the most severe EIMD (Newham et 
al., 1983b; Peñailillo et al., 2013). The measurement of EIMD is achieved through direct and 
indirect methods. For example using muscle biopsies, Newham et al. (1983b) reported that Z-
line disruption, a direct marker of EIMD, was significantly higher following eccentric exercise 
compared to concentric exercise. Due to the painful procedure and small sampling area 
associated with muscle biopsies, particularly for repeated measures as is required in the 
study of EIMD, alternative indirect measurements of EIMD are more frequently used 
(Clarkson & Hubal, 2002). In agreement with direct measure of EIMD, indirect markers of 
EIMD: isometric torque loss, muscle soreness and intramuscular proteins (specifically, 
creatine kinase (CK)) are reported to be significantly higher following eccentric exercise 
compared to concentric exercise (Poprzecki et al., 2004; Clarkson et al., 1986; Willoughby et 
al., 2003).  
The initial cause of EIMD remains inconclusive with the debate centred on the high 
strain (Lieber & Friden, 1993; Hoffman et al., 2014) or high eccentric forces (Warren et al., 
1993a; Chapman et al., 2008; Hody et al., 2013) associated with eccentric contractions. 
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Regarding high strains, the argument is conflicting due to literature being predominately 
evidenced by in vitro and in situ studies (Warren et al., 1993a; Lieber & Friden, 1993), where 
strain values are exaggerated compared to in vivo and based on the estimation of total MTU 
behaviour rather than direct measurements of the fascicles (Butterfield, 2010). Using 
ultrasound technique (Fukashiro et al., 1995), studies have been able to investigate fascicle 
and tendon behaviour independently during contractions (Fukunaga et al., 1997; Reeves & 
Narici, 2003; Guilhem et al., 2011). The development of the ultrasound technique has 
discovered that fascicles lengthen independent of the tendon during MTU lengthening 
(Fukunaga et al., 2001). Furthermore, using a muscle model Lichtwark and Wilson (2007) 
have reported a complicated interaction between tendon properties and fascicles where by 
the degree of fascicle lengthening and efficiency (denoted as energy cost / work done) of the 
movement being performed depends on the tendon stiffness. These findings support the idea 
of the tendon acting as a mechanical buffer on fascicle lengthening during eccentric 
contractions (Roberts & Azizi, 2010; Roberts & Konow, 2013; Reeves & Narici, 2003; Hoffman 
et al., 2014), however these assumptions have yet to be supported experimentally during 
MVEKE in vivo (aim two). The interaction between fascicle lengthening and tendon properties 
raises questions regarding the role and behaviour of the tendon on fascicle lengthening 
during MVEKE (aim two).  
 Although it is commonly accepted that eccentric exercise causes the most severe level 
of EIMD, large individual variability exists in the EIMD (Marginson et al., 2005; Chen et al., 
2011; Wolf et al., 2012). For example, peak CK responses range from to 100 U/L to < 2000 
U/L (Saka et al., 2009; Sewright et al., 2008; Hyldahl et al., 2011). In order to understand the 
large variability in EIMD, determinants of EIMD need to be established. Fascicle strain 
(isolated rabbit muscle (Lieber & Friden, 1993)), eccentric force (in vitro rat muscle (Warren 
et al., 1993a)), the architectural properties of the muscle (in vivo human upper and lower 
limb (Chen et al., 2011)), and circulating oestrogen levels (in vivo quadriceps (Carter et al., 
2001)) have all been suggested to act as determinants of EIMD. These variables however 
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have yet to be fully investigated in vivo, as determinants of muscle damage in the knee 
extensors (aim three). Furthermore, with the new insight on the interaction between tendon 
properties and fascicle behaviour during eccentric contractions (Lichtwark & Wilson, 2007; 
Spanjaard et al., 2007; Fukunaga et al., 2001), the tendon has been suggested to explain group 
differences in EIMD (Marginson et al., 2005; McHugh et al., 1999); however, the role of the 
tendon on EIMD has yet to be evidenced experimentally (aim three). 
Large variability in EIMD has been evidenced between groups, specifically males and 
females (Joyce et al., 2014; Wolf et al., 2012). Within animal studies, males are reported to 
have significantly higher levels of EIMD compared to females (Clarkson & Hubal, 2002; 
Komulainen et al., 1999), however within humans a sex difference remains unconfirmed 
(Stupka et al., 2000; Sewright et al., 2008). Historically, the lower EIMD in females has been 
attributed to the antioxidant role of the female sex hormone oestrogen (Tiidus, 2005; Kendall 
& Eston, 2002). Alternatively, oestrogen has been reported to have an effect on tendon 
properties (Hansen et al., 2009b), specifically tendon stiffness (Kubo et al., 2003). Kubo et al. 
(2003) attributed significantly higher tendon stiffness in males to higher circulating levels of 
oestrogen in females. With insights on the interaction between tendon properties and fascicle 
behaviour during eccentric contractions (Lichtwark & Wilson, 2007), it remains in question 
whether the sex differences in EIMD could be attributed to higher tendon stiffness in males 
compared to females (aim four).  
As mentioned previously the antioxidant role of oestrogen has been used to explain 
sex differences in EIMD (Tiidus, 2005; Kendall & Eston, 2002), however to directly measure 
the role of oestrogen on EIMD, hysterectomies (in animals) and synthetic hormones (e.g. the 
oral contraceptive pill (OCP)) have been used to investigate the role of oestrogen on EIMD 
(Thompson et al., 1997; Savage & Clarkson, 2002; Joyce et al., 2014). The OCP alters the 
hypothalamic-pituitary-ovarian feedback loop, thus inhibiting the peak in oestrogen levels 
during the ovulatory phase (Elliott-Sale et al., 2013; Van Heusden & Fauser, 2002; 
Nudemberg et al., 1973). Thus, women who take the OCP have significantly lower levels of 
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oestrogen throughout their menstrual cycle compared to non-users (Bryant et al., 2008). 
Despite maximising the difference in oestrogen levels through the use of the OCP, the role of 
oestrogen on EIMD remains inconclusive (Joyce et al., 2014; Savage & Clarkson, 2002). 
Interestingly, Bryant et al. (2008) reported, that lower levels of oestrogen in OCP users 
resulted in a decrease in tendon strain compared to non-users. Therefore it remains in 
question whether, due to the antioxidant role of oestrogen or due to a stiffening of the tendon 
and therefore a loss of the hypothesised “buffering” role of the tendon, OCP users are more 
susceptible to EIMD during eccentric contractions (aim five).  
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Literature review 
1.1. Muscle contractions 
Eccentric and concentric contractions are used during daily activities and sporting 
movements, however their contractile behaviour differs (Katz, 1939; Reeves & Narici, 2003). 
For example, by classical definition during an eccentric contraction the external load is larger 
than the force production of the muscle, therefore the muscle lengthens under contraction 
(Katz, 1939). Whereas during a concentric contraction, the external load is lower than the 
force production of the muscle, thus the muscle shortens under contraction (Katz, 1939). 
Although the force production during concentric and isometric contractions can be explained 
by the sliding filament theory (Huxley, 1957), it is unable to fully explain force production 
during eccentric contractions (Huxley, 1980; Herzog, 2014). Recently, to try and explain the 
fundamental contractile properties of eccentric contractions unsolved by the sliding filament 
theory, Herzog (2014) proposed that the sliding filament theory is a three, rather than a two 
filament model, with the addition of titin to actin and myosin filaments. It is proposed that 
titin may play a role during eccentric contractions by altering its stiffness in an activation 
(calcium) dependent manner (Herzog, 2014). However the proposed modification of the 
sliding filament theory is in its infancy, and needs to be investigated further to fully describe 
the contractile properties of eccentric contractions (Herzog, 2014). 
Eccentric contractions differ to concentric contractions for a couple of reasons. 
Firstly, eccentric contractions produce significantly higher forces compared to concentric 
contractions. The higher forces produced during eccentric contractions can be evidenced 
using the force-velocity relationship. Initially the force-velocity relationship was proposed by 
Fenn and Marsh (1935) however, the relationship has evolved over time (Hill, 1938; Edman 
et al., 1997). The force-velocity relationship is now accepted as two distinct curvatures 
(Figure 1. 1.) (Edman et al., 1997). In vivo the force-velocity relationship is largely calculated 
using torque-angular speed, however, the in-series compliance and fascicle mechanics 
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perplex the direct comparison between torque-angular speed and the force-velocity 
relationship at the fascicles (De Brito Fontana et al., 2014). Secondly, energy requirements 
are considerably lower during eccentric compared to concentric contractions (Abbott et al., 
1952; Peñailillo et al., 2013). Lower energy costs during eccentric contractions have been 
attributed to several mechanisms, including the contribution of titin (Herzog, 2014), the 
dissipation of energy rather than the generation of energy (Ryschon et al., 1997), and / or 
weakly bound myosin-actin states breaking rather than requiring ATP hydrolysis to detach 
the myosin heads as reported with concentric contractions (Huxley, 1957; Ryschon et al., 
1997). The latter may be associated with the greater levels of EIMD reported following 
eccentric contractions compared to concentric contractions, however there is no systematic 
evidence to support this hypothesis (Ryschon et al., 1997; Huxley, 1957). Therefore, although 
the mechanisms remain unclear, it is accepted that eccentric contractions produce 
significantly higher levels of force at a lower metabolic cost compared to concentric 
contractions (Peñailillo et al., 2013; Abbott et al., 1952). 
 
Figure 1. 1. Force-velocity relationship of a skeletal muscle. Po represented 100% maximal 
voluntary isometric torque (Allen, 2001). 
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A consequence of eccentric exercise is significantly higher levels of EIMD compared to 
concentric exercise (Peñailillo et al., 2013; Willoughby et al., 2003). For example, Peñailillo et 
al. (2013) found that decreases in isometric torque, counter movement jump and squat jump 
height and increase in muscle soreness were significantly higher following eccentric 
compared to concentric cycling bouts. The greater levels of EIMD associated with eccentric 
contractions have been attributed to several mechanisms however, they predominately focus 
on two contractile properties of eccentric contractions 1) high eccentric forces and 2) high 
levels of strain (Peñailillo et al., 2013; Lieber & Friden, 1993; Warren et al., 1993a; Hody et al., 
2013; Chapman et al., 2008). Although determinants of EIMD have been proposed (see 
below), it still remains to be established whether one of these mechanisms per se or a 
combination of the two can be used to explain eccentric EIMD in vivo.  
1.2. Model of exercise-induced muscle damage 
Armstrong (1990) proposed a four-stage model to describe the pathology of EIMD: 1) initial 
stage, 2) loss of calcium (Ca2+) homeostasis / autogenetic phase, 3) phagocytic stage and 4) 
regenerative stage (Armstrong, 1990; Armstrong et al., 1991). The first three stages of 
Armstrong (1990) model will be covered below in regards to the mechanisms involved, 
however the regenerative phase (fourth stage) will not be discussed.  
1.2.1. Stage one: Initial stage 
Following eccentric exercise the initial stage of EIMD remains controversial. The debate 
regarding the initial cause of EIMD focuses on two mechanical factors, either structural 
damage to the muscle sarcomeres or damage to the excitation-contraction coupling (E-C) 
process (Proske & Morgan, 2001; Armstrong et al., 1991).  
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1.2.1.1. Initial stage: The popping sarcomere theory 
The mechanical theory of EIMD has stemmed from the lengthening characteristics of 
eccentric contractions, and can be applied to the length-tension relationship described by 
Gordon et al. (1966). The length-tension relationship reports that peak tension occurs 
between sarcomere lengths of 2.00 m and 2.20 m (Morgan, 1990; Gordon et al., 1966). If 
sarcomeres exceed 2.20 m then they are stretched onto the descending limb of the length-
tension relationship until there is no actin-myosin interaction (Figure 1. 2, (Morgan, 1990; 
Gordon et al., 1966)). The popping sarcomere theory, proposed by Morgan (1990), suggests 
that EIMD occurs when sarcomeres are extended onto the descending limb of the length-
tension relationship. The popping sarcomere theory is based on the concept of ‘systematic 
sarcomere lengthening’ from the weakest to the strongest sarcomeres during active 
lengthening. Initially, the weakest sarcomeres lengthen to accommodate the increase in 
myofibril length during eccentric contractions. Consequently, the weakest sarcomeres 
surpass their yield point on the descending limb of the length-tension relationship and 
lengthen beyond the point of no myofilament overlap. During subsequent contractions, a 
number of sarcomeres fail to re-interdigitate, placing neighbouring sarcomeres under greater 
lengthening tension. Consequently, the next weakest sarcomeres surpass their yielding point, 
increasing the area of disrupted sarcomeres (Morgan, 1990). Morgan (1990) suggested that 
this process continues during subsequent active stretch, resulting in large areas of muscle 
damage.  
Although the principle of the popping sarcomere theory is appealing, its integrity has 
recently been questioned (Telley et al., 2006; Panchangam & Herzog, 2011). For example, 
following the attainment of maximal isometric force in rabbit psoas myofibrils, Telley et al. 
(2006) passively stretched the myofibrils 15-20% beyond resting length. Despite reporting 
non-uniform lengthening of sarcomeres, Telley et al. (2006) reported no evidence of 
sarcomeres lengthening beyond the point where no myofilament overlap occurred, 
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subsequently rejecting the popping sarcomere theory. The severity of the damage protocol 
used by Telley et al. (2006) however, is questioned due to the use of a activation solution 
(pCa 4.5) and uncertainty as to whether sarcomeres extended onto the descending limb of 
the length-tension relationship at all, which is necessary for investigating the popping 
sarcomere theory (Morgan & Proske, 2006). The aforementioned limitations may explain 
why Telley et al. (2006) did not see sarcomeres stretched to the point of no myofilament 
overlap (Morgan & Proske, 2006).  
 
Figure 1. 2: A) Schematic diagram of the length-tension relationship. B) Schematic diagram of 
myosin and actin overlap at different sarcomere lengths. The numbers in graph 2A) and 2B) 
A) 
B) 
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correspond to demonstrate the myosin and actin overlap at each stage of the length-tension 
relationship (Gordon et al., 1966).  
More recently in agreement with Morgan (1990), during active lengthening of isolated rabbit 
psoas myofibrils, Panchangam and Herzog (2011) reported that several psoas myofibrils were 
unable to re-interdigitate following active lengthening (sarcomere length > 4.0 m). 
However, Panchangam and Herzog (2011) still reported torque loss in myofibrils where no 
overstretched sarcomeres were reported, thus Panchangam and Herzog (2011) concluded 
that structural damage to myofibrils and the popping sarcomere theory per se do not fully 
explain EIMD.  
1.2.1.2. Is the popping sarcomere applicable in vivo? 
The popping sarcomere theory described as the initial stage of EIMD is predominately 
evidenced in situ and in vitro, however due to different muscle preparations, activation 
techniques and the magnitudes of fascicle lengthening used, the application to in vivo remains 
unclear. It is suggested that in vivo the tendon alters the degree of fascicle lengthening, 
resulting in the muscle fibres to contract predominately on and around the plateau region 
(optimal region) of the length-tension relationship (Austin et al., 2010; Hoffman et al., 2014; 
Butterfield & Herzog, 2005). For example recently, Hoffman et al. (2014) investigated 
gastrocnemius fascicle lengthening, the length-tension relationship and EIMD during in vivo 
backwards walking. Hoffman et al. (2014) reported that an 18% increase in gastrocnemius 
fascicle length resulted in several fascicles extending onto the descending limb of the length-
tension relationship but predominantly the fascicles contracted onto the ascending and 
plateau region. Therefore, the conclusion that the magnitude of gastrocnemius fascicle 
lengthening and maximal isometric voluntary contraction (MVC) torque loss were not 
significantly associated, and that a loss in MVC torque was reported despite fascicles 
predominantly contracting on the plateau region is inconsistent with the popping sarcomere 
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theory. From the findings of Hoffman et al. (2014) study however, it is impossible to discount 
whether weaker individual sarcomeres have lengthened onto the descending limb of the 
length-tension relationship, as result of heterozygous lengthening (Palmer et al., 2011), 
which would support the mechanism reported by the popping sarcomere theory. 
Although the mechanics of the popping sarcomere theory are plausible in vivo, 
potentially due to the role of the tendon, it appears that the magnitude of fascicle lengthening 
investigated in vivo is considerably smaller than those used in vitro and in situ (e.g. 125% in 
situ (Lieber & Friden, 1993) and 18% in vivo gait (Hoffman et al., 2014)) (Butterfield, 2010). 
Therefore although in vitro and in situ studies are necessary to understand the popping 
sarcomere theory and strain induced muscle damage, it may be difficult to directly 
extrapolate and apply these findings in vivo.  
The popping sarcomere theory is the preferable mechanism for the initial phase of 
EIMD but due to the complex role of tendon and fascicle lengthening during eccentric EIMD 
the data in vivo is not over whelming (Hoffman et al., 2014; Butterfield, 2010). 
1.2.1.3. Initial stage: Excitation-Contraction coupling  
Alternative to the popping sarcomere theory, the initial stage of EIMD has been attributed to 
failure of the E-C process (Ingalls et al., 1998; Warren et al., 1993b). The E-C process refers to 
an electric stimulus, typically an action potential that results in a mechanical response (see 
Costantin (1976) for a review). In brief the E-C process encompasses the following sequence. 
An action potential travels down to the neuromuscular junction, where acetylcholine is 
released into the synaptic cleft. The release of acetylcholine into the synaptic cleft alters the 
electrical impulse to a chemical stimulus, causing the opening of ion channels in the fibre 
membrane which depolarises and spreads the impulse to the transverse or T-tubules. 
Dihydropyridine receptors detect the depolarisation and trigger the opening of ryanodine 
receptors, resulting in an efflux of Ca2+ from the sarcoplasmic reticulum (SR) into the 
cytoplasmic concentration. Calcium finally interacts with troponin-C to initiate the muscle 
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contraction. Although damage to the E-C process could occur at any stage of the 
aforementioned sequence, it has predominately been attributed to a loss of sarcolemma 
integrity, shearing of the SR and / or t-tubles.  
To investigate whether damage occurs as a result of disruption to the E-C process, 
exogenous exposure to caffeine has been used (Warren et al., 1993b). Caffeine facilitates 
activation of fibres by bypassing E-C process and triggers Ca2+ release from the SR (Lüttgau & 
Oetliker, 1968). For example, in isolated mouse soleus muscle, Warren et al. (1993b) 
reported large differences in force loss following 20 eccentric contractions compared to 20 
isometric contractions (43% vs. 4%, respectively). When the muscle fibres were exposed to 
50 mM of caffeine post the 20 eccentric contractions, peak isometric tetanic force post 
damage was significantly increased by 118% (Warren et al., 1993b). The 118% restoration of 
force loss through exposure to exogenous caffeine suggests that EIMD occurs during the E-C 
process and not to structural properties of the muscle (Warren et al., 1993b). Following a 
review of the literature, Warren et al. (2001) suggested that ≥ 75% of tension lost during the 
first 32 hours post EIMD, can be ascribed to failure of the E-C process. Although these 
findings suggest the majority of damage is initiated through failure at the E-C process, it also 
insinuates that 25% of damage must be attributed to other mechanisms. Nevertheless, if 
failure during the E-C process is the primary event of EIMD it fails to explain, 1) why damage 
is prevalent on the descending limb of the length-tension relationship and 2) why a rightward 
shift in the length-tension relationship is found following EIMD (Proske & Morgan, 2001; 
Katz, 1939). Whereas the mechanisms associated with the popping sarcomere provides 
evidence to answer these question. 
It remains unexplained why eccentric damage would ‘target’ the E-C process first, 
then cause structural damage (Proske & Morgan, 2001). Through the strain and high force 
associated with eccentric contractions, it is plausible that damage initially occurs through the 
popping sarcomere theory (Proske & Morgan, 2001; Morgan, 1990), with damage to the E-C 
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process occurring almost immediately after or even concurrently to structural damage (Allen, 
2001). 
1.2.2. Stage two: Loss of Ca2+ homeostasis / autogenetic phase  
1.2.2.1. Loss of Ca2+ homeostasis 
Although it remains unclear whether EIMD is a resultant of initial damage to the structural 
integrity, E-C process or both, in the time frame of events post EIMD a subsequent loss of Ca2+ 
homeostasis is reported (Armstrong et al., 1991). 
As discussed previously, during the final stages of the E-C process Ca2+ is released out 
of the sarcoplasmic reticulum (Berchtold et al., 2000), increasing Cystolic Ca2+ levels 100 
times higher than resting Ca2+ levels (50 nM). Through Ca2+ channels and structural changes 
of the dihydropyridine receptor, Ca2+ is released into the muscle where Ca2+ binds to troponin 
on the thin filament to initiate a contraction (Catterall, 1991). Thus, Cytosolic free Ca2+ 
concentration is essential to muscle function as it exerts control over the initiation, time 
course and force of all muscle contractions (Catterall, 1991).  
At rest, to maintain Ca2+ within the physiological range, ATPase pumps transport Ca2+ 
across the cell membrane (Gissel, 2006; Berchtold et al., 2000). However, due to the large 
Ca2+ gradient differences between extracellular (1 mM Ca2+ (Gissel, 2006)) and intracellular 
Ca2+ levels (50 nM (Berchtold et al., 2000)), if the sarcolemma is damaged during EIMD, there 
is a rapid influx of Ca2+. Following eccentric contractions Ca2+ can enter the intracellular 
membrane through mechanical tears and / or through the opening of stretch-activated 
channels, resulting in a disruption to Ca2+ homeostasis (Zhang et al., 2012; Guharay & Sachs, 
1984). A loss of Ca2+ homeostasis occurs when Ca2+ levels exceed the physiological resting 
values (~50 nM) and the muscle’s transport systems are unable to buffer the Ca2+ influx 
(Berchtold et al., 2000; Armstrong, 1990). Once Ca2+ homeostasis is lost for a sufficient period 
of time, or elevated in specific components of the fibres, various Ca2+ activated degradative 
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mechanisms are activated, e.g. calpain, which initiates the start of the autogenetic phase 
(Gissel, 2006; Morgan, 1990).  
1.2.2.2. Autogenetic phase 
Once Ca2+ homeostasis is lost, the remaining sequences associated with the damaging process 
is irreversible (Armstrong et al., 1991; Verburg et al., 2005). The loss of Ca2+ homeostasis 
activates proteases and protolytic enzymes (Armstrong, 1990). For example, the influx Ca2+ 
post EIMD, activates the Ca2+ dependent protease, calpain, which has been suggested to 
explain the uncoupling of the E-C process post EIMD (Verburg et al., 2005).  
There are three types of calpain, -calpain, m-calpain and calpain-3 (Goll et al., 2003). 
The isoform of calpain that is activated however is dependent on the severity of the change in 
Ca2+ homeostasis, with low levels of Ca2+ (M) activating -calpain, whereas m-calpain is 
activated with higher levels of Ca2+ (mM). Calpain-3 is slightly different as it is sensitive to 
Ca2+ at submicromolar levels and is specific to the skeletal muscle (Belcastro et al., 1998; 
Allen et al., 2005). When Ca2+ homeostasis is lost, calpain mediates the proteolysis of titin 
(Huff-Lonergan et al., 1996; Lim et al., 2004). Titin, a large elastic protein which anchors the 
M line to the Z line, provides structural integrity of the myofibril (Verburg et al., 2005) and 
transmits force to the sarcolemma (Zhang et al., 2008). The role of calpain on EIMD has been 
evidenced through the use of calpain inhibitors such as leuptin (Verburg et al., 2005). 
Following exposure to 40 M of Ca2+ solution Verburg et al. (2005) reported that passive 
force in toad fibres was reduced by 69% however, when exposed to 1 mM of leuptin force 
was only reduced by 15%. Furthermore, Zhang et al. (2008) concluded, although they 
reported force loss to be significantly reduced when exposed to 100 M leuptin (44% to 31% 
torque loss), following exposure to leuptin however there was still a decrease in force 
reported. Although the findings of Zhang et al. (2008) and Verburg et al. (2005) suggest that 
EIMD is caused by loss of Ca2+ homeostasis, the influx of Ca2+ and the activation of calpain, it is 
apparent that it does not fully explain the force loss post EIMD. Although the loss of Ca2+ 
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homeostasis has been shown to activate Ca2+ dependent protease, which result in the 
proteolysis of structural proteins like titin, the proteolysis of such proteins has also been 
reported through eccentric strain (Verburg et al., 2005). For example, Verburg et al. (2005) 
reported that titin was most susceptible to proteolysis when toad fibres were stretched to 
twice the length of concentric contractions, suggesting mechanical strain also plays a role in 
proteolysis of structural proteins.  
1.2.3. Stage three: Phagocytic phase 
The phagocytic stage, also known as the inflammatory response, starts within one hour post 
EIMD (Figure 1. 3, (MacIntyre et al., 2001)). Neutrophils, macrophages and T-lymphocytes 
migrate through the circulation to the injured site via chemotaxis. Neutrophils are the first to 
infiltrate the cell and they contribute to the phagocytic phase in two ways, 1) they have a 
phagocytic function which degrades cellular debris and activates proteolysis and 2) 
neutrophils magnify the damage response through the releases of pro-inflammatory 
cytokines such as IL-6 and tumor necrosis factor-α (TNFα). The release of pro-inflammatory 
cytokines may cause further damage to surrounding tissue (Tidball, 1995; MacIntyre et al., 
2001), for example, when neutrophil infiltration was blocked the magnitude of muscle 
damage (denoted by cell membrane permeability) was reduced by 38% (Kyriakides et al., 
1999).  
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Figure 1. 3: The average time scale of peripheral immune cells following muscle damage. The 
extent of the immune response depends on the severity of the muscle damage (Smith et al., 
2008). 
In addition to the invasion of neutrophils, the invasions of phagocytic macrophages also play 
a major role in the breakdown of cellular debris (Smith et al., 2008). Unlike neutrophils, 
macrophages have different subtypes which invade the damaged area at different times, thus 
suggesting multiple functions of macrophages (Smith et al., 2008). In addition to the 
phagocytic role, macrophages have been suggested to promote muscle regeneration, 
specifically through the chemotaxis of satellite cells (Chazaud et al., 2003). It is clear that the 
inflammatory response is an almost immediate process which is essential to the damage 
process, however the primary role of neutrophils and macrophages remains inexact with a 
discourse between further injury or repair (Tidball, 2005). Although Armstrong (1990) 
describes the model of EIMD as a sequence of events, it is more than likely that the four 
stages over lap. It is essential to understand the fundamental mechanisms of EIMD to 
comprehend how they manifest through markers of EIMD. The current thesis has discussed a 
narrow explanation of the model of EIMD therefore caution must be taken when interpreting 
the basic schematic summary of EIMD presented in Figure  1. 4. 
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Figure 1. 4: Schematic diagram of the four stage model of exercise-induced muscle damage 
(EIMD) proposed by Armstrong (1990). Red lines indicate stages that may result in further 
damage. 
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1.3. Markers of exercise-induced muscle damage  
Although the fundamental process of EIMD is predominately reported at subcellular levels, 
the magnitude of EIMD can manifest itself through direct and indirect markers of EIMD 
(Warren et al., 1999). The severity of EIMD is evidenced directly by using muscle biopsies or 
indirectly through muscle swelling, muscle proteins in the blood (e.g. CK), reduction in MVC 
isometric torque production and muscle soreness (Warren et al., 1999). Indirect methods are 
commonly used in the literature due to direct methods being invasive, only providing a small 
sample and requiring a technique which may exacerbate the amount of EIMD (Roth et al., 
2000; Staron et al., 1992). Each marker of EIMD has a unique time frame of appearance and 
clearance following EIMD; therefore in order to understand the determinants of EIMD it is 
essential to understand the temporal characteristics of these measurable markers.  
1.3.1. Structural damage: Muscle biopsies 
To investigate the structural damage following EIMD, studies have used histological and 
ultrastructure analysis of muscle biopsies (typical muscle sample size 10-50 mg) (Friden et 
al., 1981). Within skeletal muscle, sarcomeres are enclosed by two Z-lines at the end of each 
sarcomere, which are organised in a square lattice (an example of square lattice can be seen 
in Figure 1. 6. However, following EIMD, broadening, smearing and total disruption of the Z-
lines has been reported (Figure 1. 6 (Takekura et al., 2001; Friden & Ekblom, 1983)). For 
example, Friden and Ekblom (1983) was one of the first groups to investigate muscle biopsies 
post EIMD in humans. Muscle damage was evidenced through streaming, broadening and 
disruption of the Z-lines, 1, 72 and 144 hours post backwards cycling (Friden & Ekblom, 
1983). Initially, Z-line disruption was reported on every third muscle fibre, then between 72 - 
144 hours, Z-line disruption was reduced to every tenth fibre (Friden & Ekblom, 1983). Thus 
structural damage is accepted to peak immediately post EIMD and slowly regress to baseline 
(Takekura et al., 2001; Friden & Ekblom, 1983). Although it is evident that structural damage 
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does occur post EIMD, it remains unclear whether it is a result of damage to the E-C process 
(e.g. through an activation of calpain) or due to the mechanical strain placed on the fibres 
(Zhang et al., 2008).  
 
 
Figure 1. 5: Schematic diagram of sarcomeres during A) resting and B) under contraction. a: 
thin filaments, m: thick filaments, z: Z-lines, d: desmin and t: titin. The dotted line resemble 
titin anchoring the Z-line to the thick filament, t2 represents titin lengthening during 
contraction. The dashed lines represent desmin linking adjacent Z-lines, d2 represents 
desmin under strain during contraction (adapted from Allen (2001)). 
Z-line streaming has been associated with the loss of two cytoskeletal proteins, desmin and 
titin (Barash et al., 2002; Zhang et al., 2008; Lieber et al., 1996). Desmin and titin are involved 
in the transverse and longitudinal filament structure, respectively (Luther, 2009; Horowits & 
Podolsky, 1987; Tskhovrebova & Trinick, 2002; Paulin & Li, 2004). Firstly, desmin anchors 
each Z-line to adjacent Z-lines and costameres found on the surface membrane, therefore any 
disruption to desmin can be expected to be evidenced at the Z-line (Magaudda et al., 2004). 
A) 
B) 
d2 
t2 
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For example, Lieber et al. (1996) reported ~23% loss in desmin staining 24 hours post 
eccentric exercise of the extensor digitorum longus. In an earlier study Lieber et al. (1994) 
reported a loss in desmin staining 24 hours post EIMD in rabbit extensor digitorum longus, 
before any increase in extracellular matrix protein fibronectin was reported. Therefore, a loss 
in desmin staining despite no change in fibronectin indicates that fascicle strain and not 
cellular disruption is responsible for the initial loss of desmin during eccentric EIMD (Lieber 
et al., 1994). Secondly, titin anchors the Z-line to the myosin filaments, which provides 
stability and plays an essential role in re-interdigitating sarcomeres following EIMD 
(Horowits & Podolsky, 1987; Tskhovrebova & Trinick, 2002). Following EIMD, a loss of 
irregular labelling of titin has been associated with Z-line disruption in muscle biopsies 
(Trappe et al., 2002). For example, following eccentric exercise in the lower limb Trappe et al. 
(2002) reported a 30% reduction in titin 24 hours post EIMD. The association between a loss 
of titin and EIMD could be explained by the popping sarcomere theory (Morgan, 1990). 
Whereby damage to titin during fascicle lengthening prevents sarcomeres from regaining 
normal shape, thus increasing the strain on surrounding sarcomeres (Figure 1. 5 (Trappe et 
al., 2002)). Furthermore, damage to titin, may reduce muscle stability and increases fibre 
compliance (Herzog, 2014), which may also explain the rightward shift in the length-tension 
relationship following EIMD (Allen, 2001). 
 It is clear that the use of muscle biopsies to measure structural damage and 
cytoskeletal protein response is the gold standard for measuring EIMD (Warren et al., 1999). 
The uncomfortable procedure and the potential of accentuating muscle damage through the 
sampling method has resulted in alternative markers of EIMD being used (Warren et al., 
1999).  
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Figure 1. 6: Longitudinal muscle biopsies of the human vastus lateralis (VL) before A) 48 
hours B) and 168 hours C) post exercise-induced muscle damage (EIMD) (Hortobágyi et al., 
1998). 
1.3.2. Loss of torque 
Post EIMD loss of isometric torque or isometric force is valued as one of the most reliable 
indirect markers of EIMD (Warren et al., 1999). Although conceptually different, the 
calculation of force reflects the inclusion of an external moment arm in the position of the 
force transducer during measurement of MVCs, whereas torque does not. Within the context 
of this literature review the functional marker of strength measured during maximal 
isometric contractions will be referred to as MVC torque and MVC force loss interchangeably. 
To ensure the measurement of MVC torque loss is reliable and valid however, several points 
need to be taken into consideration. Firstly, although, torque is directly proportional to force 
it is essential for measurements of torque to be performed at the same joint angle for a valid 
comparison between and within participants to be made (Byrne et al., 2001; Warren et al., 
1999). Secondly, torque is velocity dependent therefore to control for the confounding factors 
of shortening and lengthening velocities, isometric contractions should be used to measure 
MVC torque loss post EIMD.  
 Maximal voluntary torque loss is reported immediately post EIMD with a gradual 
return to pre-damage within 7-14 days (Brown et al., 1997; Clarkson et al., 2005; Byrne et al., 
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2001); however, in extreme cases, MVC torque loss has taken 47 days to fully recover (Sayers 
& Clarkson, 2001). The extended duration of MVC torque loss (> 1 hour) post EIMD enables 
torque loss to be attributed to muscle damage and not fatigue (Walsh et al., 2004). Post EIMD 
studies have reported peak MVC torque loss to range between 10-70% of pre-damage values, 
however the severity of torque loss depends on the type and intensity of the eccentric 
exercise (Brown et al., 1997). For example, downhill running results in MVC torque losses 
ranging from 10-30% (Eston et al., 1996), whereas isolated eccentric extensions of the elbow 
flexors report torque losses > 60% (Sayers & Clarkson, 2001). 
 In addition to torque loss post EIMD being a result of damage to the aforementioned 
contractile elements of the muscle (peripheral damage), MVC torque loss may be attributed 
to the reduction in neural drive from the brain to the contracting muscle (central 
mechanisms) (Hubal et al., 2007). For example, a reduction in neural drive can occur through 
a decrease in the motor neuron firing rate (Hubal et al., 2007; Sayers et al., 2003). Recently 
however, Hubal et al. (2007) reported similar neural functions (Electromyogram (EMG) and 
central muscle action potential) between high and low responders despite large variability in 
MVC torque loss post damage (MVC torque loss 49% and 23% respectively). Therefore, in 
agreement with recent work (Sayers et al., 2003), Hubal et al. (2007) concluded that torque 
loss is a result of difference in peripheral rather than neural mechanisms. The mechanisms of 
damage at the contractile muscle however, remain divided between the popping sarcomere 
theory and damage to the E-C process. 
As previously discussed the popping sarcomere theory describes the process of 
damage when fibres are stretched beyond the point of no myosin overlap (Morgan, 1990), 
which according to the length-tension relationship, results in loss of torque generation. 
Furthermore, sarcomere disruption can cause damage to contractile proteins which may 
further impede the muscles ability to contract (Herzog, 2014). Following subsequent 
contractions, the loss in torque through the popping sarcomere theory can be evidenced by a 
rightward shift in the length-tension relationship (Jakeman & Eston, 2013; Hoffman et al., 
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2014). A rightward shift in the length-tension relationship and greater torque loss at shorter 
muscle lengths represents an increase in fascicle length required to produce optimal torque, 
and lower myofilament cross bridge formation at the original optimal tension length 
(Jakeman & Eston, 2013; Byrne et al., 2001). Alternatively another well supported theory to 
explain MVC torque loss post EIMD is damage to the E-C process (Warren et al., 1993b). 
Damage to the E-C involves shearing of the t-tubules and SR. As discussed previously, 
evidence that caffeine reduces the magnitude of torque loss post EIMD, suggests that damage 
does occur to the E-C process (Warren et al., 1993b). Furthermore, the association between 
damage to the E-C process and torque loss has been evidenced through the reduction in both 
(JP1 and JP2) junctophilin proteins following eccentric contractions but not concentric 
contractions (Corona et al., 2010). Junctophilin proteins anchor the t-tubule membrane to the 
SR membrane, and are associated with Ca2+ release channels. Corona et al. (2010) reported a 
significant correlation between junctophilin proteins content post EIMD and loss in isometric 
torque post EIMD following eccentric exercise. Further research however, is required to 
understand which initial cause of EIMD can be associated with the prolonged torque loss post 
EIMD (Hyldahl & Hubal, 2014).  
Alternative methods (electrical stimulation) can be used to measure torque loss post 
EIMD to ensure that participants are contracting maximally, a caveat associated with MVC, 
however electrical stimulation can alter the recruitment pattern of muscle fibres reported in 
vivo (Crameri et al., 2007). Therefore, although the primary mechanisms for MVC torque loss 
remains unconfirmed, it is deemed and accepted the most representative indirect marker of 
muscle function and EIMD (Warren et al., 1999).  
1.3.3. Intracellular proteins: Creatine kinase 
Post EIMD due to structural damage to the sarcomeres or the E-C process; there is an 
increase in the detection of intracellular proteins within the blood. Myoglobin, troponin and 
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myosin heavy chains are several proteins which have been used as markers of EIMD, 
however, possibly due to its large response post EIMD, CK is the most investigated 
intracellular protein within EIMD research (Baird et al., 2012; Clarkson & Hubal, 2002; 
Sewright et al., 2008; Stupka et al., 2000). Creatine kinase has three tissue-specific 
isoenzymes, CK-BB (found in the brain), CK-MB (found in cardiac muscle) and the muscle 
specific CK, (CK-MM) (Baird et al., 2012; Dawson & Fine, 1967; Eppenberger et al., 1964). As 
the current thesis is focusing on the skeletal muscle, ‘CK’ will refer to the muscle specific 
isoform unless otherwise stated. Within the muscle 5-10% of CK is bound to the M-line 
(Hornemann et al., 2003), therefore post EIMD CK within the blood, represents structural 
damage and an accompanying loss of muscle membrane permeability. 
Similar to MVC torque loss, the severity and timeframe of the CK response is 
dependent on the type of exercise. Downhill running results in the quickest, but lowest CK 
response, with peak CK attained within 24 hours and CK values ranging from 100-900 U/L 
(Sorichter et al., 2001; Malm et al., 2004); whereas with isolated unilateral, maximal eccentric 
contractions, CK peaks between 3-6 days, with peak CK values between 100-1000 U/L 
(Hyldahl et al., 2011; Stupka et al., 2001). The greatest increase in CK however, is reported 
following upper body exercise and bilateral eccentric exercise, where CK peaks 4-6 days post 
EIMD with CK >2000 U/L (Sewright et al., 2008; Saka et al., 2009; Clarkson et al., 1992). 
However, caution needs to be taken when measuring average CK within and between groups 
as the CK can demonstrate large within participant variability (Hyldahl et al., 2011). The 
determinants of this large variability in the CK response has yet to be determined (Warren et 
al., 1993a; Chrismas et al., 2014). 
The large variability with CK has resulted in scepticism regarding CK as a structural 
measure of EIMD (Baird et al., 2012; Friden & Lieber, 2001; Komulainen et al., 1995; 
Chrismas et al., 2014). For example, an increase in CK despite no damage reported at the 
sarcolemma or the Z-line (Costa et al., 2009; Yu et al., 2002), and, a lack of correlation 
between Z-line disruption (Stupka et al., 2000) and torque loss (Friden & Lieber, 2001; Lieber 
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et al., 1994) with CK, questions CK as a structural marker of EIMD. Regardless, an influx in CK 
does represent an extracellular expression of an intracellular protein, and is widely used as a 
marker of EIMD (Warren et al., 1999). It is not possible to decipher however, whether an 
increase in CK represents a change in cell membrane permeability or the magnitude of 
structural damage. Therefore, CK data should be considered as a quantitative measure of 
EIMD with the caveat in mind that any increase may be due to either a loss of membrane 
stability or disruption to the contractile proteins. 
1.3.4. Muscle soreness 
Muscle soreness otherwise known as ‘delayed onset muscle soreness’ (DOMS) is a sensation 
of pain or discomfort following exercise (Armstrong, 1984). Muscle soreness is measured 
using a visual analogue scales (VAS), which typically ranges from 0 (no soreness at all) to 10 
(very, very sore). Although the measure of muscle soreness using the VAS scale is subjective, 
it is a reliable (inter class correlation (ICC) 0.95 – 0.98) method of measuring muscle soreness 
(Bijur et al., 2001). The validity of muscle soreness however remains in question, Nosaka et 
al. (2002) reported significant correlations, albeit weak, between muscle soreness and peak 
CK (r = 0.23) or MVC torque loss (r = -0.27). The negative correlation between muscle 
soreness and MVC torque loss however, is opposite to what physiologically would be 
expected (i.e. greater muscle soreness = greater MVC torque loss), therefore raising further 
questions regarding the validity of muscle soreness as an indicator of EIMD (Nosaka et al., 
2002). Using VAS and measuring soreness during extension, rather than flexion, improves the 
correlation with other markers of EIMD, although the correlations remain weak (Nosaka et 
al., 2002). Despite poor validity with other markers of EIMD, muscle soreness consistently 
peaks 24-48 hours post EIMD and subsides 7-10 days post EIMD (Cleak & Eston, 1992; 
Howell et al., 1993; Clarkson et al., 1992; Savage & Clarkson, 2002). Similar to other markers 
of EIMD, the severity of muscle soreness depends on the type of eccentric exercise, for 
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example downhill running causes lower muscle soreness scores compared to dynamometer 
based, single joint muscle contractions (Clarkson & Hubal, 2002).  
Although muscle soreness may be seen as the most familiar marker of EIMD with 
participants, the aetiology of muscle soreness remains unclear. Armstrong (1984) proposed a 
four-stage model to describe the aetiology of muscle soreness. The proposed stages are, 1) 
Damage to structural proteins. 2) Loss of Ca2+ homeostasis and the activation of proteolytic 
enzymes. 3) Invasion of monocytes and macrophages. 4) Activation and sensitisation of 
nociceptors. When initially proposed, Armstrong (1984) model of muscle soreness was 
mainly hypothetical, however it is now proposed that these four stages work in concert. 
Recently there has been evidence to suggest that noxious substances released following 
EIMD, contribute to the sensation of muscle soreness. By altering the administration time of 
antibodies, i.e. before or after eccentric exercise, the timeline of noxious substances can be 
calculated (Nie et al., 2009; Murase et al., 2010). For example, Murase et al. (2010) found that 
hyperalgesia (muscle soreness) was completely prevented in mice, when a bradykinin 
antibody was administered 30 minutes prior to eccentric exercise. Interestingly, when the 
bradykinin antibody was administered post EIMD no effect on muscle soreness was reported 
(Murase et al., 2010). Therefore Murase et al. (2010) concluded bradykinin is involved in the 
primary onset of muscle soreness but does not explain a delayed response in peak muscle 
soreness post EIMD. Additionally, the importance of nerve growth hormone and muscle 
soreness was evidenced when Murase et al. (2010) administered an antibody for the nerve 
growth hormone post EIMD which completely attenuated muscle soreness. Further evidence 
put forward to support the role of the nerve growth hormone on muscle soreness is the fact 
that the up regulation of nerve growth hormone post EIMD is 12 hours and can last up to 48 
hours, which coincides with the time response of muscle soreness (Murase et al., 2010). 
Murase et al. (2010) concluded that bradykinin initiates muscle soreness whereas nerve 
growth hormone maintains muscle soreness post EIMD. 
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It is apparent that eccentric exercise causes structural and metabolic damage, which results 
in disruption to, contractile properties, structural integrity and muscle function. It is evident 
however, that the response to EIMD varies between groups and individuals. In order to 
discuss and understand these group differences, it is necessary to understand the 
determinants of EIMD.   
1.4. Determinants of exercise-induced muscle damage 
The previous section has described the typical response of direct (Z-line smearing) and 
indirect (loss of force, CK release and muscle soreness) markers of EIMD. The timeframe and 
response to EIMD using direct and indirect markers of EIMD is well investigated within the 
literature however, an understanding for the variability in the response remains unclear. For 
example, post EIMD participants have been categorised into high and low responders for 
MVC torque loss (Hubal et al., 2007) and the CK response (Brancaccio et al., 2007), 
furthermore, group differences have been reported between children and adults (Marginson 
et al., 2005), and males and females (Joyce et al., 2014). The next sections of the literature 
review will discuss some of the suggested determinants of EIMD.  
1.4.1. High strain versus high torque 
During eccentric contractions the muscle produces high torques whilst lengthening, however 
it remains unclear which, if any, of these characteristics are the main determinant of EIMD. 
By independently manipulating the level of strain and torque during eccentric contractions 
authors have investigated the effects on markers of EIMD.  
1.4.1.1. Fascicle strain 
Fascicle strain, denoted by fascicle lengthening, has been described as a determinant of EIMD 
in situ (Lieber & Friden, 1993; Talbot & Morgan, 1998). For example, using isolated tibialis 
anterior muscle in rabbits, Lieber and Friden (1993) categorised eccentric contractions into 
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two groups, either high strain or low strain (125% and 112.5% respectively). Following 900 
eccentric stretches Lieber and Friden (1993) found significantly higher force loss when the 
tibialis anterior was stretched 125% compared to 112.5% of optimal muscle length. Thus, 
Lieber and Friden (1993) concluded that strain was the main determinant of EIMD. 
Alternatively, in vitro Warren et al. (1993a) investigated the role of fascicle strain (110, 120 
and 130% of muscle length at maximal isometric tetanic tension) during five eccentric 
contractions of rat soleus muscle. Warren et al. (1993a) concluded that there was no 
association between fascicle strain and markers of EIMD between the different strain levels. 
The discrepancies between the two studies may be attributed to a couple of reasons; firstly to 
the volume of eccentric contractions used within the two studies was substantially different 
(900 versus five, respectively). Secondly, due to fascicle lengths not being measured directly 
in either study, and estimated as a percentage of MTU lengthening, the true fascicle 
lengthening may have been under or overestimated in the studies. Although, the theory of 
fascicle strain being associated with EIMD fits well with the mechanisms proposed by the 
popping sarcomere theory (Morgan, 1990), evidence supporting strain as a determinant of 
EIMD remains inconclusive.  
 As described previously, the role of strain has been investigated in vitro and in situ 
however, it is difficult to extrapolate and apply these findings in vivo (Butterfield, 2010). 
Firstly, in vitro and in situ preparations typically involve the removal of or a reduction in the 
contribution of the in series compliance of the MTU. In vivo the tendon has been reported to 
play an essential role in muscle contractions and has been suggested to alter fascicle 
lengthening (Lichtwark & Wilson, 2007; Finni et al., 2001), peak fascicle torques (Roberts & 
Azizi, 2010) and potentially attenuate EIMD (Roberts & Konow, 2013; Joyce et al., 2014; 
McHugh et al., 1999). Therefore, in vivo MTU behaviour is not directly replicated by in situ 
and in vitro studies (Butterfield, 2010). Secondly, fascicle strains used in situ and in vitro are 
considerably larger than those reported in vivo. For example in situ studies have investigated 
fascicle strains of 125% whereas in vivo during backwards walking peak fascicle lengthening 
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has been reported to be as small as 18% of gastrocnemius fascicle length at peak isometric 
MVC. Finally as mentioned previously, due to either the role of the tendon, the reduced 
fascicle lengthening or an interaction between the two, the popping sarcomere theory may 
not fully explain EIMD in vivo. For example, Hoffman et al. (2014) are the first group to 
investigate whether gastrocnemius fascicle lengthening during a backwards walking protocol 
was a determinant of EIMD in vivo. Hoffman et al. (2014) reported that several fascicles did 
lengthen onto the descending limb of the length-tension relationship, however due to the 
Achilles tendon accounting for ~90% of the MTU lengthening, the majority of fascicles 
contracted onto the ascending and plateau region of the length-tension relationship. The 23% 
reduction in MVC torque loss could not be explained by fascicle lengthening, thus Hoffman et 
al. (2014) suggested that, due to the role of the tendon the popping sarcomere theory may 
not explain EIMD in vivo. It cannot be discounted however, that the loss in torque may be 
attributed to the lengthening of sarcomeres being heterozygous along a fibre (Palmer et al., 
2011). As a result of heterozygous lengthening, it remains possible that individual 
sarcomeres may have been extended onto the descending limb of the length-tension 
relationship thus adhering to the mechanisms of the popping sarcomere theory. 
Compared to other types of eccentric exercise, backwards walking results in the low 
levels of EIMD, thus a more vigorous damaging protocol is required in vivo to establish 
whether, 1) fascicle strains used in vitro and in situ are comparable in vivo and, 2) whether 
greater fascicle strain in vivo, denoted by fascicle lengthening, is a determinant of EIMD 
(Hoffman et al., 2014). 
1.4.1.2. High torque 
It is well accepted that eccentric contractions can produce high torques (Katz, 1939), it 
remains unclear however, whether eccentric torques can explain differences in EIMD. For 
example, by delaying the timing of stretch (200 ms and 0 ms) in rabbit tibialis anterior, 
Lieber and Friden (1993) investigated the effect of high and low forces (respectively) on 
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muscle damage. Following 900 eccentric stretches, Lieber and Friden (1993) reported no 
significant differences in markers of EIMD between high and low eccentric forces. As 
mentioned previously, Lieber and Friden (1993) reduced the compliance of the MTU by 
applying the forces directly to the muscle. Therefore, due to the mediating role of the tendon 
on peak force and peak torque (Roberts & Azizi, 2010; Roberts & Konow, 2013), it is difficult 
to apply Lieber and Friden (1993) findings in vivo. In agreement with Lieber and Friden 
(1993) however, Chapman et al. (2008) was the first group to investigate whether in vivo 
eccentric torque correlated with any markers of EIMD in the elbow flexors. In agreement 
with previous work (Talbot & Morgan, 1998; Lieber & Friden, 1993), Chapman et al. (2008) 
reported no correlation between markers of EIMD (MVC torque loss or CK) and eccentric 
torque (averaged over 10 sets of 6 maximal eccentric elbow contractions) in vivo. The 
findings of Chapman et al. (2008) appear to disagree with those reported by Warren et al. 
(1993a). Warren et al. (1993a) manipulated force levels and investigated forces 100%, 125% 
and 150% of peak isometric force. Warren et al. (1993a) found a significant linear 
relationship between eccentric torque and torque loss post EIMD, however this linear 
relationship was lost when eccentric torque was below ~113% of isometric torque. It is 
concluded that the yield strength of a muscle fibre is above 113% of maximal isometric torque 
(Warren et al., 1993a; Hasselman et al., 1995) in animals. Interestingly, when Chapman et al. 
(2008) expressed the eccentric torque as a percentage of pre-damage isometric torque, 
eccentric torque was 94% of pre-damage isometric torque. Therefore, when eccentric torque 
is made relative to isometric torque, the findings of Chapman et al. (2008) do support those 
reported by Warren et al. (1993a). It remains in question however, if eccentric torque in vivo 
can go beyond the suggested yield threshold, and if so, is eccentric torque is a determinant of 
EIMD?  
1.4.2. Tendon as a determinant of exercise-induced muscle damage 
32 
 
Previously the compliance of the MTU has been suggested to explain group differences in 
EIMD (McHugh et al., 1999; Marginson et al., 2005); however, it remains to be evidenced 
experimentally. Due to the tendon’s ability to engage energy at initial impact and therefore 
reduce or delay the energy being absorbed by the muscle, the tendon has commonly been 
referred to as a mechanical buffer (Roberts & Azizi, 2010; Griffiths, 1991; Reeves & Narici, 
2003). Although, due to its ability to alter the storage and timing of energy release, the term 
‘capacitor’ has been suggested as a more accurate description of the tendon (Roberts & 
Konow, 2013). However, because the term is more consistent with the passive absorption of 
energy during eccentric contractions (rather than rebound plyometric contractions), within 
the current thesis the tendon will be referred to as a ‘buffer’. Although the tendon has been 
suggested to act as a mechanical buffer during eccentric contractions (Roberts & Azizi, 2010; 
Griffiths, 1991; Reeves & Narici, 2003), the role of the tendon in association with EIMD has 
yet to be established in vivo.  
 
 
Figure 1. 7: Schematic example of a stress-strain curve demonstrating the mechanical 
properties of tendon (Wang, 2006).  
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1.4.2.1. Measuring tendon properties  
Collagen, predominantly type 1 collagen, forms 65-85% of the tendon, with 1-2% elastin 
(O'Brien, 1997). Within the tendon collagen fibrils cross over each other creating plaits and 
spirals to form a collagen fibre, which is the basic structure of a tendon (Jozsa et al., 1991). 
Under light microscope, the collagen has a wavy configuration, otherwise known as the 
crimped region, which can explain the toe region of the stress-strain relationship (Figure 1. 
7). When the tendon is stretched, due to the straightening of the collagen, the crimped region 
is lost, however if the stretch remains below 4% the crimped region will be regained upon 
relaxation (Rigby et al., 1959). Previously it was anticipated that if the stretch exceeds 8% the 
tendon would rupture, however in vitro it has been established that strains of >14% can be 
obtained without rupture in chicken tendons (Devkota & Weinhold, 2003) and human patella 
tendons (Johnson et al., 1994). The strength of the tendon is indicated by the collagen content 
and the size of the tendon. The tendon’s tensile strength can be calculated, independent of 
cross-sectional area, by dividing tendon stress (tendon force divided by tendon cross-
sectional area) by tendon strain (ratio of tendon lengthening to tendon length) and is 
expressed as Young’s modulus (Maganaris & Paul, 1999). Although the higher the Young’s 
modulus the ‘stiffer’ the tendon, this equation does not calculate tendon stiffness. Tendon 
stiffness is calculated as tendon force divided by change in tendon length. Unlike Young’s 
modulus however, tendon stiffness does not take into consideration tendon size or length. 
Previously the viscoelastic properties of the tendon have been measured indirectly by 
either the ‘α method’ (Morgan, 1977) or the spindle null-point’ method (Rack & Westbury, 
1984). However, with the introduction of real time imaging techniques, Fukashiro et al. 
(1995) used ultrasound to directly measure tendon properties in vivo. During a ramped 
isometric dorsiflexion contraction, Fukashiro et al. (1995) used the ultrasound to record the 
movement of the tibialis anterior tendon. Further research has established that total tendon 
strain is under estimated by 38-45% if tibial movement is not account for (Onambélé et al., 
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2007; Hansen et al., 2006). Therefore to measure total tendon elongation, patella tendon 
elongation at the distal and proximal end of the tendon needs to be recorded (Onambélé et 
al., 2007; Hansen et al., 2006). Additional measurements, including tendon moment arm, 
antagonist co-activation, tendon cross-sectional area, and tendon length, are required to 
calculate tendon force, tendon compliance and Young’s modulus (Maganaris & Paul, 1999). 
What is more, the introduction of imaging technique has allowed for an in vivo understanding 
of tendon compliance and how it interacts in series with the muscle during functional 
movements (Fukunaga et al., 2001), and more specifically to this thesis how it may impact on 
eccentric contractions and the associated EIMD. 
1.4.2.2. Tendon as a mechanical buffer 
The role of the tendon is multifaceted and depends on what movement is being carried out. 
For example, during counter-movement jumps, the tendon has been reported to slowly 
absorb energy and then rapidly release energy (Aerts, 1998; Kawakami et al., 2002), whereas 
during gait (walking and running) the tendon has been reported to reduce the degree of 
fascicle lengthening thus reducing metabolic work and improve the metabolic efficiency of 
gait (Fukunaga et al., 2001; Roberts et al., 1997; Lichtwark & Wilson, 2007).  
Historically it has been assumed that fascicles follow similar lengthening patterns to 
the tendon and the MTU during eccentric contractions, however recent evidence disproves 
this assumption (Fukunaga et al., 2001). For example, during the eccentric phase of gait and 
stair decent the gastrocnemius medialis fascicles have been reported to contract quasi-
isometrically (Fukunaga et al., 2001) and shorten (Spanjaard et al., 2007), respectively 
despite a lengthening of the MTU. Although the differences in fascicle lengthening may be 
attributed to the different foot placements required during gait (heel contact) and stair 
descent (toe contact), both Spanjaard et al. (2007) and Fukunaga et al. (2001) concur that 
lengthening of the MTU occurs mainly at the tendon during eccentric contractions. Due to the 
majority of MTU lengthening occurring at the tendon, rather than the fascicles, the tendon 
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has been suggested to act as a mechanical buffer during eccentric contractions (Reeves & 
Narici, 2003; Roberts & Azizi, 2010; Roberts & Konow, 2013; Lichtwark & Wilson, 2007). For 
example, Lichtwark and Wilson (2007) used a three element Hill muscle model to estimate 
the effect of increasing Achilles tendon stiffness by 0.5, 1, 2, and 4 times above previously 
measured average Achilles tendon stiffness (Lichtwark & Wilson, 2006). Lichtwark and 
Wilson (2007) calculated that during the eccentric phase of gait, gastrocnemius medialis 
fascicle lengthening increased with an increase in tendon stiffness, despite no change in total 
MTU lengthening. Therefore, Lichtwark and Wilson (2007) concluded that the tendon does 
act as a mechanical buffer on fascicle lengthening. However, the model used by Lichtwark and 
Wilson (2007) assumed tendon stiffness to be linear despite the previously reported ‘toe 
region’ in tendon stress-strain properties (Figure 1. 7), thus this may result in an under 
estimation of fascicle shortening during eccentric contractions, particularly at low forces. 
Although the findings of Lichtwark and Wilson (2007) have yet to be established in vivo, 
group differences in fascicle lengthening have been suggested, although not measured, to 
differences in tendon properties. For example, despite the same MTU lengthening during the 
eccentric stance phase of gait, Mian et al. (2007) attributed differences in fascicle lengthening 
to differences in tendon properties between the elderly and young. Mian et al. (2007) 
explained the lower fascicle lengthening in the elderly compared to the young, to higher 
tendon stiffness in the young. However, Mian et al. (2007) did not measure tendon stiffness 
within or between the two groups. Therefore, it remains unknown whether in vivo tendon 
stiffness does act as a mechanical buffer on fascicle lengthening, and explain group 
differences in fascicle lengthening behaviour.  
In addition to the tendon being suggested to act as a mechanical buffer on fascicle 
lengthening during eccentric contractions, the tendon has also been suggested to mediate the 
degree of peak force and torque transmitted to the fascicles (Roberts & Azizi, 2010). For 
example, using turkey gastrocnemius, Roberts and Azizi (2010) found the peak power input 
during MTU lengthening was significantly lower at the fascicles compared to the MTU. 
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Furthermore, Roberts and Azizi (2010) found the negative work done by the fascicles during 
the force rise of muscle lengthening contractions was significantly lower than that of the 
MTU. Thus, the tendon accounted for the differences in negative work between fascicles and 
the MTU. Roberts and Azizi (2010) concluded, the tendon attenuates peak power, energy and 
decouples fascicle lengthening from MTU lengthening, which may serve to protect the muscle 
from high forces during eccentric contractions (Roberts & Azizi, 2010; Roberts & Konow, 
2013).  
As discussed previously, it remains unknown whether EIMD can be attributed to the 
high strain or high stress of eccentric contractions, however it appears that the tendon may 
act as a mediator of both high stress and high strain (Roberts & Azizi, 2010; Roberts & 
Konow, 2013). Therefore tendon properties have been suggested to act as a determinant of 
EIMD (Marginson et al., 2005; Roberts & Azizi, 2010; Roberts & Konow, 2013). Previous 
studies have attributed group differences in EIMD to the flexibility of the MTU as an entity. 
For example, Marginson et al. (2005) reported that young boys experienced significantly 
lower levels of EIMD compared to adult men following repeated maximal plyometric jumps. 
Marginson et al. (2005) attributed the reduced muscle damage to greater MTU flexibility in 
the boys compared to men. Furthermore, in an earlier study McHugh et al. (1999), reported 
that muscle damage in the hamstring was significantly higher in participants with stiffer 
hamstring MTU compared to those with a more compliant hamstring MTU. Applying the 
popping sarcomere theory proposed by Morgan (1990), both Marginson et al. (2005) and 
McHugh et al. (1999) suggested that EIMD may be lower in compliant participants due to a 
reduction in fascicle strain. However, neither McHugh et al. (1999) or Marginson et al. (2005) 
measured tendon stiffness, thus it remains unknown whether the tendon can act as a 
determinant or explain group differences in EIMD. 
1.4.3. Oestrogen as a determinant of exercise-induced muscle damage 
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1.4.3.1. Oestrogen as an antioxidant 
Before discussing oestrogen as a determinant of EIMD, an understanding of oestrogen 
structure and its antioxidant properties needs to be established. Oestrogen is a group of 18-
carbon steroids, which are mainly secreted from the female ovaries, with smaller quantities 
secreted by the adrenal glands (Kendall & Eston, 2002). Despite oestrogen being 
predominately a female sex hormone, small quantities, albeit significantly lower than 
females, are secreted from male testes and adrenal glands (Velle, 1966). Oestrogen is an 
umbrella term for estradiol-17b, estrone and estriol. Although all three types of oestrogen are 
structurally similar, estradiol-17b is most commonly investigated because it is the most 
abundant form of oestrogen (Kendall & Eston, 2002). Oestrogen has three properties that 
have been associated with attenuating EIMD (Figure 1. 8). Firstly, oestrogen has been 
reported to have a high antioxidant capacity (Tiidus, 1995; Ayres et al., 1998; Sugioka et al., 
1987). Oestrogen displays a hydroxyl group on their phenolic ring in a similar configuration 
as vitamin E, another well-known antioxidant (Tiidus et al., 2001; Traber & Stevens, 2011). 
Although it remains unclear how oestrogen limits lipid peroxidation, it is suggested that 
oestrogen donates the hydrogen atom from its a-phenolic ring to lipid peroxy radicals 
(Sugioka et al., 1987; Ayres et al., 1998; Badeau et al., 2005). The donation of the hydrogen 
atom prevents the hydroxyl radical attacking the polyunsaturated fatty acids in the cell 
membranes and subsequently maintaining cell membrane stability (Kendall & Eston, 2002). 
Secondly, oestrogen has been reported to decrease membrane fluidity and in turn increases 
membrane stability (Wiseman et al., 1993). Oestrogen is lipophilic therefore, it intercalates 
into the bilayer of the cell membrane. It is this interaction between oestrogen and membrane 
phospholipids which is suggested to decreases cell membrane fluidity and increase the 
stability of the membrane (Wiseman et al., 1993). Wiseman et al. (1993) reported a positive 
association between oestrogen’s antioxidant ability and decreased membrane fluidity. 
Wiseman et al. (1993) concluded that the hydrophobic rings of oestrogen may interact with 
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the poly-unsaturated residues within the phospholipid layer, thus decreasing membrane 
fluidity and stabilising the membrane against peroxidation. Thirdly, oestrogen has been 
reported to have a gene regulatory effect (Ghisletti et al., 2005). Oestrogen has been found to 
inhibit nuclear factor kappa beta intracellular transport (central mediator of the immediate 
inflammatory response), thus preventing inflammatory gene transcription (Ghisletti et al., 
2005). By reducing the inflammatory process (Silvestri et al., 2003), oestrogen may allay 
further damage by attenuating the infiltration of neutrophils and cytokines (MacNeil et al., 
2011). Although the primary role of oestrogen as an antioxidant remains unclear, it is clear 
that through the several mechanisms descried above and presented in Figure 1. 8, levels of 
oestrogen may act to attenuate EIMD.  
 
 
Figure 1. 8: The interaction between oestrogen and exercise-induced muscle damage (EIMD) 
(Kendall & Eston, 2002). 
39 
 
1.4.3.2. Muscle damage and oestrogen 
To establish whether oestrogen may attenuate EIMD, oestrogen levels have previously been 
manipulated either experimentally or through group comparisons. For example, Bär et al. 
(1988) reported that ovariectomised female rats demonstrate the same CK response as male 
rats however, the CK response in both males and ovariectomised females can be diminished 
following oestrogen supplements prior to exercise. Bär et al. (1988) concluded that oestrogen 
attenuates the leakage of muscle proteins by stabilising cell membrane permeability. 
Interestingly the level of protection has been reported to depend on what age the 
ovariectomy is performed (Amelink et al., 1988). For example, female rats that were 
ovariectomised before reaching sexual maturity resulted in greater damage compared to 
female rats ovariectomised after reaching sexual maturity (Amelink et al., 1988). This 
indicates that in addition to an acute protective mechanisms (Bär et al., 1988), oestrogen may 
also provide a long term protective mechanism to EIMD (Amelink et al., 1988). It may be 
speculated that the acute role may be attribute to the antioxidant and membrane stabilising 
properties of oestrogen, whereas the long term may reflect an additional protective 
mechanism through the role of oestrogen on the tendon, however there is no systematic 
evidence to support this. 
Contrasting the data showing an influence of oestrogen on EIMD, Moran et al. (2007) 
reported oestrogen supplementation did not attenuate EIMD. Ovariectomized mice were 
separated into three groups one group consumed 0.18 mg of oestrogen for either 30 or 60 
days, whereas the other groups received either a placebo or no treatment. Following 10 
eccentric contractions of the soleus in vitro, Moran et al. (2007) reported no significant 
difference in MVC isometric force loss or membrane damage (assessed by Lactate 
Dehydrogenase levels) following EIMD regardless of oestrogen levels. Moran et al. (2007) 
concluded oestrogen supplementation did not alter markers of EIMD. Furthermore the lack of 
difference between the loss of membrane damage, contradicts the theory of oestrogen acting 
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as a membrane stabiliser. It must be noted that Moran et al. (2007) only investigated the 
acute damage response for 30 minutes post EIMD, therefore the protective effect of oestrogen 
may have been missed.  
The methods used to manipulate oestrogen levels within animal studies 
(ovariectomizes) are difficult to replicate in humans. Alternatively in vivo oestrogen can be 
manipulated in several ways, 1) natural fluctuations of oestrogen throughout the menstrual 
cycle, 2) damage comparisons between males and females, and 3) the use of synthetic 
hormones (hormone replacement therapy (HRT) or the OCP). The following section will 
discuss the role of the OCP on EIMD.  
1.4.3.3. The oral contraceptive pill 
Within females, oestrogen is heavily involved with the menstrual cycle. The menstrual cycle 
(from first menses to the next menses) last 28 days and occurs repeatedly from menarche 
(median age 13 years, (Whincup et al., 2001)) and ceases post menopause (aged ~51 years 
(Rosner & Colditz, 2011)). The menstrual cycle can be divided into three phases, the follicular 
phase, ovulation and the luteal phase (Maki et al., 2002). Oestrogen levels fluctuate 
throughout the menstrual cycle: Low levels of oestrogen are reported in the mid follicular 
phase (~175 pg/ml) oestrogen then peaks pre-ovulation (day 14 ± 1, ~510 pg/ml), and 
slowly decreases throughout the luteal phase (day 14-28, mid luteal ~336 pg/ml) (Eiling et 
al., 2007). The natural fluctuations in oestrogen can be manipulated using synthetic 
hormones, specifically the OCP (Bryant et al., 2008) or reverted using HRT (Dieli-Conwright 
et al., 2009).  
According to the National Survey for Family Growth, the OCP is the leading form of 
hormone contraception, with 10.7 million women using the OCP (Mosher & Jones, 2010). The 
OCP is a combination of synthetic oestrogen and progesterone hormones, and is taken either 
continuously (taken for the whole 28 day cycle) or cyclical (21 days pill, seven days pill free), 
the cyclical method however has been associated with ovarian rebound activity (Schlaff et al., 
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2004). Ovarian rebound activity is where oestrogen levels peak after the seven day free 
period (Schlaff et al., 2004). Regardless of the type of OCP being used it has the same main 
effect, of attenuating oestrogen levels throughout the menstrual cycle (Schlaff et al., 2004). 
During a normal cycle, the hypothalamus secretes Gonadotropins-releasing hormone, which 
in turn stimulates the release of follicle stimulating hormone (FSH) and luteinising hormone 
(LH) (Silberstein & Merriam, 2000). Through negative feedback, the OCP alters the 
hypothalamic-pituitary-ovarian feedback loop subsequently reducing the secretion of FSH 
and LH and preventing follicular development (ovulation) (for a review see (Rubinstein et al., 
1978; Van Heusden & Fauser, 2002). Within OCP users oestrogen levels increase twofold 
during the menstrual cycle and then plateau, whereas within non-users oestrogen levels 
increase fourfold and fluctuate (Yeung et al., 2012; Endrikat et al., 2002). Thus OCP users 
have significantly lower levels of endogenous oestrogen and progesterone levels compared to 
non-users (Bryant et al., 2008; Fleischman et al., 2010; Kuhl et al., 1985). Therefore, if 
oestrogen does attenuate EIMD, a difference in EIMD between non-users and OCP users may 
be expected.  
Although within animal studies, the role of oestrogen on EIMD has been evidenced 
through ovariectomies, the role of oestrogen on EIMD is not as compelling when using the 
OCP within human studies. For example, no difference in EIMD between OCP users and non-
users has been concluded following eccentric stepping (Thompson et al., 1997) and eccentric 
contractions of the elbow flexors (Savage & Clarkson, 2002; Sewright et al., 2008). 
Alternatively, following eccentric knee extensions Joyce et al. (2014) reported the CK 
response and the rightward shift in optimal knee angle post EIMD to be significantly greater 
in female OCP users compared to female non-users. The discrepancies within human studies 
may be attributed to several reasons, 1) different measurement days, specifically with 
markers of EIMD not being measured at their peak (i.e. Joyce et al. (2014) measured CK 24 
hours post EIMD, rather than 96 hours). 2) Different markers of EIMD being investigated, for 
example MVC torque loss was not measured by Joyce et al. (2014). 3) Due to the different 
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damage responses in upper and lower limbs (Chen et al., 2011; Saka et al., 2009), it is difficult 
to compare the role of the OCP and oestrogen when comparing studies using different muscle 
groups.  
Future studies are required to establish whether 1) oestrogen levels are a 
determinant of EIMD and 2) whether women taking the OCP are more susceptible to EIMD.  
1.5. Group differences in exercise-induced muscle damage 
The following section will discuss group differences in EIMD and potential mechanisms that 
may explain the reported group differences. 
1.5.1. Sex differences 
A large variability in markers of muscle damage following eccentric contractions is accepted 
however, it still remains unclear whether a sex difference in EIMD exists. Within animals, 
males are reported to have higher values of markers for EIMD compared to females (Clarkson 
& Hubal, 2002; Komulainen et al., 1999) however; within human studies it remains 
inconclusive. Human studies have evidenced (Borsa & Sauers, 2000; Sewright et al., 2008; 
Wolf et al., 2012; Joyce et al., 2014) or refuted (Rinard et al., 2000; Stupka et al., 2000; 
Dannecker et al., 2012) sex differences in EIMD.  
 Following eccentric exercise in the lower limbs (36 unilateral leg press and 108 
unilateral knee extensions), Stupka et al. (2000) investigated sex differences in EIMD. Using 
muscle biopsies of the VL, Stupka et al. (2000) reported no sex differences in Z-line 
disruption or the serum CK response post EIMD. Interestingly, the inflammatory response 
(presented as changes in bcl-2 cell count) was significantly higher in males compared to 
females. Stupka et al. (2000) attributed the higher inflammatory response in males, to 
oestrogen acting as a membrane stabiliser in females. The findings of no differences in the CK 
response and Z-line disruption may only appear to contradict the conclusion of oestrogen 
acting as a membrane stabiliser because they were not measured at their peak. Stupka et al. 
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(2000) measured muscle biopsies at 48 hours post EIMD and CK at 48 and 144 hours post 
EIMD, whereas Z-line disruption and CK are reported to peak immediately (Takekura et al., 
2001; Friden & Ekblom, 1983), and 72-96 hours (Saka et al., 2009; Clarkson et al., 1992; 
Stupka et al., 2001) post eccentric EIMD respectively. Recently however, Joyce et al. (2014) 
investigated sex differences in EIMD following 240 eccentric knee extension, unilaterally, on 
both legs (480 contractions in total). Joyce et al. (2014) reported CK to be significantly higher 
in males compared to females, despite measuring peak CK at the same time as Stupka et al. 
(2000) (48 hours). Regardless of using the same muscle groups, the differences in the volume 
(Machado et al., 2012) of eccentric knee extensions (140 versus 480 respectively) and the 
different methods used (leg press machine versus isokinetic dynameters respectively) may 
explain the discrepancies between Stupka et al. (2000) and Joyce et al. (2014) respectively. 
Other studies have reported peak CK following eccentric exercise in the elbow flexors to be 
significantly higher in males compared to females (Sewright et al., 2008). It is difficult to 
compare these findings to the aforementioned studies due to damage in upper limbs being 
significantly higher compared to the lower limb (Chen et al., 2011; Saka et al., 2009). 
Furthermore, due to the sensitivity and variability of CK as a marker of EIMD, different rest 
intervals may potentially explain the discrepancies regarding the CK responses (for a review 
see Koch et al., (2014)). 
 Although CK is a marker of EIMD, as mentioned previously loss of isometric MVC 
torque is deemed the best indirect marker of EIMD (Warren et al., 1999) however, 
investigations regarding sex differences in MVC torque loss is sparse. Furthermore, the 
limited work that has investigated a sex difference in torque loss has predominately been in 
the elbow flexors, where a sex difference has been rejected (Rinard et al., 2000; Sayers & 
Clarkson, 2001) or evidenced (Sewright et al., 2008). Sewright et al. (2008) reported MVC 
torque loss in the elbow flexors to be significantly greater in females compared to males 
immediately post EIMD; however, they found no significant difference at any other time 
point. Therefore, although Sewright et al. (2008) findings could suggest that EIMD is higher in 
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females, the sex difference in MVC torque loss was only found immediately post EIMD which 
is a timeframe more representative of fatigue rather than EIMD (Walsh et al., 2004).  
It remains unclear, especially in the lower limbs, whether a sex difference in EIMD 
does exist, however, it is clear that the markers of EIMD used, the measurement day post 
EIMD and the type of eccentric exercise undertaken, may confound the conclusion. Markers 
of EIMD need to be measured at peak time frames, with set rest intervals to establish a 
confident conclusion as to whether a sex difference does exist.  
1.5.2. Alternative explanations  
Typically the sex differences in EIMD, specifically the CK response, has been attributed to 
oestrogen’s antioxidant and membrane stabilising properties (Joyce et al., 2014), however 
Wolf et al. (2012) controlled for the menstrual cycle by testing women in the early follicular 
phase of their menstrual cycle, where oestrogen levels were not significantly different 
between males and females. Despite similar oestrogen levels, Wolf et al. (2012) reported the 
CK response to be significantly higher in males compared to females. Highlighting that sex 
differences in EIMD, may not be attributed to the direct role of oestrogen per se.  
In addition to oestrogens antioxidant properties, oestrogen has also been reported to 
alter tendon properties (Hansen et al., 2009b), specifically tendon stiffness (Kubo et al., 
2003). Although oestrogen levels fluctuate naturally during the menstrual cycle, no 
differences in tendon stiffness has been reported at different phases of the menstrual cycle 
(Burgess et al., 2010). Nevertheless the attenuation in oestrogen is only acute throughout the 
menstrual cycle and may therefore not be severe enough to see a difference in tendon 
stiffness. However, the interaction between oestrogen and tendon properties has been 
evidenced through sex differences, where significantly lower tendon stiffness in males has 
been attributed to significantly higher levels of oestrogen in females (Kubo et al., 2003). 
Within OCP users however, despite lower oestrogen levels compared to non-users, the 
45 
 
findings remain contentious with arguments supporting (Bryant et al., 2008) or contesting 
(Hansen et al., 2013) the role of oestrogen on tendon properties. Therefore, it remains 
unknown if the OCP alters tendon properties in females. 
As described previously, the tendon may act as a mechanical buffer and explain group 
differences in EIMD in males versus females, and OCP users versus non-users (e.g. Joyce et al. 
(2014)). Furthermore, an understanding of oestrogen, tendon properties and EIMD may 
provide further information regarding the risk of injury in females during their menstrual 
cycle (Lefevre et al., 2013). Therefore, tendon properties in OCP users and non-users need to 
be investigated to establish whether the tendon acts as a determinant of EIMD, alongside 
oestrogen. 
1.6. Aims 
In light of the aforementioned research areas, the five aims of the current thesis are as 
follows: 
1. The aim of chapter two is to investigate the reliability of the measurement techniques 
used throughout the thesis, specifically the ultrasound to measure fascicle 
lengthening during MVEKE. 
 
2. The aim of chapter three is to establish whether patella tendon stiffness alters VL 
fascicle lengthening during eccentric contractions in males and females. 
 
 
3. The aim of chapter four is to establish whether muscle and tendon properties are 
associated with EIMD in vivo. 
 
46 
 
4. The aim of chapter five is twofold: Firstly to establish whether there is a sex 
difference in EIMD. Secondly, dependent on the outcome of the first aim, to establish 
whether tendon stiffness may explain the potential sex difference in EIMD. 
 
 
5. The aim of chapter six is twofold: Firstly to determine whether tendon properties 
differ between OCP users and non-users and secondly, to establish whether muscle 
damage is significantly different between OCP users and non-users.  
 
To answer the five aims of the current thesis, the majority of the method will be 
replicated throughout the thesis. Where required the method has been altered to 
make it specific to the additional variables being measured within each chapter.  
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Chapter two: The reliability of using ultrasound to measure 
patella tendon and muscle properties at rest and during 
MVEKE.  
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2.1. Introduction 
Historically, knowledge of human muscle tendon unit (MTU) morphology and elastic 
properties has been based on cadaveric data (Wickiewicz et al., 1983; Friederich & Brand, 
1990; Makihara et al., 2006). When using cadavers however, the architectural and structural 
muscle and tendon properties are typically altered through the age of the deceased, the 
preservatives used and the fixation techniques adopted (typically fixed in an elongated 
position) (Narici, 1999; Cutts, 1988). The introduction of imaging techniques has enabled 
tendon and muscle properties to be measured non-invasively in vivo, either at rest or during 
contraction (Kawakami et al., 1993; Fukunaga et al., 1997; Fukashiro et al., 1995).  
Two types of imaging techniques are commonly used to non-invasively measure 
muscle architecture in vivo, nuclear magnetic resonance imaging (MRI) and B-mode 
ultrasound (Narici, 1999). Although by using MRI several muscles can be scanned 
simultaneously, the scans are typically performed at rest and require multiple scans (Cutts, 
1988). The requirement to stay still in a semi-enclosed/enclosed ‘tunnel’ during MRI scans, 
has resulted in MRI being impractical, specifically in a clinical setting (i.e. stroke patients) 
(Singer et al., 2004). Furthermore, MRI scans are required to be performed in a fixed plane, 
whereas the ultrasound technique enables muscle and tendon properties to be measured 
during contraction (Fukunaga et al., 1997; Fukunaga et al., 2001). Measuring muscle and 
tendon properties during contraction provides further insight on their independent 
contribution to total MTU behaviour (Fukunaga et al., 1997; Fukashiro et al., 1995; Reeves & 
Narici, 2003). Therefore, ultrasound is adopted when assessing the in vivo properties of the 
muscle under isometric and dynamic conditions. 
The reliability of imaging techniques is crucial when carrying out longitudinal 
analysis of muscle properties involving repeated measurements. For example, the importance 
of precise measurements is evidenced when measuring changes in muscle architecture 
following a 12 week training intervention e.g. 1.57 cm (19.4%) increase in resting fascicle 
length (Baroni et al., 2013). High reliability has been reported when using ultrasound to 
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measure patella tendon cross-sectional area at rest (interclass correlation (ICC), 0.96) and 
patella tendon lengthening under contraction (ICC 0.91) (Onambélé et al., 2007). 
Furthermore, a recent review has investigated the reliability of using ultrasound to measure 
fascicle length and pennation angle in a variety of muscle groups (Kwah et al., 2013). Within 
the review, Kwah et al. (2013) collated moderate–to-high ICCs for repeated measures of 
vastus lateralis (VL) fascicle length (0.62-0.99) and VL pennation angle (0.51-1.00), however, 
contractile state was not specified. When measuring muscle architecture, ultrasound 
reliability may be affected by part of the fascicle extending out of the ultrasound’s field of 
view. Thus to calculate the missing portion of the fascicle length, the linear extrapolation 
method is used to estimate total fascicle length (Figure 2. 6). During isometric contractions of 
the tibialis anterior, a 2.4% error has been associated with the linear extrapolation method 
(Reeves & Narici, 2003). Furthermore, potentially due to the longer fascicle length in the VL 
compared to the tibialis anterior (~11.3 cm and ~5.4 cm respectively), a 2-7% error has been 
reported when using the extrapolation in the VL at a knee angle of 120 (Finni et al., 2001). 
Recently, when comparing ultrasound to cadaveric measurements, the linear extrapolation 
method has been concluded as a valid technique for measuring VL fascicle length at rest (ICC = 
0.853) (Ando et al., 2014). During eccentric contractions however, unlike isometric 
contractions where the MTU length remains constant, the MTU undergoes lengthening 
(Fukunaga et al., 2001; Guilhem et al., 2011). To account for the change in MTU during 
maximal eccentric knee extensions (MVEKE) either the tendon, fascicles or both are required 
to lengthen (Fukunaga et al., 2001; Lichtwark & Wilson, 2007). Therefore, although it remains 
to be determined in vivo, by nature of the changing joint angle during eccentric contractions, 
it can be assumed a greater proportion of the fascicle extends out of the ultrasound field 
compared to isometric contractions. Furthermore, due to the rapid change in MTU length 
during MVEKE it may be difficult to prevent small probe movements, which may contribute to 
lower reliability during eccentric movements. Klimstra et al. (2007) reported small rotations 
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of the ultrasound probe altered measurements of tibialis anterior architecture (fascicle 
length and pennation angle) during maximal dorsi-flexion contractions. For example, rotating 
the ultrasound probe -5 longitudinal and sagittal-frontal (from a neutral position 14 
longitudinal rotation and 4 sagittal-frontal rotation), resulted in a 12% (1.9) change in 
pennation angle (Klimstra et al., 2007). Therefore, it is essential to investigate whether the 
reliability of ultrasound to measure muscle architecture during isometric contractions can be 
extended to MVEKE.  
To the author’s knowledge Guilhem et al. (2011) is the only study to report the 
reliability of ultrasound during MVEKE. Guilhem et al. (2011) reported moderate ICCs for VL 
fascicle length, pennation angle and muscle thickness (0.82, 0.75 and 0.93 respectively). 
However, Guilhem et al. (2011) only used ICC, which is only deemed appropriate for 
reliability when combined with Bland-Altman plots (Rankin & Stokes, 1998; Atkinson & 
Nevill, 1998). Furthermore, Guilhem et al. (2011) did not measure the degree of probe 
movement during the MVEKE. Thus, the aim of this chapter is to investigate between session 
reliability of using ultrasound to measure patella tendon properties and muscle properties, 
specifically during MVEKE.  
2.2. Materials and method 
2.2.1. Subjects 
A total of 13 participants (22.1 ± 1.1 years of age, with a mass and stature of 68.0 ± 5.5 kg and 
175 ± 8 cm, respectively) signed written informed consent to participate in the current study. 
All participants self-reported no lower limb injuries. All procedures complied with the 
Declaration of Helsinki (World Health Association, 2013) and ethical approval was obtained 
through the local ethics committee.  
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2.2.2. Testing protocol 
Participants were asked to visit the laboratory on two different occasions (day one and day 
two). The two testing sessions were separated by 48 hours, to represent the time differences 
between pre-damage and the damage session in the subsequent chapters. Day one and two 
consisted of morphological measures of the patella tendon (tendon size and stiffness) and VL 
(muscle architecture, muscle length and VL anatomical cross-sectional area (VLACSA)), and 12 
reps MVEKE. The order of measurements in day two mirrored day one, and was performed at 
the same time of day to control for the effect of time-of-day variation on torque and tendon 
properties (Pearson & Onambele, 2006; Martin et al., 1999). 
All tests were carried out in the non-dominant leg. The non-dominant leg was defined 
as the leg that provided stability during movements, e.g. kicking. Participants were seated in 
an isokinetic dynamometer (Cybex Norm, Cybex International, NY, USA), with a hip angle of 
85 (Figure 2. 1). To reduce any extraneous movement during maximal efforts participants 
were secured in a seated position using inextensible straps around the shoulders and hips. 
The isokinetic dynamometer axis of rotation was visually aligned with the knee joint’s centre of 
rotation. The setup of the dynamometer chair on day one (including lever arm length, distance 
from the chair to dynamometer, seat height and back angle) was recorded to ensure precise 
replication of participant posture in the following session (i.e. day two).  
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Figure 2. 1: Example of participant seated in the isokinetic dynamometer with a hip angle of 
85. 
2.2.3. Vastus lateralis resting architecture 
Vastus lateralis resting architecture (fascicle length, pennation angle and muscle thickness) 
was measured using a real-time B-mode ultrasound (AU5 Harmonic, Esaote Biomedica, 
Genoa, Italy). Prior to the measurement of resting VL muscle architecture, participants laid 
supine for 20 minutes to allow for fluid distribution to equilibrate (Berg et al., 1993). With 
the participant laid supine and their non-dominant leg fully extended (knee angle 0), the 
distal and proximal insertions sites of the VL were identified using an ultrasound probe (7.5 
MHz linear array probe, 38 mm wide). For muscle properties, the ideal ultrasound probe 
frequency range is between 7.0-12.0 MHz, however there is a trade-off between higher 
frequency / precision and lower depths (Gibbon, 1996). Within the current chapter a probe 
frequency of 7.5 MHz allowed depths of up to 8 cm with an average resolution of 0.20 mm to 
be used (Gibbon, 1996). At 50% of VL length the ultrasound probe was positioned in the mid-
sagittal plane. A hypo-allergenic ultrasound gel (Parker, Park Laboratories Inc., Fairfield) was 
used to enhance coupling between the skin and ultrasound probe. To ensure there was no 
movement artefact included in the assessment of muscle architecture, an echo-absorptive 
marker was fixed on the skin to provide a visual baseline of the internal structures.  
Measurements of fascicle length, pennation angle and muscle thickness were 
measured offline using digitising software (ImageJ 1.45, National Institutes of Health, USA). 
Fascicle length was measured from the visible insertion of the fibre into either the deep or 
superficial aponeurosis. Where the fascicle extended longer than the ultrasound image, linear 
continuation of the fascicle and aponeurosis was assumed (Figure 2. 6). A 2-7% error has 
been associated with measuring VL fascicle length at 120 knee angle (Finni et al., 2001). 
Recently, when comparing ultrasound to cadaveric measurements’, the linear extrapolation 
method has been concluded as a valid technique for measuring VL fascicle length (ICC = 
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0.853) (Ando et al., 2014). The ultrasound can only scan in 2D despite fascicle rotation 
forming a 3D structure; therefore great care was taken to orientate the probe as precisely as 
possible with the fascicle. To reduce error associated with the estimation of fascicle length, an 
average of three fascicles across the image was taken. Pennation angle was determined as the 
angle created from the visible insertion of the fascicle into the deep aponeurosis (Figure 2. 6). 
An average of three pennation angles was taken across the image. VL muscle thickness was 
determined as the vertical distance between the deep and superficial aponeurosis, an average 
was taken at three points across the width of the probe (Figure 2. 6). 
2.2.4. Vastus lateralis anatomical cross-sectional area  
Vastus lateralis anatomical cross-sectional area (VLACSA) was measured using a real-time B-
mode ultrasound (AU5 Harmonic, Esaote Biomedica, Genoa, Italy). With the participant laid 
supine and their non-dominant leg fully extended (knee angle 0), the distal and proximal 
insertions sites of the VL were identified using an ultrasound probe (7.5 MHz linear array 
probe, 38 mm wide). At 50% of VL muscle length echo-absorptive markers were placed in 
parallel, at intervals of 30 mm, from the lateral to the medial edge of the VL muscle. The 
ultrasound probe was held perpendicular to the VL muscle in the axial plane. The ultrasound 
probe was moved steadily over the echo-absorptive markers from the lateral to the medial 
edge of the muscle (Figure 2. 2). Constant, light pressure was placed on the muscle during 
scanning to avoid compression of the muscle (Esformes et al., 2002). The images were 
recorded in real time at 25 frames per second (Adobe Premier pro Version 6, Adobe Systems 
Software, Ireland). Using capturing software (Adobe Premier Elements, version 10), 
individual images were acquired at each 30 mm interval. Shadows cast by the echo-
absorptive markers allowed the images to be aligned by the outline of the muscle, thus 
forming the entire VLACSA in a single image (Adobe Photoshop Elements, version 10, (Figure 2. 
2)). Digitising software (ImageJ 1.45, National Institutes of Health, USA) was used to measure 
VLACSA. This method of calculating VLACSA has previously been accepted as reliable and valid 
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when compared to MRI, with a reported interclass correlations between 0.997 - 0.999 and 
0.998 and 0.999 respectively (Reeves et al., 2004). 
 
 
Figure 2. 2: A) Example of echo-absorptive markers at 50% of VL length B) Example figure of 
VLACSA in one male participant using ultrasound. 
2.2.5. Patella tendon length and cross-sectional area 
A real-time B-mode ultrasound (AU5 Harmonic, Esaote Biomedica, Genoa, Italy) was used to 
measure patella tendon cross-sectional area (PTCSA) and patella tendon length (PTL) at a fixed 
90 knee angle. The distance between the apex of the patella and the tibial tuberosity, marked 
using sagittal ultrasound images, was taken as PTL. To measure PTCSA the ultrasound probe 
was placed in the transverse plane and images were captured at 25%, 50%, and 75% of PTL 
(Figure 2. 3). The images were later analysed offline using ImageJ (1.45, National Institutes of 
Health, USA (Figure 2. 3), with the mean of all three images being used for further analysis 
(O’Brien et al., 2010). 
 
A) B) 
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Figure 2. 3: A) Example of the ultrasound probe placed in the transverse plane at 50% of 
patella tendon length. B) Example figure of PTCSA at 50% of patella tendon length. Area 
measured using ImageJ (1.45, National Institutes of Health, USA). 
 
2.2.6. Patella tendon elongation 
The participants were seated in the isokinetic dynamometer, with the knee angle fixed at 90, 
and were instructed to perform a ramped, isometric MVCKE lasting ~5-6 seconds. Ramped 
MVCKE torque and displacement of the patella tendon were synchronised using a voltage (10-
V) square wave signal generator. Patella tendon displacement was measured over two MVCKE, 
once with the ultrasound probe positioned over the distal edge of the patella and on the 
second contraction over the tibial tuberosity (Onambélé et al., 2007). Total tendon 
displacement was computed from the composite of proximal and distal patella motions (see 
below). Torque was presented on a Macintosh G4 computer (Apple Computer, Cupertino, CA, 
USA), via an A/D converter and subsequently analysed with the accompanying software 
(Acknowledge, Biopac Systems, Santa Barbara, CA). To create an external marker on the 
A) B) 
1 
cm 
56 
 
ultrasound images, an echo-absorptive marker was placed on the skin. Using the marker to 
calculate displacement, the distance of the marker (shadow) from an anatomical reference 
point at the beginning of the contraction, to the position of the shadow at the end of the 
contraction was calculated (Figure 2. 4). Images were captured at ~10% intervals of ramped 
MVCKE torque (Onambélé et al., 2007). Total patella tendon displacement was calculated as 
displacement at the apex of the patellar plus the displacement at the tibial tuberosity 
(Onambélé et al., 2007). 
 
Figure 2. 4: Example of measuring distal patella tendon lengthening using ultrasound. Red 
line emphasise the shadow cast by the echo-absorptive marker on the skin. 
Patella tendon moment arm was measured at 90 knee angle (full extension = 0) in the 
sagittal plane (Figure 2. 5), from a single energy (frame 23.3 cm × 13.7cm) DEXA scan 
(Hologic Discovery, Vertec Scientific Ltd, UK). Using OsiriX (DICOM viewer, ver. 4.0, Pixemo, 
Switzerland), PTMA length was determined as the perpendicular distance from the centre of 
the patella tendon to the estimated tibio–femoral contact point ((Baltzopoulos, 1995; Erskine 
et al., 2014) Figure 2. 5). Compared to the MRI, the DEXA has been reported a reliable and 
valid technique when measuring moment arm length (Erskine et al., 2014) 
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Figure 2. 5: A) Representative image of a participant positioned on the DEXA bed with the 
knee set at 90 B) field of view correctly identified using laser beam C) single energy image to 
measure patella tendon moment arm (PTMA). P: Patella, F: Femur, T: Tibia, PT: Patella tendon 
and C: Tibio–femoral contact point. 
 
2.2.7. ‘Damaging’ eccentric exercise 
Prior to eccentric exercise, a warm-up of 10 isokinetic knee extensions and knee flexions 
were carried out at 60°·s-1, ensuring a progressive increase in effort (with the last contraction 
being maximal). A maximal effort contraction performed during the warm up has been 
P 
F 
T 
C 
PT 
PTMA 
A) 
C) 
B) 
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reported to reduce systematic error in repeated eccentric contractions (Almosnino et al., 
2012). For the eccentric exercise, the knee extension range of motion was set at 20 – 90 (0 
= full extension). Participants were asked to perform 12 MVEKE repetitions. The eccentric 
phase of the contractions was performed at an isokinetic angular velocity of 30s-1 (Jamurtas 
et al., 2005). The concentric phase was performed sub-maximally at an angular velocity of 
60s-1 to minimise fatigue and enhance eccentric damage (Chapman et al., 2006). The 
combination of visual and verbal feedback has been reported to increase maximal efforts 
when compared to no feedback or just verbal encouragement (Campenella et al., 2000). 
Therefore visual feedback and verbal encouragement was continuously provided throughout 
the protocol. Torque was presented, in real time, on a Macintosh G4 computer (Apple 
Computer, Cupertino, CA, USA), via an A/D converter (Biopac Systems, Santa Barbara, CA). 
Torque measurements were later analysed offline with the accompanying software 
(Acknowledge, version 3.9.2). Peak MVEKE torque was determined as the highest torque out 
of the 12 repetitions. 
2.2.8. Change in vastus lateralis fascicle length during the eccentric protocol 
To measure VL fascicle length during MVEKE, the ultrasound probe was fixed at 50% of VL 
muscle length in the mid-sagittal plane of the non-dominant leg. During the 12 MVEKE 
contractions, ultrasound images were recorded onto a PC, in real time, at 25 frames per 
second (Adobe Premier pro Version 6, Adobe Systems Software, Ireland). An externally 
generated square wave signal was used to synchronise the ultrasound images with the torque 
acquisition system. Three MVEKE contractions were chosen from the set of 12 repetitions for 
architectural analysis. Using frame capture software (Adobe Premier Elements, version 10), 
an ultrasound image (frame corresponding to every 10 of knee angle, ranging from 20 - 90) 
was acquired for offline analysis. To ensure there was no movement artefact included in the 
measurement of fascicle length, an echo-absorptive marker was fixed on the skin to provide a 
visual reference point for the internal structures. If movement of the reference line (relative 
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to its baseline position on the ultrasound screen gridline) was observed, the contraction was 
discarded and another repetition was chosen for analysis. Using an external marker to 
calculate change in muscle architecture is a common procedure, however it assumes that the 
marker, skin and ultrasound do not move during the contraction. Using the same ultrasound 
method to measure displacement of the gastrocnemius medialis MTU under passive stretch, 
Morse et al. (2008) reported the ultrasound probe translated distally by 1.8 ± 0.2 mm. 
However, the movement of the ultrasound probe, marker or skin has not been measured 
during MVEKE (see below).  
Using digitising software (ImageJ 1.45, National Institutes of Health, USA), VL fascicle 
length was analysed offline at every 10. Fascicle length was measured from the visible 
insertion of the fibre into either the deep and superficial aponeurosis (Reeves & Narici, 
2003). Where the fascicle extended longer than the ultrasound image (frame width 3.50 cm 
and height 4.15 cm), linear continuation of the fascicle and aponeurosis was assumed (Figure 
2. 6). To reduce error associated with the estimation of VL fascicle length, an average of three 
fascicles across the image was taken (Guilhem et al., 2011). Change in fascicle length during 
eccentric contractions was measured at 10 increments throughout the MVEKE. Using the 
ultrasound to track lengthening of the muscle tendon junction, Morse (2011) has reported a 
mean error of 0.06 mm, with a high coefficient correlation (r = 0.999). Morse (2011) 
therefore evidences that ultrasound is reliable when measuring small increases in 
architecture, i.e. fascicle lengthening. Absolute fascicle length is presented as fascicle length 
from 20 to 90, change in fascicle length is then made relative to fascicle length measured at 
a knee angle of 20. Due to the sparse data regarding the reliability of absolute and relative 
fascicle lengthening during MVEKE, a total of 13 participants were used rather than 8 used in 
the other measures of tendon and muscle architecture. 
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Figure 2. 6: Example of the linear extrapolation method used to calculated total vastus 
lateralis (VL) fascicle length A) at rest (full leg extension) B) at 90 knee angle during 
maximal voluntary eccentric knee extensions (MVEKE). At rest and under MVEKE estimated 
fascicle length was 48% and 67% (respectively) of total fascicle length. 1: Total fascicle 
length, 2: Muscle thickness, 3: VL pennation angle.  
 
2.2.9. Ultrasound probe movement 
As mentioned previously, the ultrasound method used to measure fascicle lengthening during 
MVEKE relies on the assumption that the ultrasound probe does not move. Although 
ultrasound probe movement has been measured during stretch of the gastrocnemius medialis 
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(Morse et al., 2008), ultrasound probe movement has yet to be measured during MVEKE. Thus 
to measure whether the ultrasound probe moved whilst measuring fascicle lengthening during 
MVEKE, an external video camera (Casio EX-F1, 60 frames per second) fixed to a three-legged 
tripod, was aligned in parallel with the non-dominant leg. At the distal end of the ultrasound 
probe, echo absorptive tape was placed on the skin as an external marker. During the 12 MVEKE, 
images were captured at 20 knee angle (0 = full extension) and 90 knee angle, as indicated by 
the isokinetic chair. Using digitising software (ImageJ 1.45, National Institutes of Health, USA) 
probe movement (forward and backwards) was measured offline. Movement of the probe was 
determined as the change in distance from the distal edge of the probe to the external marker on 
the skin, from 20 to 90 knee angle. 
2.2.10. Statistics 
The difference between the mean values of both testing days was plotted on a scatter plot to 
assess the presence of heteroscedasticity. The corresponding association was assessed using 
Pearson’s product moment correlation. All data was homoscedastic therefore log 
transformation was not required. To ensure the data were parametric, the Shapiro-Wilk and 
Levene’s tests were utilized to assess the normality and variance of the data, respectively. 
These statistical assumptions were not breached. Inter-reliability of tendon and muscle 
properties between day one and day two, were analysed with a one-way random effects ICC 
model. The coefficient of variation, independent T-test and 95% limits of agreement (LoA) 
were reported to assess the agreement between day one and two for tendon and muscle 
properties (Atkinson & Nevill, 1998). All data is presented as mean ± standard deviations.  
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2.3. Results 
2.3.1. Vastus lateralis muscle architecture 
There was significant ICC between day one and day two measurements of all muscle 
architecture measures (Table 1. 2). Coefficient of variations remained below 6% for all 
architectural measures at rest (Table 1. 2). There was no significant systematic bias between 
day one and day two for resting muscle architecture: VL fascicle length (5.13 ± 1.00 cm, 5.12 
± 0.99 cm, respectively, p = 0.99 (n = 8)), muscle thickness (3.60 ± 0.53 cm, 3.57 ± 0.45 cm, 
respectively, p = 0.93, (n = 8)), pennation angle (15.9 ± 3.0, 15.8 ± 3.0, respectively, p = 0.40, 
(n = 8)), VLACSA (22.4 ± 2.7 cm2, 22.4 ± 2.7 cm2, respectively, p = 0.98, (n = 8)) and VL length 
(30.0 ± 2.0 cm, 30 ± 2.0 cm, respectively, p = 1.00, (n = 8)). The ICC, coefficient of variance, 
and 95% absolute limits of agreements are shown in Table 1. 2. Figure 2. 7 shows Bland-
Altman plots for resting muscle architecture using 95% confidence interval levels. 
2.3.2. Patella tendon properties 
There was significant ICC between day one and day two measurements of all tendon 
properties measures (Table 1. 1.). There was no significant systematic bias between day one 
and day two for resting tendon measures: PTL (5.02 ± 0.04 cm, 5.04 ± 0.05 cm, respectively, p 
= 0.19, (n = 8)), PTCSA (85.0 ± 13.2 mm2, 84.0 ± 12.9 mm2, respectively, p = 0.18, (n = 8)), PTMA 
(4.30 ± 0.30 cm, 4.32 ± 0.31 cm, p = 0.459, (n = 8)) and relative PT elongation (5.55 ± 1.26 cm, 
5.88 ± 1.32 cm, respectively, p = 0.73, (n = 8)). The ICC, coefficient of variance and 95% 
absolute limits of agreements are shown in Table 1. 1. Figure 2. 8 shows Bland-Altman plots 
for patella tendon properties using 95% confidence interval levels. 
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Table 1. 1. The reliability of B-mode ultrasound when measuring patella tendon properties at 
rest and during MVCKE. 
 
ICC CV (%) LoA (95%) 
PT length (mm) 0.58 0.69 0.02 ± 0.09 
PTCSA (cm2) 0.99 3.50 0.01 ± 0.04 
PT elongation (cm) 0.97 5.98 0.17 ± 0.67 
PTMA (cm) 0.97 0.45 0.02 ± 0.04 
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Figure 2. 7: Bland Altman plots identifying the bias (small dashed line) and the limits of agreement (large dashed line, ± 1.96) between day one and 
day two for the measurements of A) VL resting fascicle length, B) VL resting pennation angle, C) VL resting thickness and D) VL anatomical cross-
sectional area.  
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Figure 2. 8: Bland Altman plots identifying the bias (small dashed line) and the limits of agreement (large dashed line, ± 1.96) between day one and 
day two for the measurements of A) PTL: Patella tendon length, B) PTCSA: Patella tendon cross-sectional area, C) Patella tendon elongation during 
maximal isometric knee extension and D) PTMA: Patella moment arm at 90 knee angle. 
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Figure 2. 9: Bland Altman plots identifying the bias (small dashed line) and the limits of agreement (large dashed line, ± 1.96) between day one and 
day two for the measurements of A) Absolute change in VL fascicle length from 20 to 90 knee angle (0= full extension) B) Relative change in VL 
fascicle length, and C) Peak MVEKE: Maximal voluntary eccentric knee extension. 
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2.3.3. Vastus lateralis properties during eccentric contractions 
There was significant ICC between day one and day two measurements of all muscle 
architecture measures (Table 1. 2). There was no significant systematic bias between day one 
and day two for absolute fascicle lengthening (2.47 ± 1.15 cm, 2.46 ± 0.71 cm, respectively, p 
= 0.46, (n = 13)), relative fascicle lengthening (40.5 ± 3.9%, 40.4 ± 3.85%, respectively, p = 
0.492, (n = 13)), and MVEKE (176 ± 47 Nm, 175 ± 49 Nm, respectively, p = 0.488, (n = 8)). The 
ICC, coefficient of variance and 95% absolute limits of agreements are shown in Table 1. 2. 
Figure 2. 9 shows the Bland-Altman plots for fascicle lengthening and MVEKE using 95% 
confidence interval levels.  
Table 1. 2. The reliability of B-mode ultrasound when measuring muscle properties at rest 
and during MVEKE. 
  ICC  CV (%) LoA (95%) 
Resting fascicle length (cm) 0.99 1.12 0.01 ± 0.11 
Resting pennation angle (o) 0.99 0.68 0.01 ± 0.26 
Muscle thickness (cm) 0.99 3.76 0.01 ± 0.21 
VLACSA (cm2) 1.00 0.33 0.05 ± 0.06 
VL length (cm) 1.00 0.00 0.00 ± 0.00 
MVEKE (Nm) 0.99 5.38 0.95 ± 21.0 
Absolute Fascicle lengthening (cm) 0.99 2.95 0.00 ± 0.17 
Relative fascicle lengthening (%) 0.99 4.77 0.22 ± 4.36 
 
2.3.4. Ultrasound probe movement 
The movement of the ultrasound probe when measuring fascicle lengthening from 20 knee 
angle to 90 knee angle during MVEKE was 0.02 ± 0.05 cm proximally. Therefore, ultrasound 
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probe movement in the current chapter represents a 0.6% error in change in fascicle length 
(average change in fascicle length 3.2 cm) during MVEKE.  
 
2.4. Discussion 
The main aim of the current chapter was to determine whether B-mode ultrasound is a 
reliable imaging technique for repeated measures of muscle and tendon properties at rest 
and under isometric and MVEKE contractions. Three main findings merit highlighting: 1) 
ultrasound is a reliable method for measuring PTL and PTCSA at rest and patella tendon 
lengthening under maximal isometric contraction, 2) ultrasound is a reliable method for 
measuring resting VL architecture (fascicle length, pennation angle and muscle thickness) 
and 3) ultrasound is a reliable method for measuring fascicle lengthening during MVEKE.  
 The measurement of Young’s modulus is dependent on the accurate measurement of 
PTCSA and PTL. It is therefore essential to ensure resting tendon measurements are accurate to 
prevent errors in subsequent calculations of Young’s modulus. In agreement with previous 
literature (Kubo et al., 2003), the current chapter reported ultrasound to be a reliable 
technique when measuring tendon properties, specifically PTCSA and PTL. Kubo et al. (2003) 
reported a high correlation coefficient of 0.97 between two separate measurements of PTCSA. 
Although a correlation coefficient of 0.97 is high (Taylor, 1990), correlation coefficients can 
be affected by large variability and do not account for systematic bias (Bates et al., 1996; 
Bland & Altman, 1996; Atkinson & Nevill, 1998). To account for systematic bias, ICCs are 
commonly used in place of correlation coefficients in reliability analysis (Atkinson & Nevill, 
1998). In agreement with the current chapter, Onambélé et al. (2007) reported high ICCs for 
patella tendon elongation, PTCSA and isometric patella tendon knee extension torque (0.91, 
0.96 and 0.99 respectively). Although ICCs are an acceptable measure of reliability, the output 
could be skewed by sample heterogeneity (Bland & Altman, 1990). It is therefore 
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recommended that ICCs should not be used as a sole indicator of reliability and should be 
supported by the use of Bland-Altman plots (Bland & Altman, 1990; Atkinson & Nevill, 1998). 
The triangulation of ICC, coefficient of variance and limits of agreement reported within the 
current chapter indicates high reliability when using ultrasound to measure patella tendon 
properties at rest and under maximal contraction.  
Following exercise training programmes adaptations in resting muscle architecture 
are used to measure the training response, for example Baroni et al. (2013) reported VL 
fascicle length to increase by 1.57 cm (19.4%) following 12 weeks of eccentric training. Thus, 
high reliability of imaging techniques is crucial to avoid under / over estimation of changes to 
resting muscle architecture (Klimstra et al., 2007). In agreement with previous research the 
current chapter can conclude that ultrasound is a highly reliable technique for measuring 
resting VL muscle architecture (De Boer et al., 2008; Alegre et al., 2006). In agreement with 
the ICCs reported in the current chapter, Alegre et al. (2006) reported ICCs of 0.95, 0.96 and 
0.96 for resting VL fascicle length, muscle thickness and pennation angle respectively. It 
remains unknown however, if the high ICCs presented by the current chapter and by Alegre 
et al. (2006) are skewed by the large variability (a known limitation of ICCs (Bland & Altman, 
1990)) associated with resting muscle architecture (Stebbings et al., 2013; Weir, 2005). By 
using a triangulation of methods, ICC, coefficient of variance and Bland-Altman plots, the 
current chapter demonstrates high agreement and low bias. Thus the current chapter can 
confirm that the ultrasound is a reliable measurement for resting VL muscle architecture, 
including fascicle length, pennation angle and muscle thickness.  
 In addition to resting muscle architecture, the introduction of ultrasound has enabled 
fascicle behaviour to be directly measured during contraction (Fukunaga et al., 1997). Due to 
a small field of view (typically 38 mm wide) on the ultrasound probe, extrapolation and 
partial estimation of the fascicles is required to calculate total fascicle length. Within the VL, a 
2-7% error is associated with the linear extrapolation method when used to calculate fascicle 
length at a knee angle of 120 (Finni et al., 2003a). However, under maximal isometric 
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contraction, a 2.4% error has been associated with estimating fascicle length in the tibialis 
anterior (Reeves et al., 2003). The greater error within the VL may be attributed to the 
greater fascicle length (~11.3 cm) in the VL (Finni et al., 2003a) compared to the tibialis 
anterior (~5.4 cm) (Reeves et al., 2003), thus a greater portion of the fascicle may have to be 
estimated within the VL. For example within the current chapter, at rest a VL fascicle length 
of 6.91 cm required 48% of the fascicle length to be estimated, whereas during MVEKE a VL 
fascicle length of 10.4 cm at 90 knee angle required 66.7% of the fascicle to be estimated 
(Figure 2. 6). Furthermore, greater error reported from the VL may be attributed to, unlike 
during isometric contractions and at rest, fascicles lengthening during eccentric contractions 
(Reeves & Narici, 2003). Although the validity of the linear extrapolation method has been 
unreported in the VL during MVEKE, the fascicle length we report is similar to those reported 
by Finni et al. (2003a), thus similar measurements of error (2-7%) can be assumed. The 
current chapter confirms that during eccentric contractions the ultrasound can be used as a 
reliable imaging technique, despite greater estimation of fascicle length, to directly calculate 
fascicle lengthening during MVEKE. Our findings concur with Guilhem et al. (2011) who 
reported ICCs of 0.93-0.95, 0.82-0.88, and 0.75-0.87 for muscle thickness, fascicle angle and 
fascicle length, respectively in the VL, during MVEKE. Unlike Guilhem et al. (2011), to account 
for systematic error, the current chapter combined ICCs and Bland-Altman plots. Supported 
by a triangulation of reliability statistics and an extremely low bias (0.0025 cm), the current 
chapter can therefore conclude that ultrasound is a reliable method of measuring fascicle 
length in vivo during MVEKE.  
 During eccentric contractions the muscle lengthens rapidly under high torque, 
therefore it may be difficult to maintain probe placement. Morse et al. (2008) reported the 
ultrasound probe translated distally by 1.8 ± 0.2 mm during stretch of the gastrocnemius 
medialis, however probe movement during MVEKE has yet to be investigated. The current 
chapter however, can confirm that the probe movement when measuring fascicle lengthening 
during MVEKE was negligible, accounting for 0.6% measurement error in change in fascicle 
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length during MVEKE. Thus, providing further confidence that the measurements can be 
attributed to fascicle lengthening and not probe movement.  
 When measuring maximal voluntary contractions an assumption is made that the 
participants are contracting maximally. The adherence to the instructions to push maximally 
is crucial when investigating MVEKE and exercise-induced muscle damage. Introducing a 
maximal effort within the warm up has been reported to increase the probability of the 
participants to contract maximal in repeated measures of isometric torque (Almosnino et al., 
2012). Although high ICCs (0.96) have been reported when using the isokinetic dynamometer 
to measure MVEKE torque at 60s-1 (Impellizzeri et al., 2008), the low bias and CVs within the 
current chapter can conclude high reliability when MVEKE are performed at a slower speed 
(30s-1).  
2.5. Conclusion 
The current chapter can conclude that the ultrasound is a highly reliable technique to 
measure resting architecture in both tendon and muscle. Therefore, the current chapter 
supports the use of ultrasound as an alternative method for measuring muscle and tendon 
morphology when an MRI is impractical, e.g. within stroke patients (Singer et al., 2004). 
Furthermore, during MVEKE the ultrasound is a highly reliable technique to measure change 
in muscle architecture, specifically VL fascicle lengthening, with negligible probe movement. 
Due to the repeated use of the same techniques and methods throughout this thesis, the 
findings of this chapter provide confidence that the results within the subsequent chapter of 
the current thesis are true and not confounded by measurement error.   
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Chapter three: Sex differences in fascicle lengthening 
during eccentric contractions: the role of the patella tendon 
stiffness. 
 
 
 
 
 
 
 
 
 
 
 
 
This Chapter appears in publication as: Hicks, K.M., G.L. Onambele-Pearson, K. Winwood, and 
C.I. Morse, Gender differences in fascicular lengthening during eccentric contractions: the role 
of the patella tendon stiffness. Acta Physiol (Oxf), 2013. 
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3.1. Abstract 
Aim: Tendons have been suggested to attenuate fascicle lengthening during eccentric 
contractions however there is no in vivo evidence to support this hypothesis. Therefore, the 
aim of this chapter was to determine whether patella tendon stiffness modulates vastus 
lateralis fascicle lengthening during eccentric contractions in males and females. Materials 
and method: Vastus lateralis and patella tendon properties were measured in males and 
females owing to previously reported intrinsic sex differences in tendon properties. During 
maximal voluntary eccentric knee extensions, vastus lateralis fascicle lengthening and torque 
was recorded at every 10 (range of motion 20-90). Results: A significant correlation 
between maximal patella tendon stiffness and change in fascicle length (r = 0.476, p = 0.023) 
was observed. Similarly, there was a significant correlation between maximal patella tendon 
Young’s modulus and change in vastus lateralis fascicle length (r = 0.470, p = 0.049). As 
expected, patella tendon stiffness and Young’s modulus were significantly higher in males 
compared to females (p ≤ 0.05). Interestingly, change in vastus lateralis fascicle length during 
the eccentric contractions was significantly greater in males compared to females (p ≤ 0.05). 
Based on patella tendon moment arm (PTMA) measurements, vastus lateralis muscle-tendon 
unit elongation was estimated to be significantly greater in males compared to females (5.24 cm 
and 4.84 cm, respectively) Conclusion: The significant difference in fascicle lengthening 
during eccentric contractions may be partly explained by the significantly higher PTMA, 
patella tendon stiffness and Young’s modulus found in males compared to females. The 
current chapter provides in vivo evidence to support the hypothesis that the tendon acts as a 
‘mechanical buffer’ during eccentric contractions. 
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3.2. Introduction 
Historically eccentric contractions are considered and often defined as “muscle lengthening” 
(e.g. (Lindstedt et al., 2001)). However, with the advent of the sonomicrometry method 
pioneered by Griffiths (1987) and B-mode ultrasonography (Fukashiro et al., 1995), the 
quantification of muscle lengthening during eccentric contractions has been directly 
investigated. Although the findings from a small sub-population within chapter two suggest 
that vastus lateralis (VL) fascicles lengthen during knee extension, previous eccentric work 
has concluded different fascicle behaviour. During the stance phase in a freely walking cat, 
Griffiths (1991) found that muscle fascicles were shortening despite an increase in muscle 
tendon unit (MTU) length. In agreement with Griffiths (1991), Spanjaard et al. (2007) 
reported that during the eccentric phase of stair descent, the gastrocnemius medialis fascicles 
shortened despite a lengthening of the MTU. In contrast, Fukunaga et al. (2001) reported 
gastrocnemius medialis fascicles to contract quasi-isometrically during the stance phase of 
human walking, despite significant lengthening of the MTU. Although some of the discrepancy 
in fascicle lengthening can be attributed to differences in, joint range of motion and gait 
patterns during flat walking versus stair decent (Spanjaard et al., 2007), both Spanjaard et al. 
(2007) and Fukunaga et al. (2001) reported that the lengthening of the MTU during the 
eccentric phase, occurs predominately at the tendon rather than at the muscle fascicles.  
It is widely accepted that tendons are not inextensible and are in fact a viscoelastic 
tissue that deforms under loading (Magnusson et al., 2008). The degree of deformation 
(elongation) depends on the level of loading and intrinsic stiffness of the tendon (Maganaris 
& Paul, 1999). Non-invasive techniques such as B-mode ultrasonography allow the in-series 
muscle and tendon behaviour to be measured independently, at rest and during locomotion 
(Fukunaga et al., 1996; Cronin & Finni, 2013; Fukashiro et al., 1995). Understanding the 
interaction between the tendon and muscle is essential to fully understand the contribution 
of each to everyday tasks such as postural balance (Onambele et al., 2006). The shortening or 
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quasi-isometric behaviour of fascicles during eccentric contractions has previously been 
attributed to the tendon lengthening under load (Spanjaard et al., 2007; Fukunaga et al., 
2001; Reeves & Narici, 2003). The greater proportion of MTU lengthening occurring at the 
tendon, reduces the metabolic cost of muscle contractions (Roberts & Scales, 2002) and 
economy of walking is enhanced (Fukunaga et al., 2001). The impact of tendon properties on 
fascicular elongation during eccentric loading is further demonstrated through the role that 
tendon stiffness plays in explaining group differences in fascicular elongation (Mian et al., 
2007). The gastrocnemius medialis fascicles during the eccentric stance phase of gait, in the 
elderly and young, are indeed reported to behave either quasi-isometrically (in the old) or to 
lengthen (in the young) (Mian et al., 2007). With these differences in fascicle behaviour being 
attributed to tendon stiffness decreasing with age (Onambele et al., 2006) thus attenuating 
fascicle lengthening in the elderly. To explain the interaction between tendon stiffness and 
fascicle displacement under loading, Lichtwark et al. (2007) used a three element Hill muscle 
model. Using the Achilles tendon and the gastrocnemius medialis fascicle lengthening during 
the eccentric stance phase of walking they predicted increasing Achilles tendon stiffness 
increased the required amount of fascicle lengthening (Lichtwark & Wilson, 2007).  
The interaction between the tendon and muscle fascicles have also been reported 
within the VL during eccentric tasks, such as drop jumps and countermovement jumps 
(2001). Finni et al., (2001) reported the magnitude of VL fascicle lengthening during the 
eccentric phase was smaller in the drop jump compared to the countermovement jump. Due 
to similar MTU lengthening, they suggested the difference of fascicle lengthening could be 
attributed to the greater tendon elongation required in the drop jump. These findings suggest 
a modulating role of the patella tendon on the degree of VL fascicle lengthening, which is 
dependent on the movement being performed (Ishikawa et al., 2003). Thus, the above 
supports the hypothesis that the tendon may act as a ‘mechanical buffer’ (Reeves & Narici, 
2003; Roberts & Azizi, 2010). 
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 The role of the tendon in attenuating fascicle loading during eccentric contractions is 
particularly relevant when trying to address the previously reported sex differences in 
response to eccentric contractions (Sewright et al., 2008). It is well established that males 
have higher tendon stiffness than females (Kubo et al., 2003; Onambélé et al., 2007), which is 
associated with a direct impact of raised oestrogen levels on tendon properties (Bryant et al., 
2008). For example, Onambélé et al. (2007) reported patella tendon stiffness to be 57% 
higher in males compared to females. Even when corrected for tendon length and patella 
tendon cross-sectional area (PTCSA (Young’s modulus)), males’ tendon stiffness remained 
12% higher than females’. It is these sex differences in tendon properties that have 
previously been alluded to as the mechanism by which adult males experience greater levels 
of muscle damage following eccentric exercise compared to boys (Marginson et al., 2005). 
Although a lengthening of VL fascicles during eccentric knee extensions has been shown 
within chapter two and by Guilhem et al. (2011), to the authors’ knowledge, it is not known 
whether a sex difference in the elongation of muscle fascicles during eccentric contractions 
exists.  
Therefore, the aim of the present chapter was to determine whether patella tendon 
stiffness alters VL fascicle lengthening during eccentric contractions in males and females. In 
view of the evidence that males have stiffer tendons than females, it is hypothesised that 
fascicular lengthening during eccentric contractions would be greater in males compared to 
females.  
3.3. Materials and methods 
3.3.1. Subjects 
Nine males (22 ± 2 years of age, 71.9 ± 13.1 kg and 173 ± 8 cm) and nine females (21 ± 2 
years of age, 62.2 ± 6.9 kg and 165 ± 7 cm) volunteered to participate in this study. All 
participants self-reported as being recreationally active (undertaking no more than 1 hour of 
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“moderate” physical activity per week) and not undertaking any structured training regime. 
Due to the effects of the oral contraceptive pill on tendon properties (Bryant et al., 2008; 
Hansen et al., 2009b), females had no history of oral contraceptive pill (OCP) use. Ethical 
approval was obtained through the Department of Exercise and Sport Science, Manchester 
Metropolitan University and all participants signed informed consent prior to taking part in 
the chapter. All procedures complied with the Declaration of Helsinki (World Health 
Association, 2013). Exclusion criteria were established through participant questionnaire 
prior to testing. Exclusion criteria included an occupation or lifestyle that required regular 
heavy lifting or carrying, resistance trained in the last six months, the use of dietary 
supplements (e.g. Vitamin E), known muscle disorder, and any musculoskeletal injury in the 
last three months. Further exclusion criteria for female participants included, irregular 
menstrual cycles (where regular cycles were defined as 24-36 days (Cole et al., 2009; 
Landgren et al., 1980)), previous use of any other forms of hormone based contraception, and 
been pregnant or breast fed in the year preceding their application to participate in the 
present study.  
3.3.2. Testing protocol 
Participants were asked to visit the laboratory on two occasions, separated by two days; the 
first session consisted of anthropometric measures (stature and mass), VL anatomical cross-
sectional area (VLACSA), patella tendon moment arm (PTMA), and dynamometer familiarisation. 
Stature and mass were measured using a wall mounted stadiometer (Harpenden 
stadiometer, Holtain Crymych, UK) and digital scales (Seca model 873, Seca, Germany) 
respectively. Familiarisation included two practice MVCs, at two knee joint angles (90 
seconds rest). The second laboratory visit consisted of patella tendon stiffness measurements 
followed by measurement of VL fascicle length during eccentric contractions. All testing was 
carried out on the non-dominant leg. The non-dominant leg was defined as the leg that 
provided stability during movements, e.g. kicking. During the tendon properties and eccentric 
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test protocols, participants were secured (i.e. inextensible straps around the shoulders and 
hips to reduce any extraneous movement during maximal efforts) in a seated position to an 
isokinetic dynamometer (Cybex Norm, Cybex International, NY, USA), with a hip angle of 85. 
During pre-damage the isokinetic dynamometer settings (chair position, distance from the 
dynamometer, dynamometer arm length) and anatomical zero (leg full extended, knee angle 0) 
were recorded to ensure repeatability in the following sessions. 
3.3.3. Vastus lateralis anatomical cross-sectional area 
A real-time B-mode ultrasound (AU5 Harmonic, Esaote Biomedica, Genoa, Italy) was used to 
measure VLACSA. Participants laid supine with their leg full extended (knee angle 0), an 
ultrasound probe (7.5 MHz linear array probe, 38 mm wide) was used to identify the distal 
and proximal insertion sites of the VL. At 50% of VL muscle length echo-absorptive markers 
were placed in parallel, at intervals of 30 mm, from the medial to the lateral edge of the VL 
muscle. The ultrasound probe was placed perpendicular to the VL muscle in the axial plane. 
The ultrasound probe was moved slowly across the echo-absorptive markers from the medial 
to the lateral edge of the muscle. Consistent minimal pressure was placed on the muscle 
during scanning to avoid compression of the muscle. The images were recorded in real time 
onto a PC at 25 frames per second (Adobe Premier pro Version 6). At each 30 mm interval, 
individual images were acquired using capturing software (Adobe Premier Elements, version 
10). The shadows cast by the echo-absorptive markers allowed the images to be aligned by 
the contour of the muscle and the entire VLACSA to be recreated in a single image (Adobe 
Photoshop Elements, version 10). The VLACSA was then measured using digitising software 
(ImageJ 1.45, National Institutes of Health, USA). This method for calculating VLACSA has 
previously been accepted as reliable and valid when compared to MRI, with a reported 
interclass correlation between 0.998 and 0.999, for reliability and validity respectively 
(Reeves et al., 2004). Furthermore, chapter two confirms high reliability and low day-to-day 
measurement error for measuring VLACSA using the present ultrasound technique. 
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Within males a VLACSA of 24.3 cm2 has previously reported to contribute to ~32% of total 
quadriceps anatomical cross-sectional area ((QACSA) QACSA = 74.9 cm2 (Tsakoniti et al., 2008)). 
Whereas in females, a VLACSA of ~21 cm2 has been reported to contribute to 38% of QACSA 
(QACSA = ~55 cm2 (Grosset & Onambele‐Pearson, 2008)). Therefore, assuming all things equal, 
and the contribution of VLACSA remains constant within males and females, QACSA within males 
and females was estimated by dividing VLACSA by 32% and 38% respectively.  
3.3.4. Patella tendon length and cross-sectional area 
Patella tendon cross-sectional area and patella tendon length (PTL) were measured, seated in 
the isokinetic chair with the knee fixed at 90 knee angle. The distance between the tibial 
tuberosity and the apex of the patella, marked using sagittal ultrasound images, was taken as 
PTL. To measure PTCSA the ultrasound probe was placed in the transverse plane and images 
were captured at 25%, 50%, and 75% of PTL. The images were subsequently analysed offline 
using (ImageJ 1.45, National Institutes of Health, USA). A mean of the three images was taken as 
PTCSA (O’Brien et al., 2010). 
3.3.5. Patella tendon moment arm 
In order to calculate patella tendon force PTMA was measured at a knee joint angle of 90 (full 
extension = 0) in the sagittal plane, from a single energy (frame 23.3 cm x 13.7 cm) DEXA 
scan (Hologic Discovery, Vertec Scientific Ltd, UK). A goniometer was used to ensure the knee 
angle was 90. Using OsiriX, (DICOM viewer, ver. 4.0, Pixemo, Switzerland) the perpendicular 
distance from the center of the patella tendon to the tibio–femoral contact point was 
determined as the PTMA length (Baltzopoulos, 1995). Compared to the MRI, the DEXA has 
been reported a reliable and valid technique when measuring moment arm length (Erskine et 
al., 2014). Furthermore, chapter two confirms the reliability of DEXA when measuring PTMA. 
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3.3.6. Force- elongation relationship / patella tendon stiffness 
With the knee angle fixed at 90 in the isokinetic dynamometer the participants were 
instructed to perform a ramped maximal voluntary knee extension (MVCKE) lasting ~6 
seconds. Concomitantly, ramped MVCKE torque and displacement of the patella tendon were 
recorded. Patella tendon displacement was measured over two MVCKE, once with the 
ultrasound probe positioned over the tibial tuberosity and on the second contraction over the 
apex of the patella. This is consistent with Onambélé et al. (2007) as a means of obtaining 
total patella tendon displacement. Torque was displayed on a Macintosh G4 computer (Apple 
Computer, Cupertino, CA, USA), via an A/D converter (Biopac Systems, Santa Barbara, CA) 
and subsequently analysed with the accompanying software (Acknowledge, version 3.9.2). 
Patella tendon displacement was measured by positioning the ultrasound probe (7.5 MHz 
linear array probe, 38 mm wide) in the axial-plane on the tibial tuberosity (or the apex of the 
patella during alternate contractions). An echo-absorptive marker was placed on the skin to 
cast a shadow on the ultrasound and act as an external marker. The distance of the shadow 
from an internal marker at the beginning of the contraction, to the position of the shadow at 
the end of the contraction, allows patella tendon excursion to be measured. Ramped MVCKE 
torque and displacement of the patella tendon were synchronised using a 10-V square wave, 
signal generator. Images were captured at ~10% intervals of ramped MVCKE torque 
(Onambélé et al., 2007). Total patella tendon displacement was calculated as displacement at 
the tibial tuberosity plus the displacement at the apex of the patella (Onambélé et al., 2007). 
Patella tendon forces were calculated as: (MVCKE torque + antagonist co-activation torque) / 
PTMA. The measurement of antagonist co-activation torque is described below. The force – 
elongation curve stemming from data at every 10% MVCKE was then fitted with a second-
order polynomial function, forced through zero (Onambélé et al., 2007), and the tangential 
slope at discreet sections of the curve, relative to MVCKE, was computed by differentiating the 
curve at each point of interest (i.e. every 10% force intervals). To account for between subject 
 81 
 
differences in maximal force production, the slope of the tangential line, corresponding to the 
MVCKE of the weakest participant (regardless of sex), was computed for each subject. This 
therefore standardised the comparison of tendon stiffness and Young’s modulus at an 
absolute load, hereafter referred to as standardised force patella tendon stiffness and Young’s 
modulus.  
3.3.7. Co-activation 
Electromyogram amplitude of the bicep femoris (BF) was measured to determine co-
activation during the ramped MVCKE. Guided by an axial-plane ultrasound of the BF, two 
bipolar electrodes (Ambu, Neuroline 720, Malaysia) were placed in the mid-sagittal line at 
75% of BF muscle length (distal end = 0%). A reference electrode (Ambu, blue sensor, 
Malaysia) was placed on the lateral tibia condyle. The electrodes were placed in a bipolar 
configuration with a constant inter-electrode distance of 20 mm (Hermens et al., 2000). 
Preceding electrode placement; the skin was shaved, abraded and cleansed with an alcohol 
wipe to reduce skin impedance below 5000 Ω (Hermens et al., 2000). The participants were 
asked to contract and relax to ensure correct electrode placement. The raw EMG signal was 
amplified (×2000) and filtered (through low and high pass filters; i.e. 10 and 500 Hz 
respectively) with the sampling frequency set at 2000 Hz. Ramped MVCKE torque and BF EMG 
were recorded in real time and synchronised using a (10-V) square wave signal generator. In 
the isokinetic dynamometer, participants were asked to perform two maximal voluntary 
knee flexions (MVCKF) at 90 knee angle. Participants were instructed to perform MVCKF as 
quickly and as forcefully as possible against the dynamometer’s lever arm. The participants 
were instructed to stop contracting once a two second plateau had been attained (as 
observed on the dynamometer screen display). The integral of the root mean square of the BF 
EMG signal, was calculated 500 ms either side of instantaneous MVCKF maximal torque from 
the contraction corresponding to the highest MVCKF torque. Prior to contraction the baseline 
signal noise was calculated as the integral root mean square over 1s and removed from the 
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measured EMG during MVCKF and MVCKE. The absolute integral of the BF EMG was taken over 
250 ms at every 10% of ramped MVCKE torque. Co-activation torque was calculated as, (BF 
EMG during ramped MVCKE / BF EMG during MVCKF) × peak MVCKF torque (Onambélé et al., 
2007). This equation assumes that the BF is representative of the entire hamstring (Carolan 
& Cafarelli, 1992), and that a linear relationship exists between BF EMG and MVCKF torque 
(Lippold, 1952). 
3.3.8. Patella tendon stress / strain relationship 
Patella tendon stress was calculated as, patella tendon force / PTCSA. Tendon strain was 
calculated as a ratio of total patella tendon displacement and PTL. 
3.3.9. Patella tendon Young’s modulus 
Young’s modulus was calculated as: patella tendon stiffness × (PTL (mm) / PTCSA (mm2)) at 
MVCKE. Furthermore, Young’s modulus was calculated with patella tendon stiffness 
standardised to the MVCKE force of the weakest participant.  
3.3.10. Eccentric exercise 
A warm-up of 10 isokinetic knee extensions and knee flexions, ensuring a progressive 
increase in effort (with the last contraction being maximal), was carried out prior to eccentric 
exercise. For the eccentric exercise, the knee extensor range of motion was set at 20 – 90 (0 
= full extension). Participants were asked to perform 1 set of 12 maximal voluntary eccentric 
knee extensions (MVEKE) repetitions. During the eccentric phase (knee angle 20 to 90), 
contractions were performed at an isokinetic angular velocity of 30s-1 (Saka et al., 2009). 
The concentric phase was performed sub-maximally at an angular velocity of 60s-1 to 
minimise fatigue and enhance eccentric damage (Chapman et al., 2006). Visual and verbal 
encouragement was continuously provided throughout the eccentric exercise (Campenella et 
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al., 2000). MVEKE torque was recorded throughout each MVEKE and displayed via the torque 
acquisition system.  
3.3.11. Change in vastus lateralis fascicle length during the eccentric protocol 
To measure VL fascicle length during MVEKE, the ultrasound probe was fixed at 50% of VL 
muscle length in the mid-sagittal plane of the non-dominant leg. A hypo-allergenic ultrasound 
gel (Parker, Park Laboratories Inc., Fairfield) was used to enhance coupling between skin and 
the ultrasound probe.  
During the 12 MVEKE contractions, ultrasound images were recorded onto a PC, in 
real time, at 25 frames per second (Adobe Premier pro Version 6). An externally generated 
square wave pulse was used to synchronise the ultrasound images with the torque 
acquisition system. Three MVEKE contractions were randomly chosen from the 12 repetitions 
for architectural analysis. Using frame capture software (Adobe Premier Elements, version 
10), an ultrasound image (frame corresponding to every 10 of knee angle, ranging from 20- 
90) was acquired for offline analysis. To ensure there was no movement artefact included in 
the assessment of fascicle length, an echo-absorptive marker was fixed on the skin to provide 
a visual baseline of the internal structures. If movement of the probe was observed relative to 
the VL, the contraction was discarded and another MVEKE contraction was chosen for 
analysis.  
Using digitising software (ImageJ 1.45, National Institutes of Health, USA), VL fascicle 
length was analysed offline at every 10 of knee joint angle. Fascicle length was measured 
from the visible insertion of the fibre into either the deep or superficial aponeurosis (Reeves 
& Narici, 2003). The fascicle was only measured if it remained visible across the entire 
ultrasound image. Where the fascicle extended beyond the ultrasound image (frame width 
3.50 cm and height 4.15 cm), linear continuation of the fascicle and aponeurosis was 
assumed. Using ultrasound a 2-7% error has been associated with assuming linear 
continuation to calculate VL fascicle length at 120 knee angle (Finni et al., 2003a). Recently, 
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when comparing ultrasound to cadaveric measurements’, the linear extrapolation method 
has been concluded as a valid technique for measuring VL fascicle length at rest (ICC = 0.853) 
(Ando et al., 2014). Additionally, within chapter two the current thesis reports high reliability 
and low day-to-day measurement error when measuring VL fascicle length during MVEKE. To 
reduce error associated with the estimation of VL fascicle length, an average of three fascicles 
across the image was taken (Guilhem et al., 2011). Change in fascicle length was calculated at 
each angle by subtracting the fascicle length reported at knee angle 20. Change in fascicle 
length at each angle was made relative to fascicle length at 20.  
3.3.12. Vastus lateralis excursion 
In order to estimate the total VL MTU elongation, the tendon excursion method was adopted 
(Spoor et al., 1990); whereby the change in knee angle (70, 1.22 rad) was multiplied by 
measured PTMA at 90 knee angle.  
3.3.13. Statistics 
All statistical analyses were carried out using the statistical software package SPSS (v.19, 
Chicago, IL) for Windows and Microsoft Excel. To ensure the data were parametric, the 
Shapiro-Wilk and Levene’s tests were utilized to assess the normality and variance of the 
data. These statistical assumptions were not breached. For sex differences in anthropometric 
measures, VL fascicle length and patella tendon properties, Independent T-tests were used. A 
2 × 8 mixed design ANOVA (between factors: sex (2 levels), and knee angle (8 levels)) was 
used for MVEKE torque, MVEKE torque corrected for QACSA, and change in VL fascicle length. 
Wherever the assumption of sphericity was violated, the Greenhouse-Geisser correction was 
used. When a significant group effect was found, post-hoc Independent T-tests (planned 
contrast) with LSD correction were carried out. Pearson’s correlations were used to 
investigate whether significant associations were present at 90 between 1) MVEKE corrected 
for QACSA and change in fascicle length 2) patella tendon stiffness, at MVCKE and change in 
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fascicle length and, 3) Young’s modulus, at MVCKE, and change in fascicle length. Significance 
was set at p ≤ 0.05. Data are presented as mean ± standard deviation.  
3.4. Results 
3.4.1. Anthropometric measurements  
There were no significant difference in age (males aged 22 ± 2 years, females aged 21 ± 2 
years, p = 0.449) and mass (males 71.9 ± 13.1 kg, females 62.2 ± 6.9 kg, p = 0.066) in males 
compared with females. Males were significantly taller than the females (173 ± 8 cm and 165 
± 7 cm, respectively, p = 0.045).  
3.4.2. Vastus lateralis anatomical cross-sectional area 
VLACSA was significantly higher in males compared to females (23.4 ± 2.9 cm2 and 19.5 ± 3.8 
cm2 respectively, p = 0.030). Estimated QACSA was significantly higher in males compared to 
females (73.0 ± 9.2 cm2 and 51.4 ± 10.1 cm2 respectively, p = 0.0002). 
3.4.3. Patella tendon properties 
PTL (males 5.73 ± 0.50 cm, females 5.16 ± 0.55 cm, p = 0.034), PTCSA (males 0.81 ± 0.16 cm2, 
females 0.62 ± 0.14 cm2, p = 0.016) and PTMA (males 4.30 ± 0.27 cm, females 4.0 ± 0.29 cm, p = 
0.023) were significantly greater in males compared to females. Ramped MVCKE torque was 
significantly higher in males compared to females at every 10% MVCKE torque (p ≤ 0.01). 
Patella tendon force was significantly higher in males compared to females at every 10% 
MVCKE torque ((p ≤ 0.05), Table 3. 1.). Patella tendon elongation was not significantly 
different between males and females at any 10% MVCKE torque (Table 3. 1). Patella tendon 
stiffness, at MVC, was significantly higher in males compared to females (≥ 50% MVCKE p ≤ 
0.05, < 50% MVCKE p ≤ 0.01, (Table 3. 1)). The greater patella tendon stiffness in males was 
reflected in a relative shift to the left (compared to the females’ trend line) in the patella 
tendon force-elongation curve (Table 3.1). 
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Table 3. 1: Structural and mechanical patella tendon properties in males and females, in vivo. 
Sex MVCKE (%) Tendon force (N) Elongation (mm) Stiffness (N·mm-1) 
F
em
al
es
 
10 317 ± 47 1.81 ± 0.82 256 ± 59 
20 633 ± 93 3.01 ± 0.95 334 ± 84 
30 951 ± 139 3.97 ± 0.88 397 ± 106 
40 1267 ± 185 4.55 ± 1.03 450 ± 127 
50 1583 ± 229 5.46 ± 1.05 498 ± 144 
60 1899 ± 274 6.07 ± 1.25 541 ± 160 
70 2217 ± 319 6.46 ± 1.35 581 ± 174 
80 2535 ± 365 7.14 ± 1.15 619 ± 188 
90 2855 ± 412 7.64 ± 1.25 655 ± 201 
100 3177 ± 460 8.06 ± 1.51 689 ± 214  
          
M
al
es
 
10 411 * ± 94 1.90 ± 1.09 443 ± 264 
20 821 * ± 187 3.05 ± 1.34 568* ± 271 
30 1233* ± 281 4.08 ± 1.66 668* ± 285 
40 1646* ± 376 4.89 ± 1.50 754* ± 301 
50 2061* ± 472 5.56 ± 1.69 829* ± 315 
60 2475* ± 567 5.98 ± 1.75 901** ± 333 
70 2888* ± 660 6.36 ± 1.75 966** ± 349 
80 3302* ± 756 6.63 ± 1.84 1027** ± 365 
90 3725* ± 858 7.00 ± 2.12 1085** ± 381 
100 4136* ± 945 7.25 ± 2.18 1139** ± 395 
 
Note: MVCKE (%): ramped isometric maximal voluntary knee extension. Data is presented as means and standard deviations. * p ≤ 0.05, ** p ≤ 0.01.
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Young’s modulus at MVCKE was significantly higher (p = 0.014) in males (811 ± 263 MPa) 
compared to females (582 ± 186 MPa). To account for the significantly higher MVCKE torque 
in males, a patella tendon force of 2330N (corresponding to the highest MVCKE torque of the 
weakest participant (independent of sex)) was used to calculate standardised force level 
patella tendon stiffness and Young’s modulus. Standardised force patella tendon stiffness 
(males 880 ± 293 Nmm1, females 553 ± 179 Nmm1, p = 0.013) and standardised force 
Young’s modulus (males 632 ± 213 MPa, females 498 ± 137 MPa, p = 0.033) remained 
significantly higher in males compared to females.  
 
Figure 3. 1: Change in VL fascicle length from 20, at each knee angle (20-90) during 
eccentric exercise in males and females. Data is reported as mean and standard deviations. * 
p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.  
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3.4.4. Change in vastus lateralis fascicle length during eccentric exercise 
A two-way mixed repeated measures ANOVA for change in VL fascicle length, reported a 
significant main effect of angle (p ≤ 0.001) and a significant group effect of sex (p = 0.004), 
with a significant interaction effect (p = 0.001). A planned contrast showed at 30 - 90, change 
in fascicle length was significantly higher in males compared to females (p ≤ 0.05, Figure 3. 1). 
When the change in fascicle length was made relative to fascicle length at 20 knee angle, male’s 
fascicles increased by 57.6 ± 10.9% and females increased by 39.6 ± 9.8% at 90 knee angle. 
Thus, relative fascicle length increased significantly further in males compared to females (p = 
0.002). 
 
Figure 3. 2: Correlation between patella tendon Young’s modulus and change in vastus 
lateralis fascicle length. Note: R2 value is for the entire sample.  
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3.4.5. Maximal voluntary eccentric knee extensor torque 
MVEKE torque showed a significant main effect of angle (p ≤ 0.001) and a significant group 
effect of sex (p = 0.004), with a significant interaction effect (p = 0.020). A planned contrast 
demonstrated that MVEKE torque was significantly higher in males compared to females at 
60 (males 148 ± 33.2 Nm, females 101 ± 30.4 Nm, p = 0.007), 70 (males 160 ± 38.9 Nm, 
females 99.2 ± 29.1 Nm, p = 0.002) and 80 (males 145 ± 33.8 Nm, females 88.9 ± 28.8 Nm, p 
= 0.002). Independent T-test showed that peak MVEKE torque was significantly higher in 
males compared to females (161 ± 0.67 Nm, 113 ± 1.36 Nm, respectively, p = 0.015).  
When MVEKE torque was made relative to QACSA (i.e. MVEKE torque / QACSA) a significant 
main effect of knee angle (p = 0.0004) was observed but no effect of sex (p = 0.979), or an 
interaction effect was reported (p = 0.367). No significant difference in peak MVEKE made 
relative to QACSA was reported between males and females (2.24 ± Nm/cm2, 2.25 ± 0.74 
Nm/cm2, respectively, p = 0.969). 
3.4.6. Vastus lateralis excursion 
Based on the tendon moment arm excursion, the estimated increase in VL MTU length from 
20-90 was significantly greater in the males compared to the females (5.25 ± 0.33 cm, 4.84 ± 
0.35 cm, respectively, p = 0.023). 
3.4.7. Correlation 
Pearson’s correlations were conducted at 90 knee angle, as the change in fascicle length was 
greatest at this angle. There was no correlation between change in fascicle length and peak 
MVEKE (r = 0.336, p = 0.173) or peak MVEKE / QACSA (r = 0.049, p = 0.848). A significant, 
although weak, correlation between patella tendon stiffness at MVCKE and change in fascicle 
length was reported (r = 0.476, p = 0.023). A significant correlation between patella tendon 
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Young’s modulus at MVCKE and change in fascicle lengthening was reported (r = 0.508, p = 
0.016, Figure 3. 2).  
3.5. Discussion 
The aim of the present chapter was to determine whether patella tendon stiffness alters VL 
fascicle lengthening during MVEKE in males and females. There were three main findings, 1) 
VL fascicles lengthen during MVEKE, 2) in agreement with our hypothesis, the change in VL 
fascicle length and relative change in fascicle length during eccentric contractions was 
significantly greater in males compared to females, 3) a significantly longer PTMA, higher 
tendon stiffness and Young’s modulus in males compared to females, partially accounts for 
increased fascicle lengthening under loading. 
 Consistent with the classical definition of eccentric contractions and the findings of 
Guilhem et al., (2011) the current chapter reported a lengthening of VL fascicles during 
MVEKE. A lengthening of VL fascicles has previously been reported during eccentric 
movements (Finni et al., 2001), with greater lengthening during a low intensity 
countermovement jump compared to a drop jump where the fascicle lengthening was 
minimal. As a result of similar MTU lengthening between the two jumps, Finni et al. (2001), 
attributed the difference in fascicle lengthening to the greater elongation of the tendon and 
higher EMG activity found in the drop jump. The difference in fascicle behaviour was further 
explained by Ishikawa et al., (2003) who reported VL fascicle lengthening to reduce, and 
patella tendon elongation to increase when the rebound intensity of the drop jump was 
increased. These findings suggest the interaction between the fascicles and tendon during the 
eccentric phase allows for the fascicle to operate on the most ‘efficient’ part of the force–
lengthening relationship, for greater rebound intensities (Ishikawa et al., 2003). Therefore 
although the previous literature and the current chapter report a lengthening of VL fascicles 
during eccentric movements, it should also be clear that the magnitude of lengthening is 
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regulated by the amount of tendon elongation, the type of eccentric task and intensity of the 
task itself (Ishikawa et al., 2003; Finni et al., 2001).  
In the current chapter, change in VL fascicle length was found to be significantly 
higher in males compared to females during MVEKE. The significant difference remained when 
change in fascicle length was made relative to fascicle length at 20. To the best of the 
authors’ knowledge, sex differences in fascicle behaviour during eccentric contractions have 
yet to be reported. The observed sex difference in fascicle behaviour during eccentric 
contractions can be partially attributed to the observed difference in patella tendon 
compliance. Although sex differences remain unreported, the role of the tendon and group 
differences in fascicle lengthening during eccentric phases of gait have recently been 
considered (Mian et al., 2007). For example, Mian et al. (2007) suggested that the group 
differences in the fascicle behaviour of young and elderly participants might be a result of 
reduced tendon stiffness in the elderly; however this was not confirmed experimentally in 
their study.  
The idea that the tendon acts as a mechanical buffer and attenuates fascicle 
lengthening however is not novel (Fukunaga et al., 2001; Spanjaard et al., 2007; Reeves & 
Narici, 2003). Litchwark et al. (2007) used a three element Hill muscle model to predict the 
effect of different levels of tendon stiffness on the behaviour of fascicle lengthening during 
gait. They predicted that increasing Achilles tendon stiffness, increased the required amount 
of gastrocnemius medialis fascicle lengthening during the stance phase of gait (Lichtwark & 
Wilson, 2007). Thus further supporting the hypothesis that the tendon may modulate 
eccentric fascicle lengthening (Reeves & Narici, 2003; Roberts & Azizi, 2010). The accuracy of 
the model remains in question however, as Litchwark et al. (2007), did not take into account 
fibre pennation angle and used a linear model for tendon stiffness despite tendon being 
known to have a non-linear force-elongation relationship (Maganaris & Paul, 2002). The 
current chapter however, provides in vivo evidence to demonstrate the association between 
patella tendon properties and VL fascicle lengthening. In agreement with previous literature 
  
92 
 
(Onambélé et al., 2007; Kubo et al., 2003), the current chapter reported significantly higher 
patella tendon stiffness and Young’s modulus, at MVCKE, in males compared to females. This 
significant difference remained when patella tendon stiffness and Young’s modulus was 
calculated at a standardized absolute force level of 2330N. Significant correlations were 
found between 1) Patella tendon stiffness when calculated at MVCKE and change in VL fascicle 
length and 2) Young’s modulus, when calculated at MVCKE and change in VL fascicle length. 
Thus, greater fascicle lengthening in males can be partially attributed to, the significantly 
higher patella tendon stiffness and Young’s modulus in males. Although the attenuating role 
of the tendon on fascicle behaviour has been alluded to previously, the current chapter 
provides in vivo evidence to support previous models (Lichtwark & Wilson, 2007) and 
hypotheses (Reeves & Narici, 2003; Spanjaard et al., 2007; Fukunaga et al., 2001).  
In addition to the tendon one of the other contributory factors to greater fascicle 
elongation in males could be the greater MVEKE torque. MVEKE torque was significantly higher 
at 60, 70 and 80 in males compared to females. Furthermore, peak MVEKE torque was 
significantly higher in males compared to females. Males however, were estimated to have 
significantly larger QACSA compared to females. When peak MVEKE torque was corrected for 
QACSA (stress), there was no significant difference between males and females. Torque was 
therefore ‘distributed evenly’ over QACSA in both males and females. Furthermore, a significant 
correlation between MVEKE torque and change in fascicle length was not observed in the 
current chapter. Therefore, although the current chapter cannot completely dismiss the 
contribution of greater eccentric torque on fascicle lengthening, the findings conclude no 
difference in relative MVEKE torque, or any correlation with change in VL fascicle length. 
During isokinetic contractions the lengthening of the MTU through a range of motion 
is affected by the joint kinetics specifically, the joint moment arm (Spoor et al., 1990; Visser et 
al., 1990; Herbert et al., 2002). During knee extension, the most influential moment arm, is 
the PTMA (Erskine et al., 2014). Males had a significantly longer PTMA than females thus, in 
order to establish whether there was a significant contribution of the PTMA to the fascicle 
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elongation MTU elongation was estimated based on the tendon excursion method (Spoor et 
al., 1990). Although this method estimates the entire quadriceps MTU elongation, the current 
chapter estimated a significantly greater MTU elongation in males compared to females (5.24 
cm and 4.84 cm, respectively). Therefore, the difference in PTMA contributes to the difference 
in fascicle lengthening. Based on measured fascicle lengthening of 4.07 cm in males and 2.63 
cm in females, the current chapter calculated that 89% and 54% (males and females 
respectively) of the estimated total change in MTU length, from 20-90, could be attributed to 
an increase in the fascicle length. It is therefore likely that the remaining portion of the 
increase in MTU length (11% and 46% in males and females, respectively), which is not 
attributed to this increase in fascicle length, may be due to the in series elastic component. 
Highlighting that although PTMA may contribute to VL fascicle lengthening, the sex differences 
in VL fascicle lengthening can be attributed to the sex differences in patella tendon stiffness.  
Although the current chapter has provided evidence to support the role of patella 
tendon stiffness on VL fascicle lengthening during MVEKE, it is acknowledged that the elastic 
component also incorporates the aponeurosis. It is however unclear how the distinct 
contributions of the tendon vs. the aponeurosis may interplay since the relative mechanical 
properties of the aponeurosis are indeterminate with reports of significantly higher 
(Maganaris & Paul, 2000), significantly lower (Magnusson et al., 2003) or similar (Arampatzis 
et al., 2005) strain values to the tendon. It should be noted that the apparent variability 
within these cited studies could be attributed to different participant activity levels, the 
specific anatomical MTU investigated and the method used to determine MTU lengthening. 
Therefore, a limitation of the current chapter is that the mechanical properties of the VL 
aponeurosis alongside those of the tendon cannot be reported; hence the current chapter 
cannot determine the contribution of the VL aponeurosis to VL fascicle lengthening 
behaviour. However, it remains that a longer VL fascicle elongation in males compared to 
females is attributable to a larger PTMA, and an increase in stiffness of the in series elastic 
components, that of the patella tendon in particular. 
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3.6. Conclusion 
In conclusion the current chapter demonstrates that during eccentric contractions, VL 
fascicles lengthen significantly further in males compared to females. The significant 
difference in lengthening may be partly attributed to the significantly longer PTMA, higher 
patella tendon stiffness and Young’s modulus found in males compared to females. The 
current chapter provides in vivo evidence to support the hypothesis that the tendon acts as a 
mechanical buffer during eccentric contractions. Future research needs to investigate the 
contribution of the aponeurosis to the lengthening of the fascicles during eccentric 
contractions.  
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Chapter four: Fascicle lengthening and maximal voluntary 
eccentric torque are not associated with indirect markers 
of EIMD. 
 
 
 
 
 
 
 
 
 
 
Chapter four was presented at the 19th annual Congress of the European College of Sport 
Science – Amsterdam 2014. The abstract was entered into the Young Investigators Award 
and published in the congress Book of Abstracts. 
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4.1. Abstract 
Aim: The aim of the current chapter was to establish whether patella tendon properties, 
eccentric torque and vastus lateralis fascicle lengthening are associated with the magnitude of 
indirect markers of exercise-induced muscle damage (EIMD). Materials and method: 16 
recreationally active males performed maximal voluntary eccentric knee extensions (12 reps 
x 6 sets), during which vastus lateralis fascicle lengthening and eccentric torque were 
recorded every 10 (range of motion 20-90). Maximal isometric torque loss, Creatine Kinase 
activity (CK) and muscle soreness were measured pre-damage, post damage, 48, 96 and 168 
hours post damage as markers of EIMD. Results: Change in CK (peak CK value - pre CK value 
(33)) significantly correlated with relative VL fascicle lengthening ((from 20 to 90 knee 
angle), r = 0.534, p = 0.017). Neither ΔCKABS to peak nor loss in maximal isometric knee 
extensor torque, correlated with any other indirect marker of EIMD. Conclusion: The current 
chapter concludes that VL fascicle lengthening and eccentric torque are not associated with 
functional indirect markers of EIMD.  
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4.2. Introduction 
Unaccustomed eccentric exercise is accepted as the greatest cause of exercise-induced muscle 
damage (EIMD), however there is considerable variability in the range of EIMD reported 
within the literature (see Clarkson and Hubal (2002) and Hyldahl and Hubal (2014) for a 
review). The cause of differences in EIMD have been attributed to the level of fascicle strain 
experienced within the muscle (isolated rabbit muscle) (Lieber & Friden, 1993), the level of 
eccentric force the muscle is exposed to during eccentric contractions (in vitro rat muscle) 
(Warren et al., 1993a), the architectural properties of the muscle (in vivo human upper and 
lower limb)(Chen et al., 2011), the elastic properties of the tendon (although not confirmed 
experimentally) (Marginson et al., 2005; McHugh et al., 1999) and circulating oestrogen 
levels (in vivo human quadriceps)(Carter et al., 2001). While these determinants have mainly 
been identified in various animal studies (Lieber & Friden, 1993; Warren et al., 1993a), they 
may not be directly applicable to in vivo human studies. 
Although EIMD has previously been associated with the high torque and fascicle 
strain produced during eccentric contractions in animal studies (Lieber & Friden, 1993; 
Warren et al., 1993a), within human studies experimental evidence investigating the 
association between fascicle lengthening (Hoffman et al., 2014) and eccentric torques (Hody 
et al., 2013; Chapman et al., 2008) with EIMD remains limited. For example, Hoffman et al. 
(2014) reported no significant correlation between maximal gastrocnemius fascicle 
lengthening and plantar flexion MVC torque loss following a damaging bout of backwards 
walking. However, during backwards walking the magnitude of fascicle lengthening is small 
(~18% (Hoffman et al., 2014)) compared to fascicle lengthening in chapter 3 (~58%). 
Therefore it remains unknown if in vivo, using a more severe damaging protocol and 
investigating a greater magnitude of fascicle lengthening, whether fascicle lengthening may 
be associated with indirect markers of EIMD.  
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Recently, studies have alluded to the properties of the tendon being associated with EIMD 
(Roberts & Azizi, 2010; Roberts & Konow, 2013; McHugh et al., 1999; Hoffman et al., 2014). 
For example Hoffman et al. (2014) concluded that no relationship between fascicle 
lengthening and EIMD may have been reported due to the Achilles tendon accounting for 
~90% of total muscle tendon unit (MTU) lengthening. Within chapter three it was reported 
that the patella tendon mediates VL fascicle lengthening during eccentric contractions, thus 
supporting the hypothesis that the tendon may prevent sarcomeres extending onto the 
descending limb of the length-tension relationship (Hoffman et al., 2014). Furthermore, the 
tendon has also been suggested to reduce EIMD by mediating peak force, peak torque and 
fascicle lengthening velocity (Roberts & Azizi, 2010; Roberts & Konow, 2013). However, the 
association between tendon properties and indirect markers of EIMD remain speculative and 
has not been evidenced experimentally in vivo. 
In addition to the potential association between tendon properties and EIMD, muscle 
architecture has also been proposed to have an association with EIMD (Chen et al., 2011; 
Roberts & Konow, 2013). Chen et al. (2011) reported EIMD to be greatest in the upper limbs 
(specifically elbow flexors), with the lower limbs (specifically knee extensors) exhibiting the 
least damage. Chen et al. (2011) attributed the differences in EIMD to relatively larger 
pennation angles, muscle length and fibre orientation in the knee extensors compared to the 
elbow flexors. Although muscle architecture has been alluded to as a determinant of EIMD by 
Chen et al. (2011), to the current author’s knowledge it has yet to be investigated 
experimentally. 
Eccentric torque, fascicle lengthening, tendon and muscle properties have all been 
associated with EIMD, particularly in animal studies (Lieber & Friden, 1993; Warren et al., 
1993a), however animal studies may not be directly comparable to in vivo human studies for 
a couple of reason. Firstly, strain values used in animal studies (Lieber & Friden, 1993) are 
considerably larger than those reported in vivo (Hoffman et al., 2014) (125% versus 18%, 
respectively) (Butterfield, 2010). Secondly, protein metabolism and caspase pathways (i.e. 
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caspase 8 and 10 regarding cell death and lymphocyte activation) are significantly different 
between animal and human studies (for a review please refer to Sakamaki and Satou (2009) 
and Phillips et al. (2009)). Therefore measuring and establishing variables associated with 
EIMD directly in vivo is essential to further our knowledge in the events leading to EIMD and 
to further understand group differences (and / or within group variability) in EIMD. 
Therefore the aim of this chapter was to establish whether patella tendon properties, 
eccentric torque and VL fascicle lengthening are associated with indirect markers of EIMD, 
including creatine kinase (CK) and maximal voluntary isometric knee extension (MVCKE) 
torque loss. 
4.3. Materials and method 
4.3.1. Subjects 
16 males (21.1 ± 1.6 years of age, 72.0 ± 7.5 kg and 176 ± 6 cm) signed written informed 
consent to participate in this study. All participants self-reported as being recreationally 
active (undertaking no more than 1 hour of “moderate” physical activity per week) and did 
not take part in any structured resistance training. All experimental procedures complied 
with the Declaration of Helsinki (World Health Association, 2013) and ethical approval was 
obtained through the local Ethics Committee. Exclusion criteria were, any resistance training 
in the last six months, occupation or lifestyle that required regular heavy lifting or carrying, 
any known muscle disorder, the use of dietary supplements (i.e. vitamin E), and any 
musculoskeletal injury in the last three months. All inclusion and exclusion criteria were 
determined via a questionnaire. 
4.3.2. Testing protocol 
Once selected, participants were asked to visit the laboratory on five different occasions over 
nine days. The sessions were as follows: 1) pre-damage 2) damage (48 hours post pre-
damage), 3) 48 hours post damage, 4) 96 hour post damage, and 5) 168 hour post damage. Pre-
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damage assessments consisted of stature and mass (anthropometric measures), patella 
tendon moment arm (PTMA), 5-6ml blood sample, dynamometer familiarisation (within pre-
damage), morphological measures of the patella tendon (tendon size and stiffness), VL 
(muscle size and architecture), and MVCKE torque measurements at six knee angles (60, 65, 
70, 75, 80 and 90 (0 = full extension). Participants were tested at six knee angles to obtain 
optimal knee angle for MVCKE torque. Participants only performed two practice MVCs, at two 
knee joint angles during the familiarisation session. Stature and mass were measured using a 
wall mounted stadiometer (Harpenden, Holtain Crymych, UK) and digital scales (Seca model 
873, Seca, Germany) respectively. The damage session consisted of eccentric exercise, 5-6 mL 
venous blood sample and MVCKE torque measurements. 48, 96 and 168 hours session 
consisted of 5-6 mL blood sample and MVCKE torque measurements at all six knee angles (60, 
65, 70, 75, 80 and 90). 
All tests were carried out in the self-reported, non-dominant leg, defined as the leg 
that provided stability during movements. Participants were seated in an isokinetic 
dynamometer (Cybex Norm, Cybex International, NY, USA), with a hip angle of 85 (0 = 
supine). To reduce any extraneous movement during maximal efforts, participants were 
secured in a seated position using inextensible straps around the shoulders and hips. The 
isokinetic dynamometer axis of rotation was visually aligned with the estimated knee joint’s 
centre of rotation. During pre-damage testing the isokinetic dynamometer settings (chair 
position, distance from the dynamometer, dynamometer arm length) and anatomical zero (leg 
full extended, knee angle 0) were recorded to ensure repeatability in the following sessions.  
4.3.3. Vastus lateralis anatomical cross-sectional area  
Vastus lateralis anatomical cross-sectional area (VLACSA) was measured at 50% of VL length 
using a real-time B-mode ultrasound (AU5 Harmonic, Esaote Biomedica, Genoa, Italy). With 
the participant laid supine and their non-dominant leg fully extended (knee angle = 0), the 
distal and proximal insertions sites of the VL were identified using an ultrasound probe (7.5 
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MHz linear array probe, 38 mm wide). At 50% of VL muscle length echo-absorptive markers 
were placed in vertically in parallel, at intervals of 30 mm, from the lateral to the medial edge 
of the VL muscle. The ultrasound probe was held perpendicular to the VL muscle in the axial 
plane. The ultrasound probe was moved steadily over the echo-absorptive markers from the 
lateral to the medial edge of the muscle. Constant, light pressure was placed on the muscle 
during scanning to avoid compression of the underlying soft tissue. The images were 
recorded in real time at 25 frames per second (Adobe Premier pro Version 6, Adobe Systems 
Software, Ireland). Using video editing software (Adobe Premier Elements, version 10), still 
images were acquired at each 30 mm interval. The shadows cast by the echo-absorptive 
markers allowed the neighbouring still images to be aligned, thus reconstructing the entire 
VLACSA in a single image (Adobe Photoshop Elements, version 10). Digitising software (ImageJ 
1.45, National Institutes of Health, USA) was used to measure VLACSA. This method of 
calculating VLACSA has previously been accepted as reliable and valid when compared to 
magnetic resonance imaging (MRI), with a reported interclass correlation (ICC) between 
0.998 and 0.999 (Reeves et al., 2004). Furthermore within chapter two of the current thesis, 
high reliability and low day-to-day measurement error was reported when using this method 
to calculate VLACSA. 
 Using MRI, a VLACSA of 24.3 cm2 has previously reported to contribute to ~32.4% of 
total quadriceps anatomical cross-sectional area ((QACSA = 74.9 cm2 (Tsakoniti et al., 2008)). 
Therefore, assuming the contribution of VLACSA remains constant within males, QACSA within 
the current chapter was estimated using the following equation: (measured VLACSA / 0.324) × 
100.  
4.3.4. Maximal voluntary isometric knee extensor torque measurements 
At six different knee angles (60, 65, 70, 75, 80 and 90 (full extension = 0)) participants were 
instructed to perform two rapid MVCKE lasting ~two seconds at the plateau with 90 seconds 
rest between contractions. Torque was presented, in real time, on a Macintosh G4 computer 
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(Apple Computer, Cupertino, CA, USA), via an A/D converter (Biopac Systems, Santa Barbara, 
CA). Torque measurements were later analysed offline with the accompanying software 
(Acknowledge, version 3.9.2). The highest torque produced at each angle was taken as MVCKE 
peak torque. The angle where the highest MVCKE torque was produced during the pre-damage 
session was recorded as optimal knee angle in every subsequent session. Optimal knee angle 
torque was used to calculate MVCKE torque loss in the subsequent four sessions. To calculate 
loss of MVCKE torque following eccentric exercise, MVCKE torque measurements were 
repeated 60 minutes post eccentric exercise (to reduce any fatigue effect (Walsh et al., 2004)) 
and 48 hours, 96 hours and 168 hours (recovery) post eccentric exercise.  
4.3.5. Patella tendon length and cross-sectional area 
A real-time B-mode ultrasound (AU5 Harmonic, Esaote Biomedica, Genoa, Italy) was used to 
measure patella tendon cross-sectional area (PTCSA) and patella tendon length (PTL) at a fixed 
90 knee angle. The distance between the apex of the patella and the tibial tuberosity, marked 
using sagittal ultrasound images, was taken as PTL. To measure PTCSA the ultrasound probe 
was placed in the transverse plane and images were captured at 25%, 50%, and 75% of PTL. 
The images were later analysed offline using (ImageJ 1.45, National Institutes of Health, USA). 
A mean of all three images were taken for PTCSA (O’Brien et al., 2010) 
4.3.6. Patella tendon stiffness  
The participants were seated on the isokinetic dynamometer, with the knee angle fixed at 
90, and were instructed to perform a ramped, isometric MVCKE lasting ~5-6 seconds. 
Ramped MVCKE torque and displacement of the patella tendon were synchronised using a 10-
V square wave signal generator. Patella tendon displacement was measured over two MVCKE, 
once with the ultrasound probe positioned over the distal edge of the patella and on the 
second contraction over the tibial tuberosity (Onambélé et al., 2007), so that total 
displacement would be computed from the composite of proximal and distal patella motions 
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(see below). Torque was presented on a Macintosh G4 computer (Apple Computer, 
Cupertino, CA, USA), via an A/D converter and subsequently analysed with the accompanying 
software (Acknowledge, Biopac Systems, Santa Barbara, CA). To create an external marker on 
the ultrasound images, an echo-absorptive marker was placed on the skin. Using the marker 
to calculate displacement of the tendon, the distance of the marker (shadow) from an 
anatomical reference point at the beginning of the contraction, to the position of the shadow 
at the end of the contraction was calculated. A 10-V square wave signal generator was used to 
synchronise the ultrasound images with the torque acquisition system. Images were captured 
at ~10% intervals of ramped MVCKE torque (Onambélé et al., 2007). Total patella tendon 
displacement was calculated as displacement at the apex of the patellar plus the displacement 
at the tibial tuberosity (Onambélé et al., 2007). Patella tendon forces were calculated as: 
(MVCKE torque + antagonist co-activation torque) / PTMA.  
Patella tendon moment arm was measured at 90 (full extension = 0) in the sagittal 
plane, from a single-energy X-ray absorptiometry scan (frame 23.3 cm x 13.7cm) Hologic 
Discovery, Vertec Scientific Ltd, UK). Using OsiriX (DICOM viewer, ver. 4.0, Pixemo, 
Switzerland), patella tendon moment arm length was determined as the perpendicular 
distance from the centre of the patella tendon to the estimated tibio–femoral contact point. 
Single-energy X-ray absorptiometry scans have been compared to MRI measures, 
demonstrating consistent reliability and validity against this standard (Erskine et al., 2014). 
To compute tendon forces, the calculation of antagonist co-activation torque is 
described below. The patella tendon force - elongation curve stemming from data at every 
10% MVCKE was then fitted with a second-order polynomial function forced through zero 
(Onambélé et al., 2007). The tangential slope at discreet sections of the curve, relative to 
MVCKE force, was computed by differentiating the curve at every 10% force intervals. In 
addition, to standardise the comparison of tendon stiffness and Young’s modulus at an 
absolute load, the slope of the tangential line, corresponding to the MVCKE force of the 
weakest participant (2972 Nm), was computed for each subject.  
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4.3.7. Co-activation 
To determine co-activation during the ramped MVCKE, Electromyogram (EMG) of the bicep 
femoris (BF) was recorded. Guided by an axial-plane ultrasound of the BF, two bipolar 
electrodes (Ambu, Neuroline 720, Denmark) were placed in the mid-sagittal line at 25% of BF 
muscle length (distal end = 0%). A reference electrode (Ambu, Blue Sensor, Denmark) was 
placed on the lateral tibial condyle. The electrodes were placed in a bipolar configuration 
with a constant inter-electrode distance of 20 mm (Hermens et al., 2000). Prior to electrode 
placement; the skin was shaved, gently abraded and cleansed with an alcohol wipe to reduce 
skin impedance below 5000 Ω (Hermens et al., 2000). To minimise cross talk, and ensure a 
mid-sagittal placement of electrodes, ultrasonography was used to identify the medial and 
lateral aspects of the BF muscle. The raw EMG signal was amplified (× 2000) and filtered 
(through low and high pass filters of 10 and 500 Hz respectively) with the sampling 
frequency set at 2000 Hz. Ramped MVCKE torque and BF EMG were recorded in real time and 
synchronised using an external square wave signal generator. Participants performed two 
maximal voluntary isometric knee flexions (MVCKF) at 90 knee angle. They were instructed 
to perform MVCKF rapidly and as forcefully as possible against the dynamometer’s lever arm. 
The participants were instructed to relax once a two second plateau had been attained (as 
observed on the dynamometer screen display). The root mean square of the integral of the 
raw BF EMG signal, was calculated 500 ms either side of instantaneous MVCKF maximal 
torque from the contraction corresponding to the highest MVCKF torque. Prior to contraction 
the baseline signal noise was calculated as the integral root mean square over 1s and 
removed from the measured EMG during MVCKF and MVCKE. At every 10% of ramped MVCKE 
torque the absolute integral of the BF EMG was taken over 250 ms. Co-activation torque was 
calculated as, (BF EMG during ramped MVCKE / BF EMG during MVCKF) × peak MVCKF torque 
(Onambélé et al., 2007). This equation assumes that the BF is representative of the entire 
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hamstring (Carolan & Cafarelli, 1992) and that a linear relationship exists between BF EMG 
and MVCKF torque (Lippold, 1952). 
4.3.8. Patella tendon stress / strain relationship 
Patella tendon strain was calculated as a ratio of total patella tendon displacement to PTL. 
Patella tendon stress was calculated as: patella tendon force (N) / PTCSA (mm2). 
4.3.9. Patella tendon Young’s modulus 
Young’s modulus was calculated as: Patella tendon stiffness × (PTL (mm) / PTCSA (mm2)).  
4.3.10. ‘Damaging’ eccentric exercise 
Prior to eccentric exercise, a warm-up of 10 isokinetic knee extensions and knee flexions 
were carried out, ensuring a progressive increase in effort (with the last contraction being 
maximal). For the eccentric exercise, the knee extension range of motion was set at 20 – 90 
(0 = full extension), and the Participants performed six sets of 12 MVEKE repetitions. The 
eccentric phase of the contractions was performed at an isokinetic angular velocity of 30s-1 
(Jamurtas et al., 2005). The concentric phase was performed sub-maximally at an angular 
velocity of 60s-1 to minimise fatigue and enhance eccentric damage (Chapman et al., 2006). 
Two minutes rest was provided between each set. Participants remained seated throughout 
the entire exercise protocol, including rest periods. Visual feedback and verbal 
encouragement was continuously provided throughout the protocol (Campenella et al., 
2000). Average peak MVEKE torque was calculated as an average of peak MVEKE across six 
sets. 
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4.3.11. Change in vastus lateralis fascicle length during the eccentric protocol 
A real-time B-mode ultrasound (AU5 Harmonic, Esaote Biomedica, Genoa, Italy) was used to 
measure VL fascicle length during MVEKE. The ultrasound probe (7.5 MHz linear array probe) 
was fixed at 50% of VL muscle length in the mid-sagittal plane of the non-dominant leg. VL 
fascicle length was determined as the linear distance along the fascicle as it ran from the deep 
to the superficial aponeurosis. Pennation angle was determined as the angle created from the 
visible insertion of the fascicle into the deep aponeurosis. A hypo-allergenic ultrasound gel 
(Parker, Park Laboratories Inc., Fairfield) was used to enhance acoustic coupling between the 
skin and the ultrasound probe.  
During the first set (out of six) of MVEKE contractions, ultrasound images were 
recorded onto a PC, in real time, at 25 frames per second (Adobe Premier pro Version 6). An 
externally generated square wave signal was used to synchronise the ultrasound images with 
the torque acquisition system. Three MVEKE contractions were chosen at random from the 
first set of 12 repetitions for architectural analysis. Using frame capture software (Adobe 
Premier Elements, version 10), an ultrasound image (frame corresponding to every 10 of 
knee angle, ranging from 20 - 90) was acquired for offline analysis. To ensure there was no 
movement artefact included in the measurement of fascicle length, an echo-absorptive 
marker was fixed on the skin to provide a visual reference point for the internal structures. If 
movement of the reference line was observed, the contraction was discarded and another 
repetition was chosen for analysis.  
Using digitising software (ImageJ 1.45, National Institutes of Health, USA), VL fascicle 
length was analysed offline at every 10 knee angle (range 20 - 90, 0 = full extension) 
throughout the MVEKE. Where the fascicle extended longer than the ultrasound image (frame 
width 3.50 cm and height 4.15 cm), linear continuation of the fascicle and aponeurosis was 
assumed. Within the VL, a 2-7% error is associated with the linear extrapolation method 
when used to calculate VL fascicle length (e.g. measured at 11.3 cm) at a knee angle of 120 
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(Finni et al., 2003a). Recently, when comparing ultrasound to cadaveric measurements’, the 
linear extrapolation method has been concluded as a valid technique for measuring VL 
fascicle length at rest (ICC = 0.853) (Ando et al., 2014). Within chapter two, high reliability 
and low day-to-day measurement error has been demonstrated using this method to 
measure VL fascicle length during MVEKE. Although the validity of the linear extrapolation 
method has been unreported in the VL during MVEKE, the fascicle length reported is similar to 
those reported by Finni et al. (2003a), thus similar measurements of error (2-7%) can be 
assumed. In order to reduce any error associated with the estimation of VL fascicle length, an 
average of three fascicles across the image was taken. Change in fascicle length is presented 
as fascicle length at a knee angle of 90 made relative to fascicle length measured at a knee 
angle of 20; hereafter termed “relative fascicle lengthening” and reported as a percentage 
change from starting length at 20. Pennation angle was measured and is presented at a knee 
angle of 90. An average of three pennation angles was taken across a single image. 
4.3.12. Blood samples 
Venous blood samples were taken to measure CK levels. A 21-gauge needle was inserted into 
the antecubical vein of the forearm, using a 10 mL syringe. 5-6 mL of blood was drawn into a 
serum collection tube. The sample was left on a crushed ice bed for 60 minutes. The sample 
was then centrifuged at 4500 rpm at 0C for 10 minutes. Using a 200 – 1000 µl pipette 
(Eppendorf), the resulting serum sample was separated into three aliquots (~500 µl each) 
and stored in eppendorfs at -20C until CK analysis was performed. Creatine kinase levels 
were measured using a standard colorimetry procedure, measuring at optical density 340 nm 
(BioTek ELx800 96 well Microplate Reader) and immediately analysed (Gen5, version 2.0). 
Individual samples were run in either duplicate or quadruplets using an EnzyChromTM CK 
Assay Kit (BioAssay Systems, Hayward, CA, sensitivity 5 U/L, manufacturer reported intra-
assay variability ≤ 5%), reading enzyme activity after 20 minutes (25 minutes if necessary) 
and 40 minutes of exposure to the assay mix. An average of two – four readings was taken. CK 
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activity is reported in absolute values and absolute change from pre-damage values ((ΔCKABS) 
i.e. the peak CK value - the pre CK values).  
4.3.13. Statistics 
Statistical analysis was carried out using the statistical software package SPSS (v.19, Chicago, 
IL) for Windows and Microsoft Excel. To check for parametricity, the Levene’s and Shapiro-
Wilk tests were used to assess the variance and normality of the data, respectively. These 
assumptions were not violated. A one-way repeated measures ANOVA (time, 5 levels) was 
used for absolute CK and MVCKE torque loss. Wherever the assumption of sphericity was 
violated, the Greenhouse-Geisser correction was applied. Pairwise comparison, with 
Boneforroni correction was used to investigate if there was any significant difference to pre-
damage. Pearson linear correlations were used to determine whether ΔCKABS to peak 
correlated with muscle properties, tendon properties, fascicle lengthening, MVEKE torque or 
MVEKE torque / QACSA. Pearson linear correlations were also used to determine whether 
MVCKE torque loss was associated with, muscle properties, tendon properties, VL fascicle 
lengthening, MVEKE torque or MVEKE torque / QACSA. Data is presented as mean ± standard 
deviation. Statistical significance was accepted at p≤ 0.05. 
4.4. Results 
4.4.1. Muscle and patella tendon measurements  
Muscle architecture and patella tendon properties, assessed at the ‘pre-damage phase’, are 
presented in Table 4.1. 
4.4.2. Patella tendon properties 
To account for varying ramped MVCKE torques, the patella tendon force corresponding to the 
highest MVCKE torque of the weakest participant (2972 N) was used to calculate standardised 
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force level patella tendon stiffness (1213 ± 436 Nmm-1) and Young’s modulus (1030 ± 591 
MPa).  
4.4.3. Torque during maximal voluntary eccentric knee extensions 
During MVEKE, average peak (over six sets) MVEKE torque was 255 ± 51 Nm. To account for 
varying muscle size, MVEKE torque was normalised to the estimated QACSA (3.28 ± 0.69 
Nm/cm2). Peak MVEKE torque was 96% (± 15%) of ‘pre-damage’ MVCKE torque.  
4.4.4. Vastus lateralis fascicle lengthening during maximal voluntary eccentric knee 
extensions 
Absolute change in VL fascicle length from 20 knee angle (7.06 ± 0.43 cm) to 90 knee angle 
during MVEKE contractions (11.3 ± 0.20 cm) was 4.20 ± 0.82 cm. Absolute change in VL 
fascicle length was made relative to fascicle length at knee angle of 20 denoting a 59.4 ± 
12.0% increase in relative fascicle length.  
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Table 4. 1. Vastus lateralis and patella tendon properties. 
Variable Mean ± SD 
Pennation angle ()  12.1 ± 1.6 
VL muscle length (cm) 32.8 ± 2.1 
VLACSA (cm2) 25.3 ± 4.2 
QACSA (cm2) 79.0 ± 13.1 
Tendon length (mm) 57.8 ± 6.0 
Tendon CSA (mm2) 78.1 ± 26.1 
Ramped MVCKE (Nm) 196 ± 37 
Maximal tendon elongation (mm) 6.56 ± 2.12 
Patella tendon strain (%) 11.5 ± 4.10 
Patella tendon stress (MPa) 58.0 ± 17.3 
PTMA (cm) 4.33 ± 0.34 
Maximal tendon force (N) 4590 ± 847 
Maximal tendon stiffness (Nmm-1) 1450 ± 554 
Maximal Young’s modulus (MPa) 1247 ± 808 
 
Note: Patella tendon stiffness and Young’s modulus are calculated at ramped 100% maximal 
voluntary isometric knee extension (MVCKE). Pennation angle is presented at 90 knee angle 
during maximal voluntary eccentric knee extension (MVEKE). VL: Vastus lateralis. VLACSA: 
Vastus lateralis anatomical cross-sectional area. QACSA: estimated quadriceps anatomical 
cross-sectional area. PTMA: Patella tendon moment arm. Data is presented as means ± 
standard deviation. 
4.4.5. Creatine kinase levels 
One-way repeated measures ANOVA reported a main effect of time (p = 0.005) on absolute 
CK values. Pairwise comparison, with Bonferroni correction, reported CK to significantly 
increase from pre to 96 hours (p = 0.014) but was not significantly different at any other time 
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point compared with pre-damage (Figure 4. 1). Relative to pre-damage (136 ± 114 U/L), 
ΔCKABS to peak (883 ± 667 U/L) increased by 855% (± 779%).  
 
 
Figure 4. 1: Absolute creatine kinase (CK) response following exercise-induced muscle 
damage (EIMD). Data is presented as means ± standard deviation. * Significantly higher than 
pre p ≤ 0.05. 
4.4.6. Maximal voluntary isometric knee extensor torque loss 
One-way repeated measures ANOVA reported a main effect of time (p = 0.0004) on torque 
loss. Pairwise comparison, with Bonferroni correction, reported torque to significantly 
decrease from pre to, 1 (p = 0.0004) and 48 hours (p = 0.004) post EIMD but was not 
significantly different at any other time point(Figure 4.2).  
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Figure 4. 2: Maximal voluntary isometric knee extension (MVCKE) torque following exercise-
induced muscle damage (EIMD). Data is presented as means ± standard deviation. 
Significantly lower than pre, ** p ≤ 0.01 *** p ≤ 0.001. 
4.4.7. Correlations between markers of exercise-induced muscle damage 
Pearson correlations between muscle and tendon properties and ΔCKABS to peak and MVCKE 
torque loss are presented in Table 4. 2.  
There was no significant correlation between ΔCKABS to peak and, pennation angle (at 
90 knee angle during MVEKE), resting VL length, QACSA, relative tendon stiffness or relative 
Young’s modulus (p ≥ 0.05). ΔCKABS to peak did significantly correlate with average peak 
MVEKE torque (p = 0.027) and relative VL fascicle lengthening (Figure 4. 3, p = 0.017). 
However, when peak MVEKE was made relative to QACSA the significant correlation was lost (p 
≥ 0.05). 
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There was no significant correlation between MVCKE torque loss and, pennation angle (at 90 
knee angle during MVEKE), QACSA, relative tendon stiffness, relative Young’s modulus, average 
peak MVEKE torque, MVEKE torque made relative to QACSA or relative fascicle lengthening (p ≥ 
0.05).  
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Table 4. 2. Pearson correlations between markers of exercise-induced muscle damage and vastus lateralis and patella tendon properties. 
 
 
 
 
 
 
Note: Pennation angle is presented at 90 knee angle. VL: Vastus lateralis. QACSA: quadriceps anatomical cross-sectional area. MVEKE: Maximal 
voluntary eccentric knee extension torque, presented as the peak torque averaged over six sets. MVEKE / VLACSA: Maximal voluntary eccentric knee 
extension torque made relative to vastus lateralis anatomical cross-sectional area. Relative change in FL: VL fascicle length at a knee angle of 90 made 
relative to VL fascicle length measured at a knee angle of 20. Slope represents the gradient of the line, where y = mx + b. * = p ≤ 0.05. 
  Pennation 
angle () 
VL 
muscle 
length 
(cm) 
QACSA 
(cm2) 
Relative 
tendon 
stiffness 
(Nmm-1) 
Relative 
Young’s 
modulus 
(MPa) 
MVEKE 
(Nm) 
MVEKE  QACSA 
(Nm·cm2) 
Relative 
change in FL 
(%) 
  
ΔCKABS to 
peak 
R -0.195 0.276 0.360 0.131 0.073 0.500 * 0.208 0.534 * 
Slope -81.9 89.1 18.6 0.201 0.123 6.58 197.6 29.8 
          
MVCKE 
torque loss 
R 0.202 -0.060 0.164 -0.221 -0.146 -0.201 -0.334 0.180 
Slope 1.62 -0.371 0.16 -0.007 -0.005 -0.051 -7.012 0.192 
  
115 
 
 
 
Figure 4. 3: Pearson’s correlation between relative vastus lateralis (VL) fascicle lengthening 
and absolute change in creatine kinase (CK). Relative VL fascicle lengthening was calculated 
as: fascicle length at a knee angle of 90 made relative to fascicle length measured at a knee 
angle of 20 during maximal eccentric knee extension. Change in CK was calculated as: the peak 
CK value - the pre CK values (ΔCKABS). * p ≤ 0.05. absolute  
4.5. Discussion  
The aim of the current chapter was to establish whether patella tendon properties, eccentric 
torque and VL fascicle lengthening during a damaging eccentric knee extension protocol, 
were associated with indirect markers of EIMD. The current paper reports three main 
findings. 1) Patella tendon stiffness does not correlate with ΔCKABS to peak or MVCKE torque 
loss. 2) Relative VL fascicle lengthening and MVEKE torque significantly correlated with ΔCKABS 
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to peak. And 3) MVEKE torque and MVEKE torque made relative to QACSA do not correlate with 
ΔCKABS to peak or MVCKE torque loss. 
 In addition to the patella tendon attenuating VL fascicle lengthening within the VL in 
chapter three, the tendon has previously been reported to reduce peak forces and torques 
during eccentric contractions (Roberts & Azizi, 2010), which have all been hypothesised to be 
determinants of EIMD. Therefore, tendon properties have been suggested to act as a 
mechanical buffer during lengthening contractions (Roberts & Azizi, 2010; Fukunaga et al., 
2001), and potentially explain group differences in EIMD (McHugh et al., 1999; Marginson et 
al., 2005). The current chapter provides evidence for the first time that there is no direct 
association between patella tendon stiffness and ΔCKABS to peak or peak MVCKE torque loss 
following EIMD. Although the current chapter reports no direct association between patella 
tendon stiffness and indirect markers of EIMD, it cannot account for the role of the 
aponeurosis or an indirect effect of the tendon on markers of EIMD during MVEKE.  
Within the current chapter relative VL fascicle lengthening was not associated with 
peak MVCKE torque loss. These findings agreed with the in vivo data conveyed by Hoffman et 
al. (2014), who reported that during an eccentric walking protocol there was no association 
between maximal medial gastrocnemius fascicle lengthening and planter flexion MVC torque 
loss. Although within the current chapter, the contribution of tendon to total MTU 
lengthening during MVEKE remains unknown, Hoffman et al. (2014) suggested that fascicle 
lengthening was not associated with MVC torque loss due to the Achilles tendon accounting 
for ~90% of total MTU lengthening. Despite incomparable differences between the Achilles 
and patella tendon properties (specifically stiffness), based on a similar concept to the 
findings of Hoffman et al. (2014), the observation of no relationship between VL fascicle 
lengthening and MVEKE torque loss may be attributed to the role of the patella tendon / 
aponeurosis mitigating VL fascicle length change during MVEKE. This remains to be confirmed 
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in the VL. The findings of no significant correlation between fascicle lengthening and MVCKE 
torque loss may be miss-interpreted to contradict the popping sarcomere theory (Morgan, 
1990). Due to heterozygous lengthening of sarcomeres however, the current chapter cannot 
discount the possibility of sarcomeres lengthening onto the descending limb of the length-
tension relationship and increasing EIMD as proposed by the popping sarcomere theory 
(Morgan, 1990). Furthermore, the current chapter cannot account for the contribution of 
fascicle lengthening at the distal and proximal region of the VL or within the other three 
quadriceps muscles. Further investigation is required to conclude whether sarcomere 
lengthening and fascicle behaviour in the total quadriceps muscle or within other regions of 
the VL are associated with EIMD in the knee extensors.  
Despite no significant correlation with MVCKE torque loss, the current chapter did find 
a significant correlation between VL fascicle lengthening and ΔCKABS to peak. The current 
chapter is the first to investigate and report a correlation in vivo, however these findings do 
contradict previous in vitro findings (Warren et al., 1993a). In vitro, Warren et al. (1993a) 
reported no correlation between the magnitude of fascicle lengthening in rat soleus muscle 
and CK following EIMD. The differences between in vitro animal studies and the current 
chapter could be attributed to several reasons including; Firstly, the use of electrical 
stimulation applied directly to the muscle in vitro (Warren et al., 1993a). Electrical 
stimulation applied directly to the muscle alters the contractile behaviour, making it difficult 
to compare to voluntary contractions (Crameri et al., 2007). Secondly, in vitro studies use 
large fascicle lengthening to investigate fascicle strain on EIMD, which may not be attainable 
in vivo (Butterfield, 2010). Regardless, the discrepancies between fascicle lengthening being 
correlated with ΔCKABS to peak, and not MVCKE torque loss make the association between 
fascicle lengthening and EIMD perplexing. Although MVCKE torque loss is accepted as marker of 
contractile muscle function, there remains uncertainty concerning the validity of ΔCKABS to peak 
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as a marker of EIMD (Friden & Lieber, 2001; Komulainen et al., 1995). The release of CK 
represents EIMD through a loss of membrane permeability. A loss of membrane permeability 
allows for CK to leak into the interstitial fluid however, the influx includes the release and the 
clearance of CK in the serum (Bijsterbosch et al., 1985). Although an increase in CK may confirm 
EIMD has occurred, the magnitude of the CK influx does not necessarily quantify the severity of 
the EIMD (Friden & Lieber, 2001). Therefore, within the current chapter, an increase in 
fascicle lengthening and ΔCKABS to peak may denote the severity of the loss of membrane 
stability rather than the severity of damage to the contractile proteins.  
Previously, significantly higher torques produced during eccentric contractions 
compared to any other type of contraction has been associated with EIMD (Armstrong et al., 
1991). The current chapter however, can report when made relative to QACSA, peak MVEKE 
torque is not associated with MVCKE torque loss or ΔCKABS to peak. The findings of the current 
chapter support previous in vivo work, which has concluded no association between total 
eccentric work, and CK (Chapman et al., 2008; Hody et al., 2013) or MVC torque loss 
(Chapman et al., 2008). It would appear however our findings are at odds with Warren et al. 
(1993a) who reported peak eccentric torque to be significantly correlated with MVC torque 
loss in rat muscle. However, Warren et al. (1993a) reported that the significant correlation 
was lost when eccentric torque was below 113% of pre-damage isometric torque. Within the 
current chapter and the work of Chapman et al. (2008), MVC torque was 96% and 94% 
(respectively) of pre-damage MVC torque, therefore upon closer inspection, the current 
findings are consistent with those reported by Warren et al. (1993a). The discrepancies 
regarding peak MVEKE torque values within the current studies and in other in vivo studies, 
with those reported by Warren et al. (1993a) represent an inherent limitation to the 
comparisons made between in vitro versus in vivo comparisons of EIMD. Therefore, although 
the current thesis cannot confirm experimentally that participants were contracting 
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maximally, our findings represent EIMD resulting from maximal eccentric efforts in vivo. 
Therefore future research needs to investigate whether voluntary eccentric torque in vivo, 
surpassing contractile yield strength (estimated above 113% of isometric MVC (Warren et al., 
1993a)), is associated with EIMD.  
Muscle architecture has previously been suggested to explain variations in EIMD 
between muscle groups. Indeed previous authors (Chen et al., 2011), hypothesised that the 
smaller pennation of the biceps could be a determinant of the greater CK following EIMD than 
in the VL. Within the current chapter however, pennation angle was not associated with 
ΔCKABS to peak or MVCKE torque loss. It is possible that pennate fibres result in a lower level of 
force transmission from the eccentric load to the muscle. However, based on the current data, 
between the lowest to highest pennation angles measured in the current participant groups 
(~5), the change in mean MVEKE torque (272 Nm) transmitted along the muscle fascicles 
would be ~6 Nm. Clearly this is not a sufficient difference in stress to expect any significant 
differences in EIMD. Therefore within the VL pennation angle during EIMD is not a 
determinant of EIMD however pennation angle may contribute to differences in EIMD 
between two muscle groups that have larger differences in pennation angle (Chen et al., 
2011).  
4.6. Conclusion 
In conclusion the current chapter has established no association between patella tendon 
properties, MVEKE torque made relative to QACSA, VL fascicle lengthening and pennation angle, 
with EIMD based on MVCKE torque loss or ΔCKABS to peak. The current chapter reports 
significant correlation between VL fascicle lengthening and ΔCKABS to peak which may reflect 
the magnitude of EIMD or indicate a loss membrane permeability has occurred however, due 
to fascicle lengthening having no association with any other marker of EIMD, it is likely the 
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significant correlation represent the latter. Future research needs to investigate whether the 
same findings would be reported if higher in vivo MVEKE torques were measured. 
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Chapter five: Sex differences in muscle damage following 
maximal eccentric knee extensions 
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5.1. Abstract 
Aim: To investigate whether there is a sex difference in exercise-induced muscle damage 
(EIMD). Materials and method: Vastus lateralis (VL) and patella tendon properties were 
measured in males and females using a combination of ultrasonography, electromyography 
and dynamometry. During maximal voluntary eccentric knee extensions ((MVEKE) 12 reps × 6 
sets), VL fascicle lengthening and MVEKE torque was recorded every 10 of knee joint angle 
(20-90). Maximal voluntary isometric knee extension (MVCKE) torque loss, creatine kinase 
(CK) and muscle soreness were measured pre, post, 48, 96 and 168 hours post damage as 
markers of EIMD. Results: Patella tendon stiffness and VL fascicle lengthening were 
significantly higher in males compared to females (p ≤ 0.05). There was no sex difference in 
MVCKE torque loss and muscle soreness post EIMD (p ≥ 0.05). Post EIMD CK was higher in 
males compared to females (p ≤ 0.05) and remained so when MVEKE torque relative to 
estimated quadriceps anatomical cross-sectional area was taken as a covariate (p ≤ 0.05). 
Conclusion: Based on MVCKE torque loss, there is no sex difference in EIMD. The higher CK in 
males could not be explained by differences in MVEKE torque, VL fascicle lengthening or 
patella tendon stiffness. The comparable MVCKE torque loss and rightward shift in optimal 
knee angle could reflect the fact that EIMD was similar between sexes. It is proposed that the 
role of oestrogen in stabilising the cell membrane may have contributed to lower CK post 
EIMD in females rather than higher EIMD in males.  
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5.2. Introduction 
It is well established that unaccustomed eccentric exercise causes exercise-induced muscle 
damage (EIMD). Although there remains no conclusion on the initial events leading to EIMD 
(direct damage to sarcomeres, or the Excitation-Contraction (E-C) coupling process); the high 
stress and strain of eccentric contractions are associated with subsequent increases in 
markers of EIMD (Warren et al., 1993a; Lieber & Friden, 1993). The degree of EIMD has been 
quantified using both direct (e.g. muscle biopsies) and indirect techniques (Warren et al., 
1999; Clarkson & Hubal, 2002). Due to the invasive procedure and the small sampling area of 
muscle biopsies, indirect techniques are more common (Clarkson & Hubal, 2002). Reduction 
in maximal isometric torque following EIMD has been reported as the most valid indirect 
marker of EIMD (Warren et al., 1999). Change in range of motion, muscle soreness, and the 
detection of intramuscular enzymes (e.g. Creatine kinase (CK)) in venous blood however, are 
frequently reported as indirect markers of EIMD (Warren et al., 1999; Savage & Clarkson, 
2002; Sayers & Clarkson, 2001; Sewright et al., 2008). 
Within animals, EIMD is reported to be significantly higher in males compared to 
females (Komulainen et al., 1999). Within human research however, the evidence is not as 
compelling; for example, Stupka et al. (2000) were among the first to measure human sex 
differences in EIMD. Following maximal leg press and leg extensions, Stupka et al. (2000) 
reported similar amounts of Z-line streaming and CK between males and females. In contrast, 
following EIMD in the elbow flexors, Sewright et al. (2008) found males to have significantly 
higher levels of CK compared to their female counterparts. The different muscle architecture 
and tendon properties in the elbow flexors compared to the knee extensors may partly 
explain the aforementioned discrepancies (Chen et al., 2011). It remains unknown however 
whether the architectural and structural properties of the muscle-tendon unit (MTU) may 
play a role in determining sex differences in EIMD. 
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Previous literature has alluded to the tendon potentially acting as a mechanical buffer 
during eccentric contractions (Roberts & Azizi, 2010; Roberts & Konow, 2013; Reeves & 
Narici, 2003). Using Hill’s three element muscle model, Lichtwark and Wilson (2007) found 
during the stance phase of walking, increasing Achilles tendon stiffness augmented fascicle 
lengthening despite total MTU lengthening remaining constant. In agreement, chapter four 
attributed greater vastus lateralis (VL) fascicle lengthening during eccentric contractions in 
males, to a significantly higher patella tendon Young’s modulus compared to females. Thus 
the males experienced significantly higher levels of VL fascicle lengthening, which, as a 
determinant of EIMD in vitro (albeit in animals (Lieber & Friden, 1993; Talbot & Morgan, 
1998)), may explain higher levels of EIMD previously reported in males (Sewright et al., 
2008; Joyce et al., 2014). However, any link between fascicle lengthening and EIMD in vivo 
remains to be confirmed experimentally and there are inherent limitations of extrapolating 
findings from animal studies (Butterfield, 2010).  
Although no data exists to attribute lower EIMD in females to sex differences in MTU 
properties, the attenuated EIMD in females has previously been attributed to the protective 
properties of oestrogen (Joyce et al., 2014). An anti-inflammatory action through high 
antioxidant capacity, suppression of nuclear factor-kappa beta, and a direct membrane 
stabilising property of oestrogen, have been suggested to contribute to the suppression of 
EIMD (Kendall & Eston, 2002). Through manipulation of oestrogen levels, e.g. using the oral 
contraceptive pill (OCP (Savage & Clarkson, 2002)), hormone replacement therapy (HRT) 
(Dieli-Conwright et al., 2009) and pre vs. post menopause comparisons (Buckley-Bleiler et al., 
1989), both a protective (Dieli-Conwright et al., 2009; Savage & Clarkson, 2002) or no effect 
(Buckley-Bleiler et al., 1989; Sewright et al., 2008; Savage & Clarkson, 2002) of oestrogen on 
EIMD has been reported. Due to the inconsistent nature of these findings, it is unclear 
whether oestrogen can account directly for sex differences in EIMD. Alternatively, oestrogen 
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may indirectly reduce levels of EIMD through altering tendon properties. For instance, lower 
levels of oestrogen have been associated with lower tendon strain in OCP users compared to 
non-users (Bryant et al., 2008). Previously, differences in tendon stiffness have been 
suggested to explain group differences in EIMD (McHugh et al., 1999; Marginson et al., 2005) 
however, to date, there is no systematic research supporting this hypothesis. 
 Sex differences in EIMD remain equivocal. Furthermore, a physiological explanation 
for the potential differences has yet to be reported. Therefore, the aims of the current chapter 
were twofold: firstly, to establish whether there is a sex difference in EIMD, when difference 
in muscle size is accounted for; and secondly, dependent on the outcome of the first aim, to 
establish whether tendon stiffness may explain the potential sex difference in EIMD. 
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5.3. Materials and methods 
5.3.1. Subjects 
11 males (21.1 ± 1.6 years of age, 72.0 ± 7.5 kg and 176 ± 6 cm) and 11 females (21.4 ± 1.6 
years of age, 63.0 ± 5.8 kg and 165 ± 8 cm) signed written informed consent to participate. All 
participants self-reported as being recreationally active (undertaking no more than 1 hour of 
“moderate” physical activity per week) and did not take part in any structured resistance 
training. None of the female participants had ever used any form of oestrogen-based 
contraception. All women reported regular menstrual cycles, documenting an average cycle 
length of 28 ± 1 days (Cole et al., 2009). Females were tested on the 14th day of their 
menstrual cycle (self-reported) to measure oestrogen levels at ovulation (Brown, 1955; Cole 
et al., 2009). All procedures complied with the Declaration of Helsinki and ethical approval 
was obtained through the local ethics committee (World Health Association, 2013). Exclusion 
criteria included any resistance training in the last six months, occupation or lifestyle that 
required regular heavy lifting or carrying, any known muscle disorder, the use of dietary 
supplements (i.e. vitamin E), and any musculoskeletal injury in the last three months. Further 
exclusion criteria for female participants included, irregular menstrual cycles (where regular 
cycles were defined as 24-35 days (Cole et al., 2009; Landgren et al., 1980)) in the last 12 
months, and pregnant in the year preceding inclusion in the current chapter. All inclusion and 
exclusion criteria were determined through participant questionnaire prior to inclusion 
within this chapter. 
5.3.2. Testing protocol 
Participants attended the laboratory on five different occasions over nine days. The sessions 
were as follows: 1) pre-damage 2) damage (48 hours post pre-damage), 3) 48 hours, 4) 96 
hours, and 5) 168 hours post damage. Pre-damage assessments consisted of stature and mass 
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(anthropometric measures), patella tendon moment arm (PTMA), 5-6ml blood sample, 
dynamometer familiarisation (within pre-damage), morphological measures of the patella 
tendon (tendon size and stiffness) and isometric maximal voluntary knee extension (MVCKE) 
torque measurements at six knee angles (60, 65, 70, 75, 80 and 90 (0 = full extension). 
Participants were tested at six knee angles to obtain optimal knee angle for MVCKE torque. 
Participants performed two practice isometric MVCs, at two knee joint angles during the 
familiarisation session (within pre-damage). Stature and mass were measured using a wall 
mounted stadiometer (Harpenden, Holtain Crymych, UK) and digital scales (Seca model 873, 
Seca, Germany) respectively. The damage session consisted of maximal voluntary eccentric 
knee contractions (MVEKE), 5-6 mL venous blood sample, rating of muscle soreness and 
MVCKE torque measurements. 48, 96 and 168 hours session consisted of 5-6 mL blood sample, 
rating of muscle soreness, and MVCKE torque measurements at all six knee angles (60, 65, 70, 
75, 80 and 90). 
All tests were carried out in the non-dominant leg. The non-dominant leg was defined 
as the leg that provided stability during movements, e.g. kicking. Participants were seated in 
an isokinetic dynamometer (Cybex Norm, Cybex International, NY, USA), with a hip angle of 
85 (0 = supine). To reduce any extraneous movement during maximal efforts participants 
were secured in a seated position using inextensible straps around the shoulders and hips. 
The isokinetic dynamometer axis of rotation was visually aligned with the knee joint’s centre of 
rotation. During pre-damage the isokinetic dynamometer settings (chair position, distance from 
the dynamometer, dynamometer arm length) and anatomical zero (leg full extended, knee angle 
0) were recorded to ensure repeatability in the following sessions. 
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5.3.3. Vastus lateralis anatomical cross-sectional area 
Vastus lateralis anatomical cross-sectional area (VLACSA) was measured using a real-time B-
mode ultrasound (AU5 Harmonic, Esaote Biomedica, Genoa, Italy). With the participant laid 
supine and their non-dominant leg fully extended (knee angle 0), the distal and proximal 
insertions sites of the VL were identified using an ultrasound probe (7.5 MHz linear array 
probe, 38 mm wide). At 50% of VL muscle length echo-absorptive markers were placed in 
parallel, at intervals of 30 mm, from the lateral to the medial edge of the VL muscle. The 
ultrasound probe was held perpendicular to the VL muscle in the axial plane. The ultrasound 
probe was moved steadily over the echo-absorptive markers from the lateral to the medial 
edge of the muscle. Constant, light pressure was placed on the muscle during scanning to 
avoid compression of the muscle. The images were recorded in real time at 25 frames per 
second (Adobe Premier pro Version 6, Adobe Systems Software, Ireland). Using capturing 
software (Adobe Premier Elements, version 10), individual images were acquired at each 30 
mm interval. Shadows cast by the echo-absorptive markers allowed the images to be aligned 
by the outline of the muscle, thus forming the entire VLACSA in a single image (Adobe 
Photoshop Elements, version 10). Digitising software (ImageJ 1.45, National Institutes of 
Health, USA) was used to measure VLACSA. This method of calculating VLACSA has previously 
been accepted as reliable and valid when compared to magnetic resonance imaging (MRI), 
with a reported interclass correlation between 0.998 and 0.999 (Reeves et al., 2004). Within 
chapter two, high reliability and low day-to-day measurement error was reported when 
using this method to measure VLACSA. 
Within males a VLACSA of 24.3 cm2 has previously reported to contribute to ~32% of 
total quadriceps anatomical cross-sectional area ((QACSA) QACSA = 74.9 cm2 (Tsakoniti et al., 
2008)). Where in females, a VLACSA of ~21 cm2 has been reported to contribute to 38% of 
QACSA (QACSA = ~ 55 cm2 (Grosset & Onambele‐Pearson, 2008)). Therefore, assuming the 
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contribution of VLACSA remains constant within males and females, QACSA within males and 
females was estimated by dividing VLACSA by 32% and 38% respectively.  
5.3.4. Maximal voluntary isometric knee extension torque measurements 
At six different knee angles (60, 65, 70, 75, 80 and 90 (full extension = 0)) participants were 
instructed to perform two MVCKE lasting ~two seconds at the plateau with 90 seconds rest 
between contractions. Torque was presented, in real time, on a Macintosh G4 computer 
(Apple Computer, Cupertino, CA, USA), via an A/D converter (Biopac Systems, Santa Barbara, 
CA). Torque measurements were later analysed offline with the accompanying software 
(Acknowledge, version 3.9.2). The highest torque produced at each angle was taken as MVCKE 
peak torque. The angle where the highest MVCKE torque was produced during the pre-damage 
was recorded as optimal knee angle. Optimal knee angle was used to calculate MVCKE torque 
loss in the subsequent sessions. To calculate loss of MVCKE torque following eccentric 
exercise, within the damage session MVCKE torque measurements were repeated 60 minutes 
post eccentric exercise (to reduce any fatigue effect (Walsh et al., 2004)) and 48 hours, 96 
hours and 168 hours (recovery) post eccentric exercise.  
5.3.5. Patella tendon length and cross-sectional area 
A real-time B-mode ultrasound (AU5 Harmonic, Esaote Biomedica, Genoa, Italy) was used to 
measure patella tendon cross-sectional area (PTCSA) and patella tendon length (PTL) at a fixed 
90 knee angle. The distance between the apex of the patella and the tibial tuberosity, marked 
using sagittal ultrasound images, was taken as PTL. To measure PTCSA the ultrasound probe 
was placed in the transverse plane and images were captured at 25%, 50%, and 75% of PTL. 
The images were later analysed offline using ImageJ (1.45, National Institutes of Health, USA). 
A mean of all three images were taken for PTCSA (O’Brien et al., 2010). 
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5.3.6. Patella tendon stiffness  
The participants were seated in the isokinetic dynamometer, with the knee angle fixed at 90, 
and were instructed to perform a ramped, isometric MVCKE lasting ~5-6 seconds. Ramped 
MVCKE torque and displacement of the patella tendon were synchronised using a 10-V square 
wave signal generator. Patella tendon displacement was measured over two MVCKE, once 
with the ultrasound probe positioned over the distal edge of the patella and on the second 
contraction over the tibial tuberosity (Onambélé et al., 2007), so that total displacement 
would be computed from the composite of proximal and distal patella motions (see below). 
Torque was presented on a Macintosh G4 computer (Apple Computer, Cupertino, CA, USA), 
via an A/D converter and subsequently analysed with the accompanying software 
(Acknowledge, Biopac Systems, Santa Barbara, CA). To create an external marker on the 
ultrasound images, an echo-absorptive marker was placed on the skin. Using the marker to 
calculate displacement of the tendon, the distance of the marker (shadow) from an 
anatomical reference point at the beginning of the contraction, to the position of the shadow 
at the end of the contraction was calculated. A 10-V square wave signal generator was used to 
synchronise the ultrasound images with the torque acquisition system. Images were captured 
at ~10% intervals of ramped MVCKE torque (Onambélé et al., 2007). Total patella tendon 
displacement was calculated as displacement at the apex of the patellar plus the displacement 
at the tibial tuberosity (Onambélé et al., 2007). Patella tendon forces were calculated as: 
(MVCKE torque + antagonist co-activation torque) / PTMA. 
Patella tendon moment arm was measured at 90 (full extension = 0) in the sagittal 
plane, from a single-energy X-ray absorptiometry scan (frame 23.3 cm x 13.7 cm) Hologic 
Discovery, Vertec Scientific Ltd, UK). Using OsiriX (DICOM viewer, ver. 4.0, Pixemo, 
Switzerland), patella tendon moment arm length was determined as the perpendicular 
distance from the centre of the patella tendon to the tibio–femoral contact point. Single-
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energy X-ray absorptiometry scans have been compared to MRI measures, demonstrating 
consistent reliability and validity against this standard (Erskine et al., 2014).  
To compute tendon forces, the calculation of antagonist co-activation torque is 
described below. The force – patella tendon elongation curve stemming from data at every 
10% MVCKE was then fitted with a second-order polynomial function forced through zero 
(Onambélé et al., 2007). The tangential slope at discreet sections of the curve, relative to 
MVCKE force, was computed by differentiating the curve at every 10% force intervals. In 
addition, to standardise the comparison of tendon stiffness at an absolute load, the slope of 
the tangential line, corresponding to the MVCKE force of the weakest participant, was 
computed for each subject.  
5.3.7. Co-activation 
To determine co-activation during the ramped MVCKE, Electromyogram (EMG) of the bicep 
femoris (BF) was measured. Guided by an axial-plane ultrasound of the bicep femoris, two 
bipolar electrodes (Ambu, Neuroline 720, Denmark) were placed in the mid-sagittal line at 
25% of BF muscle length (distal end = 0%). A reference electrode (Ambu, Blue Sensor, 
Denmark) was placed on the lateral tibial condyle. The electrodes were placed in a bipolar 
configuration with a constant inter-electrode distance of 20 mm (Hermens et al., 2000). Prior 
to electrode placement; the skin was shaved, gently abraded and cleansed with an alcohol 
wipe to reduce skin impedance below 5000 Ω (Hermens et al., 2000). To minimise cross talk, 
and ensure a mid-sagittal placement of electrodes, ultrasonography was used to identify the 
medial and lateral aspects of the BF muscle. The raw EMG signal was amplified (×2000) and 
filtered (through low and high pass filters of 10 and 500 Hz respectively) with the sampling 
frequency set at 2000 Hz. Ramped MVCKE torque and BF EMG were recorded in real time and 
synchronised using an external square wave signal generator. Participants performed two 
maximal voluntary isometric knee flexions (MVCKF) at 90 knee angle. They were instructed 
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to perform MVCKF rapidly and as forcefully as possible against the dynamometer’s lever arm. 
The participants were instructed to relax once a two second plateau had been attained (as 
observed on the dynamometer screen display). The integral of the root mean square of the BF 
EMG signal, was calculated 500 ms either side of instantaneous MVCKF maximal torque from 
the contraction corresponding to the highest MVCKF torque. Prior to contraction the baseline 
signal noise was calculated as the integral root mean square over 1s and removed from the 
measured EMG during MVCKF and MVCKE. At every 10% of ramped MVCKE torque the absolute 
integral of the BF EMG was taken over 250 ms. Co-activation torque was calculated as, (BF 
EMG during ramped MVCKE / BF EMG during MVCKF) × peak MVCKF torque at 90 knee angle 
(Onambélé et al., 2007). This equation assumes that the BF is representative of the entire 
hamstring (Carolan & Cafarelli, 1992) and that a linear relationship exists between BF EMG 
and MVCKF torque (Lippold, 1952). 
5.3.8. Patella tendon stress / strain relationship 
Patella tendon strain was calculated as a ratio of total patella tendon displacement and PTL 
Patella tendon stress was calculated as: patella tendon force (N) / PTCSA (mm2). 
5.3.9. Patella tendon Young’s modulus 
Young’s modulus was calculated as, patella tendon stiffness × (PTL (mm) / PTCSA (mm2)). 
5.3.10. ‘Damaging’ eccentric exercise 
Prior to eccentric exercise, a warm-up of 10 isokinetic knee extensions and knee flexions 
were carried out through the full test range of motion (20-90, at 60s-1), ensuring a 
progressive increase in effort (with the last contraction being maximal). For the eccentric 
exercise, the knee extension range of motion was set at 20 – 90 (0 = full extension). 
Participants were asked to perform six sets of 12 maximal voluntary eccentric knee 
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extensions (MVEKE) repetitions, which has previously been reported to induce significant 
EIMD (Jamurtas et al., 2005). The eccentric phase of the contractions was performed at an 
angular velocity of 30s-1 (Jamurtas et al., 2005). The concentric phase was performed sub-
maximally at an angular velocity of 60s-1 to minimise fatigue and enhance eccentric damage 
(Chapman et al., 2006). Two minutes rest was provided between each set. Participants 
remained seated in the isokinetic dynamometer throughout the entire exercise protocol, 
including rest periods. Visual feedback and verbal encouragement was continuously provided 
throughout the protocol (Campenella et al., 2000). MVEKE torque was recorded throughout 
each contraction and displayed via the torque acquisition system. For each set, peak MVEKE 
torque was determined as the highest torque out of the 12 repetitions. Average peak MVEKE 
torque was calculated as an average of peak MVEKE across six sets. 
5.3.11. Change in vastus lateralis fascicle length during the eccentric protocol 
A real-time B-mode ultrasound (AU5 Harmonic, Esaote Biomedica, Genoa, Italy) was used to 
measure VL fascicle length during MVEKE. The ultrasound probe (7.5 MHz linear array probe) 
was fixed at 50% of VL muscle length in the mid-sagittal plane of the non-dominant leg. A 
hypo-allergenic ultrasound gel (Parker, Park Laboratories Inc., Fairfield) was used to enhance 
acoustic coupling between the skin and the ultrasound probe.  
During the first set (out of six) of MVEKE contractions, ultrasound images were 
recorded onto a PC, in real time, at 25 frames per second (Adobe Premier pro Version 6). An 
externally generated square wave signal was used to synchronise the ultrasound images with 
the torque acquisition system. Three MVEKE contractions were chosen from the first set of 12 
repetitions for architectural analysis. Using frame capture software (Adobe Premier 
Elements, version 10), an ultrasound image (frame corresponding to every 10 of knee angle, 
ranging from 20 - 90) was acquired for offline analysis using ImageJ (1.45, National 
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Institutes of Health, USA). To ensure there was no movement artefact included in the 
measurement of fascicle length, an echo-absorptive marker was fixed on the skin to provide a 
visual reference line for the internal structures. If movement of the reference line was 
observed in a recording, the contraction was discarded and another repetition was chosen for 
analysis.  
Using digitising software (ImageJ 1.45, National Institutes of Health, USA), VL fascicle 
length was analysed offline at every 10 knee angle (range 20 - 90, 0 = full extension) 
throughout the MVEKE. Fascicle length was measured from the visible insertion of the fibre 
into either the deep and superficial aponeurosis (Reeves & Narici, 2003). Where the fascicle 
extended longer than the ultrasound image (frame width 3.50 cm and height 4.15 cm), linear 
continuation of the fascicle and aponeurosis was assumed. Using ultrasound a 2-7% error has 
been associated with assuming linear continuation to calculate VL fascicle length at 120 
knee angle (Finni et al., 2003a). Recently, when comparing ultrasound to cadaveric 
measurements’, the linear extrapolation method has been concluded as a valid technique for 
measuring VL fascicle length at rest (ICC = 0.853) (Ando et al., 2014). Furthermore, chapter 
two concludes high reliability and low day-to-day measurement error when measuring VL 
fascicle lengthening during MVEKE. To reduce error associated with the estimation of VL 
fascicle length, an average of three fascicles across the image was taken. Change in fascicle 
length is presented as fascicle length at a knee angle of 90 made relative to fascicle length 
measured at a knee angle of 20; hereafter termed “relative fascicle lengthening” and 
reported as a percentage change from starting length at 20.  
5.3.12. Muscle soreness 
Muscle soreness was measured using a visual analogue scale. The visual analogue scale 
consisted of a 100 mm line, with 0 mm labelled “No pain at all” and 100 mm labelled 
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“Unbearable pain”. Seated in the isokinetic dynamometer the non-dominant leg was passively 
moved through a full range of motion at 30s-1. Participants were asked to mark a line 
perpendicular to the visual analogue scale to denote the level of pain they experienced during 
the passive movement. The visual analogue scale has been reported to be a valid and reliable 
measure of muscle soreness (inter class correlation ≥ 0.96 (Bijur et al., 2001)).  
5.3.13. Blood samples 
Venous blood samples were taken to measure CK levels. A 21-gauge needle was inserted into 
the antecubical vein of the forearm, using a 10 mL syringe. 5-6 mL of blood was drawn into a 
serum collection tube. The sample was left on a crushed ice bed for 60 minutes. The sample 
was then centrifuged at 4500 rpm at 0C for 10 minutes. Using a 200 – 1000 µl pipette 
(Eppendorf), the resulting serum sample was separated into three aliquots (~500 µl each) 
and stored in eppendorfs at -20C until CK analysis was performed. Creatine kinase levels 
were measured using a standard colorimetry procedure, measuring at optical density 340 nm 
(BioTek ELx800 96 well Microplate Reader) and immediately analysed (Gen5, version 2.0). 
Each sample was run in duplicate-quadruplets using an EnzyChromTM CK Assay Kit 
(BioAssay Systems, Hayward, CA, sensitivity 5 U/L, intra-assay variability ≤ 5% (as reported 
by the manufacturer)). An average of two – four readings was taken (at 20 minutes, (25 
minutes if necessary i.e. enzyme activity above assay’s detection upper limit of 300 U/L), or 
40 minutes following sample exposure to assay reagents (i.e. Substrate, assay buffer and 
enzyme mix)). CK activity is reported in absolute and absolute change ((ΔCKABS) i.e. the peak 
CK value - the pre CK values) terms.  
5.3.14. Statistics 
Statistical analyses was carried out using the statistical software package SPSS (v.19, Chicago, 
IL) for Windows and Microsoft Excel. To ensure the data were parametric, the Levene’s and 
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Shapiro-Wilk tests were used to assess the variance and normality of the data. If parametric 
tests were violated, the equivalent non-parametric tests were used. For sex differences in 
anthropometric measures, VLACSA, QACSA and patella tendon properties, independent T-tests 
and Mann-Whitney U tests were used. A 2×5 mixed design ANOVA (between factors: sex (2 
levels), and time from EIMD (5 levels) was used for muscle soreness, torque loss and CK 
levels. Wherever the assumption of sphericity was violated, the Greenhouse-Geisser 
correction was used. When a significant group effect was found, post-hoc independent T-tests 
was used (planned contrast) with LSD correction. Since an association was reported between 
change in CK levels and MVEKE normalised to QACSA, an analysis of covariance was used. 
Significance was set at p ≤ 0.05. Data are presented as mean ± standard deviation.  
5.4. Results 
5.4.1. Anthropometric measurements  
There was no significant difference in age between males and females (p = 0.326). Males had 
significantly greater mass (p = 0.009) and were taller (p = 0.007) than females. Pre-damage 
peak MVCKE torque was significantly higher in males compared to females (263 ± 27 Nm, 190 
± 33 Nm, respectively, p = 0.0004). Other dimension and functional characteristics of the 
population are described in Table 5.1. 
5.4.2. Vastus lateralis anatomical cross-sectional area  
Vastus lateralis anatomical cross-sectional area was significantly higher in males compared to 
females (24.4 ± 3.9 cm2 and 20.4 ± 3.4 cm2 respectively, p = 0.019). Estimated QACSA was 
significantly higher in males compared to females (72.8 ± 14.0 cm2 and 53.9 ± 8.51 cm2 
respectively, p = 0.0001). 
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5.4.3. Patella tendon properties  
Patella tendon properties for males and female are presented in Table 5.1. Patella tendon 
length was 14% longer in males compared to females. Patella tendon cross-sectional area 
was 39% larger in males. Ramped MVCKE was 36% higher in males compared to females. 
Patella tendon moment arm length was 12% longer in males compared to females (p = 
0.0007). Tendon stiffness and Young’s modulus at MVCKE was 54% and 35% (respectively) 
higher in males compared to females. To account for the significantly higher ramped MVCKE 
torque in males, the patella tendon force corresponding to the highest ramped MVCKE torque 
of the weakest participant (independent of sex) was used to calculate standardised patella 
tendon stiffness at a standardised force (2330 N). Standardised patella tendon stiffness 
(males 998 ± 329 Nmm1, females 542 ± 119 Nmm1, p = 0.003) remained significantly higher 
in males compared to females.  
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Table 5. 1. Patella tendon properties in males and females. 
 
Males Females 
Patella tendon length (mm) 56.4 ** ± 5.1 48.3 ± 6.0 
Patella tendon cross-sectional area (mm2) 83.9*** ± 16.4 54.2 ± 16.0 
Patella tendon moment arm (cm) 4.41*** ± 0.31 3.90 ± 0.90 
Ramped MVCKE (Nm) 203*** ± 23 129 ± 26 
Patella tendon force (N) 4707*** ± 603 3385 ± 700 
Patella tendon stiffness (Nmm1) 1387*** ± 560 610 ± 146 
Young’s modulus (MPa) 948* ± 492 620 ± 284 
 
Note: Patella tendon stiffness and Young’s modulus calculated at 100% maximal voluntary 
isometric knee extension (MVCKE), * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. Data is presented as 
means ± standard deviation. 
5.4.4. Torque during maximal voluntary eccentric knee extensions 
Average peak MVEKE torque of each set (six in total) was significantly higher in males 
compared to females (p ≤ 0.05). Peak MVEKE torque averaged over six sets was significantly 
higher in males compared to females (255 ± 50.0 Nm and 167 ± 29.0 Nm, respectively, p = 
0.0001). When peak MVEKE torque was normalised to QACSA, there was no significant 
difference between males and females (3.40 ± 0.78 Nm·cm2 and 3.15 ± 0.66 Nm·cm2, 
respectively, p = 0.160). 
Peak MVEKE torque made relative to pre-damage MVCKE torque, was not significantly 
different between males and females (97 ± 17% and 87 ± 12% respectively, p = 0.139)  
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5.4.5. Vastus lateralis fascicle length 
Fascicle length at 20 knee joint angle was not significantly different between males and 
females (6.86 ± 0.31 cm, 6.67 ± 0.75 cm respectively, p = 0.197). The increase in fascicle 
length from 20 to 90 knee angle during MVEKE was significantly higher in males compared 
to females (3.84 ± 0.92 cm, 2.82 ± 0.45 cm, respectively, p = 0.007). VL fascicle length at 90 
knee angle made relative to fascicle length at knee angle of 20, was significantly greater in 
males compared to females (56.0 ± 13.6% and 43.7 ± 10.1%, respectively, p = 0.034).  
5.4.6. Change in optimal knee angle 
Pre-damage, optimal MVCKE knee angle was not significantly different between males and 
females (median, 75.0 ± 10.0, and 75.0 ± 10.0, respectively, p = 0.458). Post EIMD both 
males (90.0 ± 5.0, p = 0.002) and females (median 80.0 ± 5.0, p = 0.007) demonstrated a 
significant rightward shift in MVCKE optimal angle. There was no significant difference in the 
magnitude of the rightward shift in MVCKE optimal angle between males and females (p = 
0.099).  
5.4.7. Maximal voluntary isometric knee extension torque loss 
Maximal voluntary isometric knee extension torque expressed as a percentage of pre-damage 
MVCKE torque is illustrated in Error! Reference source not found.. A two way mixed 
repeated measures ANOVA for MVCKE torque loss reported a significant main effect of time (p 
= 0.0005), however there was neither a sex effect (p = 0.201) nor a time × sex interaction (p = 
0.324). There was no significant difference in peak MVCKE torque loss between males and 
females (22.5 ± 8.5% and 27.1 ± 13.1% respectively, p = 0.332).  
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Figure 5. 1: Maximal voluntary isometric knee extension (MVCKE) torque in males and 
females, expressed as a percentage of pre-damage MVCKE torque. Data is presented as means 
± standard deviation. Significant difference from pre –damage * p ≤ 0.05, ** p ≤ 0.01. 
5.4.8. Creatine kinase levels 
Absolute CK response for males and females is illustrated in Figure 5. 2. Inter-assay 
variability within the current chapter was ≤ 10%. A two way mixed repeated measures 
ANOVA for the CK response reported a significant main effect of time (p = 0.004), group effect 
of sex (p = 0.0004) and interaction effect (p = 0.014). Pre-damage CK was not significantly 
different between males and females (138 ± 140 U/L and 80.8 ± 56.7 U/L, respectively, p = 
0.097). Absolute peak CK was significantly higher in males compared to females (1607 ± 
1247 U/L and 409 ± 421 U/L, respectively, p = 0.003). ΔCKABS to peak was significantly higher 
in males compared to females (1468 ± 1247 U/L and 329 ± 441 U/L, respectively, p = 0.005). 
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 Creatine kinase response made relative to QACSA for males and females is illustrated in 
Figure 5. 2. A two way mixed repeated measures ANOVA for CK response made relative to 
QACSA reported a significant main effect of time (p = 0.003) and a group effect of sex (p = 
0.004), however there was no significant interaction (p = 0.112). ΔCKABS to peak made relative 
to QACSA remained significantly higher in males compared to females (18.4 ± 15.7 U/Lcm2 and 
6.84 ± 10.75 U/Lcm2, respectively, p = 0.043). 
 A significant correlation was observed between MVEKE torque made relative to QACSA 
and ΔCKABS to peak (r = 0.635, p ≤ 0.001), it was therefore considered as a covariate of CK. The 
analysis of covariance revealed a significant effect of sex on ΔCKABS to peak when controlling 
for average peak MVEKE torque made relative to QACSA as a covariate (p = 0.0001, power 
0.468).  
5.4.9. Creatine kinase correlation 
Within males and females there was no significant correlation between ΔCKABS to peak and 
relative patella tendon stiffness (r = -0.260, p = 0.220 and r = 0.086, p = 0.419 respectively). 
Similarly, pooling the whole population, there was no correlation between ΔCKABS to peak and 
relative patella tendon stiffness (r = 0.184, p = 0.212). 
 Within males and females there was no significant correlation between ΔCKABS to 
peak and relative change in fascicle length (males r = 0.037, p = 0.457 and females r = -0.109, 
p = 0.382). Again, pooling the whole population, there was no significant correlation between 
ΔCKABS to peak and relative change in fascicle length (r = 0.251, p = 0.136). 
5.4.10. Muscle soreness  
A two way mixed measures ANOVA for muscle soreness reported a significant main effect of 
time (p = 0.0004); however, there was no significant group difference (sex, p = 0.395) nor a 
significant interaction (p = 0.759). For both males and females, peak muscle soreness 
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occurred 48 hours post EIMD. There was no difference in peak muscle soreness in males and 
females (4.82 ± 2.23 and 3.75 ± 1.68, respectively, p = 0.134).  
 
Figure 5. 2: A) Creatine kinase (CK) response following exercise-induced muscle damage 
(EIMD) in males and females B) CK made relative to vastus lateralis anatomical cross-
sectional area (VLACSA). Data is presented as means ± standard deviation. * Males CK 
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significantly higher than females p ≤ 0.05, ** Males CK significantly higher than females p ≤ 
0.01. 
5.5. Discussion 
The aims of the current chapter were twofold, firstly to determine whether there is a sex 
difference in EIMD; and secondly, dependent on the outcome of the first aim, to establish 
whether tendon stiffness may explain the potential sex difference in EIMD. The three main 
findings of the current chapter are as follows: 1) MVCKE torque loss and muscle soreness post 
EIMD do not differ between males and females, 2) the CK response is significantly higher in 
males compared to females following EIMD, and remains higher when MVEKE torque relative 
to QACSA is considered, and 3) patella tendon stiffness and VL fascicle lengthening do not 
explain the sex differences in CK. 
 In agreement with previous literature (Sayers & Clarkson, 2001; Rinard et al., 2000) 
the current chapter reports no sex difference in MVC torque loss post EIMD. Through a 
significant loss in MVCKE torque and a rightward shift in MVCKE optimal knee angle it can be 
concluded that the protocol used in this chapter was sufficient to cause EIMD. Although there 
was a trend for males to demonstrate a greater rightward shift in optimal knee angle post 
EIMD, despite sufficient power (p = 0.99) it did not reach a significant difference between 
males and females. Further supporting the finding of no difference in MVCKE torque loss 
between males and females. The findings from the current chapter concur with Sayers and 
Clarkson (2001), despite the current chapter reporting substantially smaller MVC torque loss 
(23% and 27% versus 54% and 60% in males and females, respectively). The greater MVC 
torque loss reported by Sayers and Clarkson (2001) can be attributed to the current chapter 
exercising the lower limb rather than the upper limb, which is consistent with previous data 
(Chen et al., 2011; Saka et al., 2009). The similar loss of MVCKE torque in both sexes within the 
current chapter, may be supported by the findings of Stupka et al. (2000) who, using muscle 
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biopsies of the VL, found no sex difference in structural damage (z-disk streaming) post 
EIMD. On the other hand, the current chapter contradicts the findings of Sewright et al. 
(2008) who reported MVC torque loss to be significantly higher in females compared to 
males immediately following 50 eccentric contractions of the elbow flexors. Interestingly, 
Sewright et al. (2008) reported no further difference in torque loss post EIMD (12, 72, 96, 
168 and 240 hours post EIMD). As no difference in isometric MVC torque loss was reported at 
any other time point, Sewright et al. (2008) attributed the loss in MVC torque immediately 
post EIMD to fatigue rather than EIMD. Therefore, when the confounding factor of fatigue was 
avoided in the current chapter (by measuring MVCKE torque loss 60 minutes after the damage 
protocol (Walsh et al., 2004)), it can be concluded that a sex difference in MVCKE torque loss 
post EIMD does not exist in the VL.  
 Despite no sex difference in MVCKE torque loss, a significant sex difference in the CK 
response was reported within the current chapter. The CK response in both males and 
females followed the typical CK response post EIMD, with a peak at 96 hours post EIMD 
(Newham et al., 1983a). Furthermore, the elevated CK in males in the present chapter is 
consistent with the CK responses observed following both eccentric contractions in elbow 
flexors (Sewright et al., 2008) and knee extensors (Wolf et al., 2012; Joyce et al., 2014). 
Specifically, the current chapter has demonstrated that the acute CK response following EIMD 
observed by Wolf et al. (2012) and Joyce et al. (2014), persists past 24 and 48 hours 
(respectively), to remain significantly higher in males 168 hours post EIMD. To account for 
the larger muscle mass in males within the current chapter, and the potential confounding 
impact this could have, CK was also presented relative to estimated QACSA. Creatine kinase 
normalised to QACSA remained significantly higher in males. Thus suggesting that the greater 
muscle mass in males does not contribute to the greater CK levels post EIMD. A sex difference 
in CK is not consistent with Stupka et al. (2000) whom reported no sex difference in CK 
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following eccentric exercise of the lower limbs. Despite exercising the same muscle groups, 
the discrepancies between Stupka et al. (2000) and the current chapter may be attributed to 
Stupka et al. (2000) measuring CK 48 and 144 hours post EIMD, whereas CK is suggested to 
peak 72-96 hours post EIMD (Newham et al., 1983a). Therefore, the current chapter 
confirms, regardless of greater muscle size, when CK is measured at its peak, there is a sex 
difference in the CK response post EIMD.  
 When MVCKE torque loss is taken as the primary marker of EIMD, the current chapter 
can conclude that there are no sex differences in EIMD however, if CK is used as the primary 
marker of EIMD, a sex difference is present. It remains unclear why, despite no difference in 
MVCKE torque loss, a sex difference in CK has been reported within the current chapter. The 
higher CK levels following EIMD in males may be attributed to three factors, these are: 1) 
Significantly higher patella tendon stiffness in males, 2) greater VL fascicle lengthening in 
males and 3) greater MVEKE torque in males. Firstly, higher circulating oestrogen levels have 
been reported to alter tendon properties (Hansen et al., 2009b), specifically lowering tendon 
stiffness in females (Bryant et al., 2008). In agreement with chapter three and previous 
literature, the current chapter reported males to have significantly higher tendon stiffness 
compared to females (Onambélé et al., 2007). Previously, differences in tendon properties 
have been suggested to explain differences in EIMD between compliant and stiff hamstrings 
however, the role of the tendon on EIMD has yet to be evidenced experimentally (McHugh et 
al., 1999). Within the current chapter there was no significant correlation between patella 
tendon stiffness and ΔCKABS to peak, in males, females or when participants were pooled by 
sex. Therefore, it is likely that sex differences in patella tendon properties do not explain sex 
differences in CK and some other factors are contributing to the reported sex difference. 
Secondly, the higher CK in males may be attributed to the significantly lower VL 
fascicle lengthening in females. In situ animal the magnitude of fascicle strain, denoted by 
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fascicle lengthening has been concluded as the main determinant of EIMD (Lieber & Friden, 
1993; Talbot & Morgan, 1998), in vivo however the role of fascicle lengthening on EIMD 
remains unclear (Hoffman et al., 2014). Within chapter three and within the current chapter, 
VL fascicle lengthening was significantly higher in males compared to females during MVEKE. 
Higher fascicle lengthening in the males may increase the number of fascicles extending onto 
the descending limb of the length-tension relationship, thus increasing EIMD (Morgan, 1990). 
The current chapter however, showed no relationship between relative VL fascicle 
lengthening and ΔCKABS to peak, suggesting that greater VL fascicle lengthening in males does 
not explain the sex difference in CK. Fascicle length throughout the VL is heterozygous 
(Blazevich et al., 2006), however, the current chapter cannot account for fascicle lengthening 
in other regions of the VL (i.e. the distal or proximal region), nor indeed, the other three 
muscles that form the quadriceps.  
Thirdly, the higher CK in males may be attributed to the lower MVEKE torque in 
females. In vitro animal studies have attributed EIMD to the magnitude of eccentric torque 
(Warren et al., 1993a), within in vivo studies however, the association between eccentric 
torque and EIMD remains undetermined (Hody et al., 2013; Chapman et al., 2008). Peak 
MVEKE torque was significantly higher in males compared to females within the current 
chapter. However, when peak MVEKE torque was normalised to QACSA and accounted for as a 
covariate, CK values remained significantly higher post EIMD in males compared to females. 
Therefore, although MVEKE made relative to QACSA has an interaction with ΔCKABS to peak (as 
would be expected given the greater strength and CK of the males), it did not fully account for 
the sex differences in CK following EIMD.  
Within the current chapter the higher CK response in males could not be attributed to 
sex differences in patella tendon properties, VL fascicle lengthening or MVEKE torque; it is 
possible therefore, that damage is equivocal between the sexes (evidenced by similar MVCKE 
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torque loss, rightward shift in optimal angle and muscle soreness), but in females oestrogen 
may suppress the release of CK. Oestrogen has a high antioxidant capacity in skeletal muscle 
and enhances cell membrane stability (Wiseman & Quinn, 1994). The lower CK response in 
females may be attributed to oestrogen maintaining the structural integrity of the cell 
membrane, thus reducing the leakage of CK into the serum and giving an impression of lower 
EIMD. Although CK has historically been used as an indirect marker of EIMD (Nosaka & 
Clarkson, 1996), the validity of CK has been questioned (Friden & Lieber, 2001; Komulainen 
et al., 1995). In addition to large variability, it remains unclear as to whether CK is a true 
representation of muscle function and the magnitude of damage post EIMD, but may reflect 
the membrane permeability to intramuscular proteins (Friden & Lieber, 2001). Therefore, 
the findings from the current chapter are presented with the caveat that the elevated CK may 
confirm that a loss of membrane stability and thus EIMD has occurred, rather than the 
severity of EIMD per se (Heled et al., 2007). In support of CK representing a loss of membrane 
stability, significantly higher levels of CK in males and oral contraceptive users compared to 
non-users has been attributed to the membrane stabilising role of oestrogen in females 
(Komulainen et al., 1999; Joyce et al., 2014). 
5.6. Conclusion 
The current chapter can therefore conclude; that whether a sex difference in EIMD is 
observed depends on which measure of EIMD is reported. It is anticipated that MVCKE torque 
loss is the best indirect marker of EIMD (Warren et al., 1999), whereas it remains unclear 
whether the magnitude of CK is a true indicator of the severity of EIMD (Friden & Lieber, 
2001). Within the current chapter significantly higher patella tendon stiffness, VL fascicle 
lengthening and MVEKE torque in males, could not explain the lower ΔCKABS to peak in 
females. Therefore, the lower CK in females may be attributed to oestrogen increasing 
membrane stability, thus giving the impression of greater EIMD in males (Joyce et al., 2014). 
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Therefore, with the caveat associated with CK in mind, using MVCKE torque loss as the 
primary marker of EIMD, the current chapter concludes a sex differences in EIMD does not 
exist.   
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Chapter six: Oral contraceptive pill users are not more 
susceptible to exercise-induced muscle damage compared 
to non-users.  
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6.1. Abstract 
Aim: Firstly to establish whether oral contraceptive pill (OCP) users are more susceptible to 
exercise-induced muscle damage (EIMD) compared to non-users, and secondly, whether 
differences can be attributed, in part, to differences in patella tendon properties. Materials 
and method: 9 female OCP users and 9 female non-users participated on the 14th day of their 
menstrual cycle. Vastus lateralis (VL) and patella tendon properties were assessed using 
ultrasonography. During maximal voluntary eccentric knee extensions ((MVEKE) 12 reps × 6 
sets), VL fascicle lengthening and MVEKE torque were recorded every 10 of knee joint angle 
(20 - 90). Oestrogen levels were measured at ovulation (14th day). Maximal isometric knee 
extension (MVCKE) torque loss, Creatine Kinase (CK) and muscle soreness were measured pre, 
post, 48, 96 and 168 hours post damage as markers of EIMD. Results: As expected oestrogen 
levels were significantly lower in OCP users compared to non-users (p ≤ 0.05). Patella tendon 
stiffness, VL fascicle lengthening and MVEKE torque did not differ between OCP users and 
non-users (p ≤ 0.05). Absolute change in CK ((ΔCKABS) i.e. peak CK value - pre-damage CK 
values) was significantly higher in OCP users compared to non-users. There were no other 
differences in markers of EIMD. Conclusion: The magnitude of EIMD, as determined through 
MVCKE torque loss and muscle soreness was similar between OCP users and non-users. The 
significantly higher ΔCKABS to peak in the OCP users may be attributed to oestrogen increasing 
membrane stability in non-users and/or a partially protective mechanism against EIMD.  
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6.2. Introduction 
The female sex hormone, oestrogen, has antioxidant properties (Enns et al., 2008; Wiseman 
et al., 1993; Ayres et al., 1998), which have been suggested to attenuate exercise-induced 
muscle damage (EIMD) in females compared to males (Sewright et al., 2008; Joyce et al., 
2014). Through manipulation of circulating levels, oestrogen has been shown to attenuate 
EIMD in male and female rats (Amelink et al., 1990; Amelink et al., 1991; Bär et al., 1988). For 
example, Bär et al. (1988) reported the increase in creatine kinase (CK) post EIMD, in both 
males and ovariectomised female rats, was supressed by oestrogen supplements prior to 
EIMD. However, although methods used to manipulate hormone levels within animal studies 
are very precise (ovariectomy), they are not readily used within humans in the investigation 
of EIMD. Alternatively, oestrogen levels can be manipulated through the use of synthetic 
hormones (e.g. hormone replacement therapy (HRT) or the oral contraceptive pill (OCP)). 
The OCP down regulates oestrogen levels throughout the menstrual cycle by altering the 
hypothalamic-pituitary-ovarian feedback loop, thus inhibiting the peak in oestrogen at 
ovulation (Elliott-Sale et al., 2013; Van Heusden & Fauser, 2002). Consequently, women who 
take the OCP have significantly lower levels of circulating oestrogen compared to non-users 
throughout the menstrual cycle (Bryant et al., 2008; Fleischman et al., 2010). For example, 
throughout the menstrual cycle oestrogen levels within non-users increases four fold from 
baseline (~50 to ~ 200 pg/ml (Yeung et al., 2012)), whereas within OCP users oestrogen 
increases 2 fold from baseline and then plateaus (mean 66 pg/ml (Endrikat et al., 2002)). Due 
to the lower levels of oestrogen, it is suggested that OCP users may be more susceptible to 
EIMD. However, the literature remains inconclusive with authors supporting (Carter et al., 
2001; Joyce et al., 2014) or refuting (Thompson et al., 1997; Sewright et al., 2008) this 
increased EIMD susceptibility hypothesis. Measurement days at different phases of the 
menstrual cycle and different exercising muscle groups may explain the discrepancies within 
  
152 
 
previous literature. Furthermore, although the OCP attenuates oestrogen levels, post intake 
of the OCP and following the seven day pill free period, oestrogen levels temporarily spike 
during the first 7-10 days of the next cycle (Sneader, 2005; Legro et al., 2008). Consequently, 
due to this delayed spike in oestrogen, it is crucial to control measurement times and 
measurement days not only within the non-users but also within the OCP users. Therefore, 
due to the inconsistencies within data collection, the effect of the OCP and by extension 
oestrogen on EIMD remains inconclusive in the lower limbs. 
In addition to acting as an antioxidant, oestrogen may attenuate EIMD in a couple of 
other ways. Firstly, it appears oestrogen may attenuate EIMD by mediating the influx of 
neutrophils post EIMD (MacNeil et al., 2011; Silvestri et al., 2003) and reducing markers of 
inflammation (Silvestri et al., 2003), thus preventing further EIMD occurring through the 
secondary damage response. Secondly, oestrogen has been reported to decrease tendon 
stiffness by increasing tendon fractional synthesis rate (Kubo et al., 2003; Hansen et al., 
2009a; Hansen et al., 2009b). For example, greater tendon stiffness in males compared to 
females, has been attributed to significantly higher levels of oestrogen in females (Kubo et al., 
2003). Within OCP users however, despite lower oestrogen levels compared to non-user, it 
remains unclear, with arguments supporting (Bryant et al., 2008) or contesting (Hansen et al., 
2013) differences in tendon properties between OCP users and non-users. Therefore, it 
remains unknown if the OCP alters tendon properties. 
Within chapter five we attributed the significantly lower CK response in the females 
compared to the males, to the protective role of oestrogen on EIMD. Furthermore, within 
chapter three it was shown that the patella tendon mitigated fascicle lengthening during 
MVEKE, with a greater attenuation in fascicle lengthening within males compared to females 
being attributed to higher patella tendon stiffness in males. Additionally the tendon has been 
reported to attenuate peak forces and torques during eccentric contractions, thus the tendon 
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has been suggested to act as a mechanical buffer on EIMD (Roberts & Azizi, 2010; Roberts & 
Konow, 2013; Hoffman et al., 2014). Consequently, if the OCP does alter tendon stiffness, 
differences in EIMD could be attributed to oestrogen’s antioxidant properties (as 
hypothesised in chapter five), and / or oestrogen’s effects on tendon properties. Therefore, 
the aim of the current chapter is twofold: Firstly to establish whether OCP users are more 
susceptible to EIMD compared to non-users and secondly, whether differences can be 
attributed, in part, to differences in tendon properties.  
6.3. Materials and method 
6.3.1. Subjects 
A total of 18 females were divided into two groups: women taking the OCP (n = 9, 23.4 ± 2.4 
years of age, 70.0 ± 9.9 kg and 170 ± 5 cm), and eumenorrheic women who had never taken 
the OCP ((non-users) n = 9, 21.2 ± 1.5 years of age, 63.2 ± 5.6 kg and 165 ± 9 cm). All 
participants self-reported as being recreationally active (undertaking no more than 1 hour of 
“moderate” physical activity per week) and did not take part in any structured resistance 
training. All procedures complied with the Declaration of Helsinki (World Health Association, 
2013) and ethical approval was obtained through the local ethics committee. All women 
reported regular menstrual cycles, documenting an average cycle length of 28 ± 1 days (Cole 
et al., 2009). On average the OCP users had been taking an OCP prescription with an ethinyl 
estradiol dosage between 20-30 µg for 3 ± 1 years. Exclusion criteria included any resistance 
training in the last six months, occupation or lifestyle that required regular heavy lifting or 
carrying, any known muscle disorder, the use of dietary supplements (i.e. vitamin E), and any 
musculoskeletal injury in the last three months. Further exclusion criteria included, previous 
use of any other forms of hormone based contraception, irregular menstrual cycles (where 
regular cycles were defined as 24-36 days (Cole et al., 2009; Landgren et al., 1980)) in the last 
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12 months, and pregnancy in the year preceding inclusion in the present chapter. All 
inclusion and exclusion criteria were determined through participant questionnaire prior to 
inclusion within this chapter. 
6.3.2. Testing protocol 
Once selected, participants were asked to visit the laboratory on five different occasions over 
nine days. Non-users were tested on the 14th day (self-reported) of the menstrual cycle to 
measure oestrogen levels at ovulation (Brown, 1955; Cole et al., 2009). To allow for direct 
comparison, OCP users were also tested on the 14th day of their menstrual cycle. Testing the 
OCP users on the 14th day of their menstrual cycle ensured the secondary peak in oestrogen 
witnessed following the seven day pill free period in the OCP users was avoided (Legro et al., 
2008). To avoid an acute peak in oestrogen levels the OCP users were not tested within two 
hours of taking their OCP (Sneader, 2005; Endrikat et al., 2002). The sessions were as follows: 
1) pre-damage 2) damage (48 hours post pre-damage), 3) 48 hours, 4) 96 hours, and 5) 168 
hours. Pre-damage assessments consisted of stature and mass (anthropometric measures), 
patella tendon moment arm (PTMA), 5-6 ml blood sample, dynamometer familiarisation 
(within pre-damage), morphological measures of the patella tendon (tendon size and 
stiffness) and isometric maximal voluntary knee extension (MVCKE) torque measurements at 
six angles (60, 65, 70, 75, 80 and 90 (full extension = 0)). Participants performed two 
practice MVCs, at two knee joint angles during the familiarisation session. Stature and mass 
were measured using a wall mounted stadiometer (Harpenden, Holtain Crymych, UK) and 
digital scales (Seca model 873, Seca, Germany), respectively. The damage session consisted of 
maximal voluntary eccentric knee contractions (MVEKE), 5-6 mL venous blood sample, rating 
of muscle soreness and MVCKE torque measurements. 48, 96 and 168 hours session consisted 
of 5-6 mL blood sample, rating of muscle soreness, and MVCKE torque measurements at six 
angles (60, 65, 70, 75, 80 and 90).  
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All tests were carried out in the non-dominant leg. The non-dominant leg was defined as the 
leg that provided stability during movements. Participants were seated in an isokinetic 
dynamometer (Cybex Norm, Cybex International, NY, USA), with a hip angle of 85. To reduce 
any extraneous movement during maximal efforts participants were secured in a seated 
position using inextensible straps around the shoulders and hips. The isokinetic 
dynamometer axis of rotation was visually aligned with the knee joint’s centre of rotation. 
During pre-damage the isokinetic dynamometer settings (chair position, distance from the 
dynamometer, dynamometer arm length) and anatomical zero (leg full extended, knee angle 0) 
were recorded to ensure repeatability in the following sessions. 
6.3.3. Vastus lateralis anatomical cross-sectional area 
Vastus lateralis (VL) anatomical cross-sectional area (VLACSA) was measured using a real-time 
B-mode ultrasound (AU5 Harmonic, Esaote Biomedica, Genoa, Italy). With the participant laid 
supine and their non-dominant leg fully extended (knee angle 0), the distal and proximal 
insertions sites of the VL were identified using an ultrasound probe (7.5 MHz linear array 
probe, 38 mm wide). At 50% of VL muscle length echo-absorptive markers were placed in 
parallel, at intervals of 30 mm, from the lateral to the medial edge of the VL muscle. The 
ultrasound probe was held perpendicular to the VL muscle in the axial plane. The ultrasound 
probe was moved steadily over the echo-absorptive markers from the lateral to the medial 
edge of the muscle. Constant, light pressure was placed on the muscle during scanning to 
avoid compression of the underlying soft tissue. The images were recorded in real time at 25 
frames per second (Adobe Premier pro Version 6, Adobe Systems Software, Ireland). Using 
video editing software (Adobe Premier Elements, version 10), still images were acquired at 
each 30 mm interval. The shadows cast by the echo-absorptive markers allowed the 
neighbouring still images to be aligned, thus reconstructing the entire VLACSA in a single image 
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(Adobe Photoshop Elements, version 10). Digitising software (ImageJ 1.45, National 
Institutes of Health, USA) was used to measure VLACSA. This method of calculating VLACSA has 
previously been accepted as reliable and valid when compared to magnetic resonance 
imaging (MRI), with a reported interclass correlation between 0.998 and 0.999 (Reeves et al., 
2004). In females, a VLACSA of ~21 cm2 has been reported to contribute to 38% of total 
quadriceps ACSA ((QACSA) QACSA = ~55 cm2 (Grosset & Onambele‐Pearson, 2008)). Therefore, 
assuming the contribution of VLACSA remains constant within females, QACSA within female OCP 
users and non-users was estimated using the following equation: (VLACSA / 0.38) × 100. 
6.3.4. Maximal isometric voluntary knee extension torque measurement 
At six different knee angles (60, 65, 70, 75, 80 and 90 (full extension = 0)) participants were 
instructed to perform two MVCKE lasting ~two seconds with 90 seconds rest between 
contractions. Torque was presented, in real time, on a Macintosh G4 computer (Apple 
Computer, Cupertino, CA, USA), via an A/D converter (Biopac Systems, Santa Barbara, CA). 
Torque measurements were later analysed offline with the accompanying software 
(Acknowledge, version 3.9.2). The highest peak torque produced at each angle was taken as 
MVCKE peak torque. The knee angle where the highest torque was produced was recorded as 
optimal knee angle. In a randomised order, MVCKE torque measurements were repeated at all 
six knee angles 60 minutes post eccentric exercise (to reduce any fatigue effect (Walsh et al., 
2004)) and 48 hours, 96 hours and 168 hours post eccentric exercise. MVCKE torque loss was 
calculated from optimal knee angle identified at pre-damage.  
6.3.5. Patella tendon length and cross-sectional area 
A real-time B-mode ultrasound (AU5 Harmonic, Esaote Biomedica, Genoa, Italy) was used to 
measure patella tendon cross-sectional area (PTCSA) and patella tendon length (PTL) at a fixed 
90 knee angle. The distance between the apex of the patella and the tibial tuberosity, marked 
  
157 
 
using sagittal ultrasound images, was taken as PTL. To measure PTCSA the ultrasound probe 
was placed in the transverse plane and images were captured at 25%, 50%, and 75% of PTL. 
The images were later analysed offline using (ImageJ 1.45, National Institutes of Health, USA). 
PTCSA is presented as a mean of all three images (O’Brien et al., 2010). 
6.3.6. Patella tendon stiffness  
The participants were seated in the isokinetic dynamometer, with the knee angle fixed at 90, 
and were instructed to perform a ramped, isometric MVCKE lasting ~5-6 seconds. Ramped 
MVCKE torque and displacement of the patella tendon were synchronised using a 10-V square 
wave, signal generator. Patella tendon displacement was measured over two MVCKE, once 
with the ultrasound probe positioned over the distal edge of the patella and on the second 
contraction over the tibial tuberosity (Onambélé et al., 2007), so that total displacement 
would be computed from the composite of proximal and distal patella motions (see below). 
Torque was presented on a Macintosh G4 computer (Apple Computer, Cupertino, CA, USA), 
via an A/D converter and subsequently analysed with the accompanying software 
(Acknowledge, Biopac Systems, Santa Barbara, CA). To create an external marker on the 
ultrasound images, an echo-absorptive marker was placed on the skin. Using the marker to 
calculate displacement, the distance of the marker (shadow) from an anatomical reference 
point at the beginning of the contraction, to the position of the shadow at the end of the 
contraction was calculated. A square wave, signal generator was used to synchronise the 
ultrasound images with the torque acquisition system. Images were captured at ~10% 
intervals of ramped MVCKE torque (Onambélé et al., 2007). Total patella tendon displacement 
was calculated as displacement at the apex of the patellar plus the displacement at the tibial 
tuberosity (Onambélé et al., 2007). Patella tendon forces were calculated as: (MVCKE torque + 
antagonist co-activation torque) / PTMA.  
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Patella tendon moment arm was measured at 90 knee angle (full extension = 0) in the 
sagittal plane, from a single energy (frame 23.3 cm x 13.7 cm) DEXA scan (Hologic Discovery, 
Vertec Scientific Ltd, UK). Using OsiriX (DICOM viewer, ver. 4.0, Pixemo, Switzerland), patella 
tendon moment arm length was determined as the perpendicular distance from the centre of 
the patella tendon to the tibio–femoral contact point (Baltzopoulos, 1995). The DEXA has 
been compared to MRI measures, demonstrating consistent reliability and validity against 
this standard (Erskine et al., 2014). 
For the calculation of tendon force, the calculation of antagonist co-activation torque 
is described below. The patella tendon force – elongation curve constructed from data 
analysed at every 10% MVCKE, was then fitted with a second-order polynomial function 
forced through zero (Onambélé et al., 2007). The tangential slope at discreet sections of the 
curve, relative to MVCKE force, was computed by differentiating the curve at every 10% 
patella tendon force intervals. In addition, to standardise the comparison of patella tendon 
stiffness at an absolute load, the slope of the tangential line, corresponding to the MVCKE force 
of the weakest participant, was computed for each subject.  
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6.3.7. Co-activation 
In order to compute patella tendon force co-activation was measured. To determine co-
activation during the ramped MVCKE, Electromyogram (EMG) of the bicep femoris (BF) was 
measured. Guided by an axial-plane ultrasound of the BF, two bipolar electrodes (Ambu, 
Neuroline 720, Denmark) were placed in the mid-sagittal line at 25% of BF muscle length 
(distal end = 0%). A reference electrode (Ambu, Blue Sensor, Denmark) was placed on the 
lateral tibial condyle. The electrodes were placed in a bipolar configuration with a constant 
inter-electrode distance of 20 mm (Hermens et al., 2000). Prior to electrode placement; the 
skin was shaved, gently abraded and cleansed with an alcohol wipe to reduce skin impedance 
below 5000 Ω (Hermens et al., 2000). To minimise cross talk, and ensure a mid-sagittal 
placement of electrodes, ultrasonography was used to identify the medial and lateral aspects 
of the BF muscle. The raw EMG signal was amplified (×2000) and filtered (through low and 
high pass filters of 10 and 500 Hz respectively) with the sampling frequency set at 2000 Hz. 
Ramped MVCKE torque and BF EMG were recorded in real time and synchronised using a (10-
V) square wave signal generator. Participants performed two maximal voluntary isometric 
knee flexions (MVCKF) at 90. They were instructed to perform MVCKF rapidly and as 
forcefully as possible against the dynamometer’s lever arm. The participants were instructed 
to relax once a two second plateau had been attained (as observed on the dynamometer 
screen display). The integral of the root mean square of the BF EMG signal, was calculated 
500 ms either side of instantaneous MVCKF maximal torque from the contraction 
corresponding to the highest MVCKF torque. Prior to contraction the baseline signal noise was 
calculated as the integral RMS over 1s and removed from the measured EMG during MVCKF 
and MVCKE. At every 10% of ramped MVCKE torque the absolute integral of the BF EMG was 
taken over 250 ms. Co-activation torque was calculated as, (BF EMG during ramped MVCKE / 
BF EMG during MVCKF) × MVCKF torque at 90 knee angle (Onambélé et al., 2007). This 
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equation assumes that the BF is representative of the entire hamstring (Carolan & Cafarelli, 
1992), and that a linear relationship exists between BF EMG and MVCKF torque (Lippold, 
1952). 
6.3.8. Patella tendon stress / strain relationship  
Patella tendon strain was calculated as a ratio of total patella tendon displacement and PTL. 
Patella tendon stress was calculated as: patella tendon force (N) / PTCSA (mm2). 
6.3.9. Patella tendon Young’s modulus 
Young’s modulus was calculated as: Patella tendon stiffness × (PTL (mm) / PTCSA (mm2)).  
6.3.10. ‘Damaging’ eccentric exercise 
Prior to eccentric exercise, a warm-up of 10 isokinetic knee extensions and knee flexions 
were carried out, ensuring a progressive increase in effort (with the last contraction being 
maximal). For the eccentric exercise, the knee extension range of motion was set at 20 – 90 
(0 = full extension). Participants were asked to perform six sets of 12 maximal voluntary 
eccentric knee extensions (MVEKE) repetitions. The eccentric phase of the contractions was 
performed at an isokinetic angular velocity of 30s-1 (Jamurtas et al., 2005). The concentric 
phase was performed sub-maximally at an angular velocity of 60s-1 to minimise fatigue and 
enhance eccentric damage (Chapman et al., 2006). Two minutes rest was provided between 
each set. Participants remained seated in the isokinetic dynamometer throughout the entire 
exercise protocol, including rest periods. Visual feedback and verbal encouragement was 
continuously provided throughout the protocol. MVEKE torque was recorded throughout each 
contraction and displayed via the torque acquisition system. For each set, peak MVEKE torque 
was determined as the highest torque out of the 12 repetitions. Average peak MVEKE torque 
was calculated as an average of peak MVEKE across six sets.  
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6.3.11. Change in vastus lateralis fascicle length during the eccentric protocol 
A real-time B-mode ultrasound (AU5 Harmonic, Esaote Biomedica, Genoa, Italy) was used to 
measure VL fascicle length during MVEKE. The ultrasound probe (7.5 MHz linear array probe) 
was fixed at 50% of VL muscle length in the mid-sagittal plane of the non-dominant leg. A 
hypo-allergenic ultrasound gel (Parker, Park Laboratories Inc., Fairfield) was used to enhance 
acoustic coupling between the skin and the ultrasound probe.  
During the first set (out of six) of MVEKE contractions, ultrasound images were 
recorded onto a PC, in real time, at 25 frames per second (Adobe Premier pro Version 6). An 
externally generated square wave signal was used to synchronise the ultrasound images with 
the torque acquisition system. Three MVEKE contractions were chosen from the first set of 12 
repetitions for architectural analysis. Using frame capture software (Adobe Premier 
Elements, version 10), an ultrasound image (frame corresponding to every 10 of knee angle, 
ranging from 20- 90) was acquired for offline analysis. To ensure there was no movement 
artefact included in the measurement of fascicle length, an echo-absorptive marker was fixed 
on the skin to provide a visual reference point for the internal structures. If movement of the 
reference line was observed, the contraction was discarded and another repetition was 
chosen for analysis.  
Using image analysis software (ImageJ 1.45, National Institutes of Health, USA), VL 
fascicle length was analysed offline at every 10. Fascicle length was measured from the 
visible insertion of the fibre into either the deep and superficial aponeurosis (Reeves & 
Narici, 2003). Where the fascicle extended longer than the ultrasound image (frame width 
3.50 cm and height 4.15 cm), linear continuation of the fascicle and aponeurosis was 
assumed. Using ultrasound a 2-7% error has been associated with assuming linear 
continuation to calculate VL fascicle length at 120 knee angle (Finni et al., 2003a). Recently, 
when comparing ultrasound to cadaveric measurements’, the linear extrapolation method 
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has been concluded as a valid technique for measuring VL fascicle length at rest (interclass 
correlation (ICC) = 0.853) (Ando et al., 2014). Furthermore, chapter two concludes high 
reliability and low day-to-day measurement error when measuring VL fascicle lengthening 
during MVEKE. To reduce error associated with the estimation of VL fascicle length, an 
average of three fascicles across the image was taken (Guilhem et al., 2011). Fascicle length 
during eccentric contractions was measured at every 10 knee angle (range 20 - 90, 0 = full 
extension) throughout the MVEKE. Change in fascicle length is presented as fascicle length at a 
knee angle of 90 made relative to fascicle length measured at a knee angle of 20; hereafter 
termed “relative fascicle lengthening” and reported as a percentage change from starting 
length at 20. 
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6.3.12. Muscle soreness 
Muscle soreness was measured using a visual analogue scale (VAS). The VAS consisted of a 
100 mm line, with 0 mm labelled “No pain at all” and 100 mm labelled “Unbearable pain”. 
Seated in the isokinetic dynamometer the leg was passively moved through a full range of 
motion at 30s-1. Participants were asked to mark a line perpendicular to the VAS to denote 
the level of pain they experienced during the passive movement. The VAS has been reported 
to be a valid and reliable measure of muscle soreness (ICC > 0.96 (Bijur et al., 2001)).  
6.3.13. Blood samples 
Venous blood samples were taken to measure CK and oestradiol levels. A 21-gauge needle 
was inserted into the antecubical vein of the forearm, using a 10 mL syringe. 5-6 mL of blood 
was drawn into a serum collection tube. The sample was left on a crushed ice bed for 60 
minutes. The sample was then centrifuged at 4500 rpm at 0C for 10 minutes. Using a 200 – 
1000 µl pipette (Eppendorf), the resulting serum sample was separated into three aliquots 
(~500 µl each) and stored in eppendorfs at -20C until CK and oestradiol analysis was 
performed.  
Creatine kinase levels were measured using a standard colorimetry procedure, 
measuring at optical density 340 nm (BioTek ELx800 96 well Microplate Reader) and 
immediately analysed (Gen5, version 2.0). Each sample was run in duplicate-quadruplets 
using an EnzyChromTM CK Assay Kit (BioAssay Systems, Hayward, CA, sensitivity 5 U/L, 
manufacturer intra-assay variability ≤ 5%). An average of two – four readings was taken. CK 
activity is reported in absolute values and absolute change from pre-damage values ((ΔCKABS) i.e. 
the peak CK value - the pre CK values).  
Oestradiol was measured using a standard enzyme-linked immunosorbent assay 
(ELISA) procedures (Alpha Diagnostic International, San Antonio, USA). Absorbency was 
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measured at optical density of 450 nm (BioTek ELx800 96 well Microplate Reader). The 
minimal oestroadiol detection was ~10 pg/ml, the manufacturers intra-precision and inter-
precision was 9.85% and 10.3% respectively. To calculate oestrogen levels, a standard curve 
was plotted using the six standards against their absorbance. Using the mean absorbance of 
each sample, the concentration of the sample was read directly from the standard curve.  
6.3.14. Statistics 
Statistical analyses was carried out using the statistical software package SPSS (v.19, Chicago, 
IL) for Windows and Microsoft Excel. To ensure the data were parametric, the Levene’s and 
Shapiro-Wilk tests were used to assess the variance and normality of the data. If parametric 
tests were violated, the equivalent non-parametric tests were used. For group differences in 
anthropometric measures, oestrogen levels, VLACSA, QACSA, patella tendon properties, ΔCKABS to 
peak and change in VL fascicle length independent T-tests were used. A 2×5 mixed design 
ANOVA (between factors: OCP use (2 levels), and time from EIMD (5 levels)) was used for 
muscle soreness, MVCKE torque loss and CK levels. Wherever the assumption of sphericity 
was violated, the Greenhouse-Geisser correction was used. When a significant group effect 
was found post-hoc independent T-tests were used (planned contrast) with LSD correction. 
Since an association was reported between age and MVCKE torque loss an analysis of 
covariance was used. The variables being investigated as a potential determinant of EIMD, or 
where p was close to being significant, confidence intervals and Cohen d were calculated. 
Significance was set at p ≤ 0.05. Data are presented as mean ± standard deviation.  
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6.4. Results 
6.4.1. Anthropometric measurements 
Oral contraceptive pill users were significantly older by 2.2 years (p = 0.010) and of an 11% 
greater mass (p = 0.047) than non-users. There was no significant difference in stature 
between OCP users and non-users (p = 0.061). 
6.4.2. Oestrogen levels  
As expected, serum oestrogen levels at ovulation were significantly lower in OCP users 
compared to non-users (209 ± 115 pg/ml and 433 ± 147 pg/ml, respectively, p = 0.004). 
6.4.3. Vastus lateralis anatomical cross-sectional area  
There was no significant difference in VLACSA between OCP users and non-users (21.9 ± 2.64 
cm2 and 20.1 ± 3.40 cm2, respectively, p = 0.224). There was no significant difference in 
estimated QACSA between OCP users and non-users (57.1 ± 6.88 cm2 and 52.4 ± 8.86 cm2 
respectively, p = 0.223). 
 
  
  
166 
 
 
Table 6. 1. Patella tendon properties in oral contraceptive pill users and non-users. 
  OCP users Non-users 
Patella tendon length (mm) 52.9 ± 4.3 49.0 ± 6.0 
Patella tendon cross-sectional area (mm2) 63.2 ± 15.1 56.0 ± 17.2 
Patella tendon moment arm (cm)  4.01 ± 0.24 3.96 ± 0.28 
Ramped MVCKE (Nm) 143 ± 30 132 ± 27 
Patella tendon force (N) 3634 ± 717 3430 ± 768 
Patella tendon stiffness (Nmm1) 872 ± 366 665 ± 169 
Young’s modulus (MPa) 761 ± 331 642 ± 285 
 
Note: Patella tendon stiffness and Young’s modulus are presented at 100% ramped MVCKE. 
6.4.4. Patella tendon properties 
Patella tendon properties for OCP users and non-users are presented in Table 6. 1. Patella 
tendon length, PTCSA and PTMA were 7%, 11% and 1% (respectively) greater in OCP users 
compared to non-users (p ≥ 0.05). Ramped MVCKE torque was 9% higher in OCP users 
compared to non-users (p ≥ 0.05). Patella tendon force was 6% higher in OCP users 
compared to non-users (p ≥ 0.05). Patella tendon elongation was not significantly different 
between OCP users and non-users (7.20 ± 1.30 mm, 8.16 ± 0.80 mm, respectively, p = 0.075). 
Tendon stiffness (stress-strain relationship in Figure 6. 1) at MVCKE was 24% higher in OCP 
users compared to non-users (p = 0.153, CI (-502, 88.0), d = 0.73). Young’s modulus was 16% 
higher in OCP users compared to non-users (p = 0.213, CI (-190, 428), d = 0.38). Patella 
tendon stiffness calculated at a standardised patella tendon force (2330 N) was not 
significantly different between OCP users and non-users (725 ± 219 Nmm1 and 565 ± 103 
Nmm1, respectively (p = 0.070, CI (-10.9, 331), d = 0.94). Patella tendon Young’s modulus 
calculated at a standardised patella tendon force (2330 N) was not significantly different 
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between OCP users and non-users (628 ± 219 Nmm1 and 536 ± 190 Nmm1, respectively (p 
= 0.175 CI (-111, 298), d = 0.453)).  
6.4.5. Torque production during maximal voluntary eccentric knee extension 
There was no significant difference in average peak MVEKE torque of each set (six in total) 
between OCP users and non-users (p ≤ 0.05). There was no significant difference in average 
peak MVEKE torque (averaged over 6 sets) between OCP users and non-users (182 ± 33 Nm and 
167 ± 32 Nm, respectively, p = 0.093). There was no significant difference between OCP users 
and non-users when average peak MVEKE torque was made relative to QACSA (3.19 ± 0.47 
Nm·cm2 and 3.64 ± 0.73 Nm·cm2, respectively, p = 0.141). Peak MVEKE torque made relative to 
pre MVCKE torque was significantly higher in OCP users compared to non-users (108 ± 16.7% 
and 85.0 ± 11.9%, respectively, p = 0.002). 
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Figure 6. 1: Patella tendon force – elongation relationship, during ramped maximal voluntary 
isometric contraction, in oral contraceptive pill (OCP) users and non-users. Data is presented 
as means ± standard deviation.  
6.4.6. Vastus lateralis fascicle lengthening 
Fascicle length at 20 knee joint angle was not significantly different between OCP users and 
non-users (7.07 ± 0.42 cm and 6.82 ± 0.61 cm, respectively, p = 0.175). The increase in 
fascicle length from 20 to 90 knee angle during MVEKE was not significantly different 
between OCP users and non-users (3.48 ± 0.90 cm and 2.81 ± 0.44 cm, respectively, p = 
0.062). VL fascicle length at 90 knee angle made relative to fascicle length at knee angle of 
20, was not significantly different between OCP user and non-users (49 ± 12% and 42 ± 8%, 
respectively (p = 0.135, CI (-2.60 – 17.6), d = 0.74)). 
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6.4.7. Change in optimal knee angle 
Pre-damage, optimal MVCKE knee angle was not significantly different between OCP users and 
non-user (median 75.0 ± 7.26 and 75.0 ± 7.41, respectively, p = 0.430). Post EIMD both OCP 
users (median 80.0 ± 7.07 p = 0.008) and non-users (median 80.0 ± 7.46, p = 0.026) 
demonstrated a significant rightward shift in MVCKE optimal knee angle. There was no 
significant difference in the magnitude of the rightward shift in MVCKE optimal knee angle 
between OCP users and non-users (p = 0.311).  
6.4.8. Maximal voluntary isometric knee extension torque loss 
Maximal voluntary isometric knee extension torque expressed as a percentage of pre-damage 
MVCKE torque is illustrated in Figure 6. 2. A two way repeated mixed ANOVA for MVCKE torque 
loss post EIMD, reported a significant main effect of time (p = 0.0004); however, no group 
effect (OCP users versus non-users p = 0.257) interaction (times versus group, p = 0.118) 
were reported. Pre MVCKE peak torque was not significantly different between OCP users and 
non-users (169 ± 24.3 Nm and 194 ± 36.2 Nm, p = 0.055). Peak MVCKE torque loss made 
relative to pre-damage MVCKE torque was not significantly different between OCP users 
compared to non-users (17 ± 7% and 28 ± 13%, respectively (p = 0.055, CI (-21.5, 10.5), d = 
0.94)). 
A significant correlation was observed between age and MVCKE torque loss (r = 0.58, p 
= 0.011), age was therefore considered as a covariate of MVCKE torque loss. ANCOVA revealed 
that no significant difference in MVCKE torque loss between OCP users and non-users 
remained when age was accounted for as a covariate (p = 0.179). 
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Figure 6. 2: Maximal voluntary isometric knee extensor (MVCKE) torque in oral contraceptive 
pill (OCP) users and non-users expressed as a percentage of MVCKE torque pre-damage. Data 
is presented as means ± standard deviation. 
6.4.9. Creatine kinase levels 
A two way repeated mixed ANOVA for absolute CK reported a significant main effect of time 
(p = 0.040) however no significant group (OCP users versus non-users, p = 0.057) or 
interaction (time versus group, p = 0.576) effects were reported (Figure 6. 3). Absolute peak 
CK was significantly higher in OCP users compared to non-users (1086 ± 971 U/L and 453 ± 
459 U/L, respectively, p = 0.023). ΔCKABS to peak was significantly higher in OCP users 
compared to non-users (962 ± 968 U/L and 386 ± 474 U/L, respectively (p = 0.016, CI (-186, 
1338), d = 0.76)). 
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Figure 6. 3: Absolute creatine kinase (CK) response in oral contraceptive pill (OCP) users and 
non-users following exercise-induced muscle damage (EIMD). Data is presented as means ± 
standard deviation. 
6.4.10. Muscle soreness 
A two way mixed measures ANOVA for muscle soreness reported a significant main effect of 
time (p = 0.0004); however, there was no significant group difference (OCP users versus non-
users, p = 0.598) or an interaction effect (p = 0.127). For both OCP users and non-users peak 
muscle soreness occurred 48 hours post EIMD. There was no significant difference in peak 
muscle soreness between OCP users and non-users (3.89 ± 2.23 and 4.13 ± 1.27, respectively, 
p = 0.358). 
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6.5. Discussion 
The aim of the current chapter was twofold, firstly to establish whether OCP users are more 
susceptible to EIMD compared to non-users, and secondly, whether differences can be 
attributed, in part, to differences in patella tendon properties. The current chapter reports 
three main findings. 1) Patella tendon properties are not significantly different between OCP 
users and non-users, 2) MVCKE torque loss and muscle soreness are not different between 
OCP users and non-users, and 3) ΔCKABS to peak is significantly higher in OCP users compared 
to non-users following EIMD.  
All participants were tested on the 14th day of their menstrual cycle to measure peak 
oestrogen levels at ovulation (Brown, 1955). Within the current chapter it can be assumed 
that the non-users were tested at ovulation as circulating oestrogen levels are comparable 
with previous research for this phase of the menstrual cycle (510 - 742 pg/ml (Bryant et al., 
2008; Eiling et al., 2007)). Circulating oestrogen levels within the OCP users however, are 2.8 
times higher than those previously reported (Bryant et al., 2008). The discrepancies with 
previously reported circulating oestrogen levels may be attributed to the different varieties 
of the OCP prescriptions used within the current chapter (Elliott-Sale et al., 2013). 
Furthermore, due to significantly higher mass and similar lean muscle mass (VLACSA) and 
stature in OCP users compared to non-users, it may be suggested that fatty mass was higher 
in OCP users. Therefore the elevated oestrogen levels in the OCP users compared to previous 
literature may be explained by adipose tissue (Yeung et al., 2012). Regardless, in agreement 
with previous research OCP users demonstrated a significant down regulation of oestrogen 
compared to non-users (Bryant et al., 2008), and thus it is reasonable to assume that the 
suppression of oestrogen remained throughout the menstrual cycle (Bryant et al., 2008).  
 It has been reported that oestrogen alters tendon properties through an increases in 
type 1 collagen and tendon fractional synthesis rate (Lee et al., 2004; Hansen et al., 2009a). 
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Within the current chapter however, despite significantly lower oestrogen levels in OCP 
users, there was no significant difference in patella tendon stiffness in vivo between OCP 
users and non-users. Although our data shows a trend towards higher stiffness in the OCP 
users, our findings did not reach significance and contradict those of Bryant et al. (2008) who 
concluded that exposure to the OCP (≥1 year) decreases Achilles tendon strain properties. 
The discrepancies with the current chapter may be attributed to the higher oestrogen levels 
reported in OCP users compared to previous research (Bryant et al., 2008), which may result 
in OCP users displaying similar oestrogenic effects on the tendon as found in non-users. 
Furthermore, the discrepancies with the current chapter may also be attributed to Bryant et 
al. (2008) including the aponeurosis in their calculation of strain. Therefore, due to the 
divergent strain rates between the aponeurosis and the tendon (Magnusson et al., 2003), it is 
difficult to directly compare Bryant et al’s (2008) findings to the current chapter. 
Additionally, Bryant et al. (2008) measured Achilles tendon strain and not Achilles tendon 
stiffness or Young’s Modulus. It is also possible that the Achilles and Patella tendons show 
inconsistent responses to the OCP, potentially due to difference in the number of oestrogen 
receptor sites, as our findings concur with those of Hansen et al. (2013) who recently 
reported no significant difference in patella tendon stiffness or Young’s modulus between 
female OCP users and non-users. The current chapter confirms that the OCP does not alter 
patella tendon stiffness or Young’s modulus in recreationally active participants. The 
conclusion that the OCP has no significant effect on tendon properties, specifically patella 
tendon stiffness, may discount any potential differences in EIMD between OCP users and non-
users being directly attributed to patella tendon properties, and this is reflected in similar VL 
fascicle lengthening during MVEKE. 
Consistent with others, the data from the present chapter demonstrates a greater 
ΔCKABS to peak in OCP users compared to non-users (Joyce et al., 2014) but in the presence of 
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no significant difference in MVCKE torque loss between the groups (Thompson et al., 1997; 
Sewright et al., 2008). Furthermore, within the current study an insignificant finding 
remained when group differences in age were taken as a covariate of MVCKE torque loss. The 
findings of the current chapter however appear to contradict those reported by Savage and 
Clarkson (2002) who investigated EIMD between OCP users and non-users following 50 
eccentric contractions of the elbow flexors. Savage and Clarkson (2002) reported MVC torque 
loss to be significantly higher 48 and 72 hours post EIMD in OCP users compared to non-
users. However, due to no difference in MVC torque loss being reported before 48 hours post 
EIMD, Savage and Clarkson (2002) concluded that OCP users are not more susceptible to 
EIMD but have a prolonged recovery compared to non-users. A delayed recovery in OCP 
users may be attributed to higher oestrogen levels attenuating the infiltration of neutrophils 
and cytokines (MacNeil et al., 2011; Silvestri et al., 2003) thus reducing secondary damage. 
However, the mechanisms responsible for this attribute of oestrogen requires further 
investigation (MacNeil et al., 2011).  
Regardless of groups, a loss of MVCKE torque and a rightward shift in optimal MVCKE 
knee angle within the current chapter supports the conclusion that EIMD was achieved 
(Jakeman & Eston, 2013). Interestingly a comparable shift in optimal knee angle between 
OCP users and non-users may support that no difference in structural damage exists between 
the two groups. The current chapter therefore concludes OCP users are not necessarily more 
susceptible to MVCKE torque loss compared to non-users.  
Through an interaction with cell membrane phospholipids, oestrogen has been 
reported to decrease cell membrane fluidity thus increasing cell membrane stability. An 
increase in cell membrane stability may prevent muscle proteins (i.e. CK) leaking into the 
serum (Wiseman et al., 1993; Carter et al., 2001). Furthermore, by increasing cell membrane 
stability, oestrogen may attenuate the influx of neutrophils and cytokines post EIMD (MacNeil 
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et al., 2011; Silvestri et al., 2003), thus mitigating the magnitude of secondary damage 
occurring in the non-users. The current chapter reported ΔCKABS to peak to be significantly 
higher in OCP users (low oestrogen levels) compared to non-users (high oestrogen levels). 
Thus indicating that either through an increase in cell membrane stability or a reduction in 
the influx of neutrophils, higher oestrogen levels reduce susceptibility to EIMD. Our findings 
concur with those reported by Joyce et al. (2014) who reported CK following 240 bilateral 
knee extensors on both legs (480 knee extensions in total), to be significantly higher in OCP 
users compared to non-users. Joyce et al. (2014) measured CK 48 hours post EIMD, whereas 
CK is reported to peak 96 hours post EIMD (Hyatt & Clarkson, 1998), however, the current 
chapter can confirm ΔCKABS to peak remains significantly higher in OCP users when CK is 
measured over 168 hours post EIMD. Contradictory to the current findings previous work 
has reported no significant differences in CK between OCP users and non-users (Thompson et 
al., 1997; Savage & Clarkson, 2002; Sewright et al., 2008). For example, Savage and Clarkson 
(2002) reported no significant difference in the CK response between OCP users and non-
users (despite significant differences in MVC torque loss). Due to Savage and Clarkson (2002) 
investigating the elbow flexors, the CK response was ~30% higher than compared to the 
current chapter (Chen et al., 2011). Therefore, it may be suggested that oestrogen acts as a 
membrane stabiliser up to a certain threshold, but beyond that threshold, which may be 
attained through more severe damage protocols or different muscle groups, the protective 
role of oestrogen on CK is negligible. This hypothesis requires further investigation. 
Furthermore, discrepancies regarding the role of the OCP on EIMD with previous 
research may be confounded by different measurement days at different phases of the 
menstrual cycle. For example, Carter et al. (2001) tested OCP users at the mid-luteal phase 
(22-25 days) and non-users during the mid-follicular phase (6-10 days). The measurement 
days used by Carter et al. (2001) resulted in OCP users having significantly higher oestrogen 
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levels compared to non-users, which is opposite to the oestrogen levels reported in the 
current chapter and throughout the menstrual cycle (Bryant et al., 2008). Therefore, although 
Carter et al. (2001) concluded that CK is significantly lower in OCP users compared to non-
users and appears to contradict the findings of the current chapter, at closer inspection the 
same conclusion can be made, that the higher oestrogen recorded in the OCP participants in 
their study, attenuates CK levels.  
Within the current chapter patella tendon properties, relative VL fascicle lengthening 
and MVEKE torque (all previously suggested determinants of EIMD (Lieber & Friden, 1993; 
Warren et al., 1993a; McHugh et al., 1999) were not significantly different between OCP users 
and non-users, thus cannot explain the group difference in ΔCKABS to peak. Oestrogen levels 
however were significantly lower in OCP users compared to non-users. Previously, post 
downhill running, Carter et al. (2001) reported a significant, albeit weak, moderate 
correlation (r = - 0.43) between total resting oestrogen levels and overall CK. The negative 
correlation between oestrogen and CK reported by Carter et al. (2001) may be explained by 
the membrane stabilising role of oestrogen reducing the leakage of CK from the intracellular 
membrane. Therefore, within the current chapter, the significantly higher ΔCKABS to peak in 
OCP users may reflect the membrane stabilising properties of oestrogen preventing the 
leakage of CK in non-users rather than a lower magnitude of EIMD.  
It must be noted that age and mass were significantly different between OCP users 
and non-users within the current chapter. Although mass did not act, as a covariate on any 
dependent variable, and when age was accounted for as a covariate it had no effect on the 
difference in MVCKE torque loss. Mass is especially important to control for as it may have a 
significant effect on oestrogen levels (Yeung et al., 2012), and may explain why the current 
chapter reports high oestrogen levels in OCP users. The oestrogen levels within the current 
chapter however, remain significantly lower than non-users, and within measurable limits of 
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published data from the same phase of the menstrual cycle (Bryant et al., 2008; Eiling et al., 
2007). 
6.6. Conclusion 
Due to no other differences between suggested determinants of EIMD in OCP users and non-
users (tendon properties, VL fascicle lengthening and MVEKE torque), the current chapter 
concludes that the higher ΔCKABS to peak in OCP users may be attributed to the significantly 
higher oestrogen levels in the non-users. However, the group differences in ΔCKABS to peak 
may represent differences in cell membrane stability and influx in cytokines rather than 
differences in functional EIMD. Therefore, due to MVCKE torque loss being indicative of 
muscle function and the most valid indirect marker of EIMD (Warren et al., 1999), and the 
caveats associated with CK as a marker of EIMD (Friden & Lieber, 2001), the current chapter 
concludes that OCP users are not at a greater risk of EIMD compared to non-users. Using 
muscle biopsies, further research is required to investigate the association between CK and 
oestrogen.  
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Chapter seven: Discussion, conclusion and future directions 
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7.1. Discussion 
The main findings of this thesis are summarised in Figure 7. 1. Briefly the data has confirmed 
the classical model for eccentric contractions whereby vastus lateralis (VL) fascicles lengthen 
during maximal voluntary eccentric knee extensions ((MVEKE) chapter three). The patella 
tendon, although a mediator of VL fascicle lengthening (chapter three), does not appear to be 
associated with functional markers of exercise-induced muscle damage ((EIMD) chapter 
four). Specifically in populations where the patella tendon properties differ (chapters five and 
six), there was no difference in maximal voluntary knee extension (MVCKE) torque loss post 
EIMD (chapter five and six). Furthermore, the significance of oestrogen to EIMD was 
established through sex differences (chapter five) and oral contraceptive pill (OCP) use 
(chapter six), and the findings were consistent between chapters regarding the possible role 
of oestrogen. It was observed that although no difference in EIMD MVCKE torque loss was 
reported (males = females = OCP females), creatine kinase (CK) values were significantly 
different (males > females < OCP users). It was concluded in both chapters five and six, that as 
groups show no difference in MVCKE torque loss but display differences in CK (in both 
instances the higher oestrogen group had lower CK), it is likely that the contractile disruption 
from EIMD is similar, but the previously reported role of oestrogen on membrane stability, 
attenuates the CK release post EIMD. The following discussion outlines the themes that were 
observed in investigating the in vivo determinants of EIMD throughout this thesis.  
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Figure 7.1 The hypothetical and demonstrable connections between the determinants of 
exercise-induced muscle damage (EIMD) and the measured markers of EIMD within the 
thesis. The numbers in parenthesis denote the chapter where the findings are presented. The 
joining arrows show associations within the current thesis. Muscle damage may be 
dependent on VL fascicle lengthening in males (chapter four). Patella tendon mediates 
fascicle lengthening but not muscle damage directly (chapter three). Low oestrogen 
populations have lower creatine kinase (CK) than high oestrogen populations (males > 
females < oral contraceptive pill (OCP) users (5,6)) but no differences in torque loss (males = 
females = OCP females (5,6)). 
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7.2. The role of the patella tendon on exercise-induced muscle damage 
Within chapter three it was identified that sex differences in patella tendon stiffness do exist, 
with males reporting significantly higher tendon stiffness compared to females. Although this 
has previously been identified (Onambélé et al., 2007), the implication of different tendon 
properties on fascicle lengthening (the main aim of chapter three) has yet to be established in 
vivo. Lichtwark and Wilson (2007) applied average tendon stiffness reported by Lichtwark 
and Wilson (2006) to a Hill-type muscle model to estimate the effect of increasing Achilles 
tendon stiffness by 0.5, 1, 2 and 4 times. Despite the same amount of muscle tendon unit 
(MTU) lengthening at all stiffness levels, Lichtwark and Wilson (2007) estimated 
gastrocnemius fascicle lengthening to increase with an increase in Achilles tendon stiffness. 
Due to using a muscle model it is difficult to extrapolate Lichtwark and Wilson (2007) 
findings in vivo. The findings of chapter three however agree with Lichtwark and Wilson 
(2007) and confirm a significant correlation between patella tendon stiffness and VL fascicle 
lengthening in vivo. Therefore, the findings of chapter three are the first to provide in vivo 
evidence that the magnitude of VL fascicle lengthening is not only dependent on the type of 
eccentric task and intensity of the task itself (Ishikawa et al., 2003; Finni et al., 2001), but on 
the mechanical properties of the patella tendon, specifically tendon stiffness and Young’s 
modulus. 
Based on the findings of chapter three (that there is an interaction between the 
patella tendon stiffness and VL fascicle lengthening during eccentric contractions), chapter 
four investigated the contribution of the patella tendon stiffness to EIMD in a group of males. 
In addition to attenuating fascicle lengthening, the tendon has been hypothesised to protect 
the muscle from EIMD and explain group difference in EIMD by altering peak force to the 
fascicles during eccentric contractions (Roberts & Konow, 2013; Roberts & Azizi, 2010; 
McHugh et al., 1999). For example, a reduction in the magnitude of fascicle lengthening may 
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reduce the fascicles extending onto the descending limb of the length-tension relationship, 
where eccentric EIMD is proposed to occur (Morgan, 1990; Hoffman et al., 2014). However, 
the data from chapter four showed that within males there was no significant correlation 
between patella tendon stiffness or Young’s modulus with any indirect marker of EIMD 
(ΔCKABS to peak (peak CK value - the pre CK values) or MVCKE torque loss). It cannot be 
discounted however that within chapter four the patella tendon stiffness range was not large 
enough to detect a difference (see chapter five). Therefore, contrary to the hypothesis, within the 
current thesis the mechanical patella tendon properties were not a direct determinant of EIMD 
in males in vivo.  
7.2.1. Patella tendon properties and group differences in exercise-induced muscle 
damage 
Although within chapter four, patella tendon properties did not act as a determinant of EIMD 
in males, group differences in EIMD have been attributed, although not investigated, to 
differences in tendon properties (McHugh et al., 1999; Marginson et al., 2005). For example, 
tendon properties have been suggested to explain differences in EIMD between ‘stiff’ and 
‘compliant’ hamstring MTUs however, McHugh et al. (1999) did not measure tendon 
properties.  
 Based on the findings of chapter three, and the potential caveat that the range in 
tendon stiffness in the male group may not have been sufficient to detect an association, 
chapters five and six investigated whether group differences in patella tendon properties 
may explain any group differences in EIMD. Due to oestrogen being known to alter tendon 
properties (Hansen et al., 2009a), specifically tendon stiffness (Bryant et al., 2008; Kubo et al., 
2003), two different groups with high versus low oestrogen levels were investigated, with the 
hypothesis that patella tendon stiffness would be higher in the low oestrogen groups (males 
and OCP users). Although within chapter three and chapter five it was found that males have 
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significantly higher patella tendon stiffness compared to females, a non-significant trend for 
patella tendon stiffness to be higher in OCP users compared to the non-users was reported in 
chapter six. Despite oestrogen levels being significantly lower in OCP users compared to non-
users, the oestrogen levels in the OCP users were 2.8 times higher than previously reported 
values (Bryant et al., 2008). Therefore, the unusually high oestrogen levels in the OCP user 
may explain why in chapter six OCP users displayed similar tendon properties to non-users. 
Future studies need to control for differences in body composition and OCP prescription 
being investigated to prevent confounding variables on oestrogen levels in the OCP users 
(Yeung et al., 2012; Elliott-Sale et al., 2013). Regardless, within chapter five there was no 
significant difference in MVCKE torque loss or muscle soreness, despite males having 
significantly higher tendon stiffness compared to females. However, whilst CK was 
significantly higher in males compared to females, there was no correlation between patella 
tendon stiffness and ΔCKABS to peak thus, tendon properties cannot be used to explain 
differences in ΔCKABS to peak in chapter five. Chapter six further supported these findings 
whereby, despite no significant difference in tendon properties a significant difference in 
ΔCKABS to peak was still reported.  
 Therefore, from the findings of chapter four, five and six it would appear that patella 
tendon properties may not be directly associated with EIMD in males nor can they explain 
group differences in EIMD. A common theme did emerge from chapters five and six, whereby 
ΔCKABS to peak was consistently higher in groups with lower oestrogen levels. The common 
theme suggests that oestrogen may explain differences in ΔCKABS to peak through its role as a 
membrane stabiliser and/or preventing the influx of neutrophils thus minimising further 
damage (MacNeil et al., 2011), rather than its role on tendon properties as hypothesised 
within the current thesis.  
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7.3. Oestrogen as a membrane stabiliser 
Within the current thesis the groups investigated in chapters five and six (males and females, 
OCP users and non-users, respectively) were categorised by low and high circulating 
oestrogen levels. Interestingly the current thesis consistently reports higher ΔCKABS to peak in 
the groups with lower circulating oestrogen levels (males and OCP users) despite reporting no 
significant difference in any other marker of EIMD (MVCKE torque loss or muscle soreness).  
Within chapter five a significant correlation with MVEKE torque and ΔCKABS to peak 
was reported, when MVEKE torque was accounted for as a covariate, a significant group 
difference in ΔCKABS to peak remained. Therefore MVEKE did not fully account for the group 
difference in ΔCKABS to peak per se. Additionally, patella tendon properties, VL fascicle 
lengthening or MVEKE torque in chapters five or six could not explain the reported group 
differences in ΔCKABS to peak. Interestingly, the significant correlation between VL fascicle 
lengthening and ΔCKABS to peak reported in males in chapter four was lost when VL fascicle 
lengthening was correlated with ΔCKABS to peak in males, females and even when sex was 
grouped in chapter five. The loss of association could be due to the variability in CK and the 
lower participant numbers when the males were sub-grouped in chapter five, however it may 
also be due to the presence of oestrogen acting as a confounding variable in chapters five and 
six. Therefore, in agreement with previous work the group differences in ΔCKABS to peak may 
be explained by the group differences in oestrogen (Joyce et al., 2014; Carter et al., 2001). 
Previously Carter et al. (2001) reported a moderate negative correlation (r = -0.43) between 
total oestrogen levels and CK post EIMD. Therefore, the higher ΔCKABS to peak in males and 
OCP users within chapter five and six respectively, may be attributed to the higher oestrogen 
levels in females and female non-users. Oestrogen has been reported to act as an antioxidant, 
enhance membrane stability, and prevent the influx of neutrophils and cytokines (MacNeil et 
al., 2011; Wiseman et al., 1993; Wiseman & Quinn, 1994), which individually or collectively 
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may prevent intracellular proteins, like CK, leaking into the extracellular matrix in females 
and non-users. 
The conclusion that oestrogen may explain group differences in ΔCKABS to peak in 
chapters five and six, contributes to the caveat associated with using CK as a marker of EIMD. 
Although CK has historically been used as an indirect marker of EIMD (Nosaka & Clarkson, 
1996; Savage & Clarkson, 2002; Stupka et al., 2000; Sewright et al., 2008), it has been 
suggested that the magnitude of damage cannot be determined from changes in CK post 
EIMD per se (Friden & Lieber, 2001; Komulainen et al., 1995; Chrismas et al., 2014). The 
increase in CK may reflect a loss of membrane stability as opposed to the severity of EIMD. 
The magnitude of CK being indicative of membrane stability rather than the magnitude of 
structural damage would explain why the current thesis and other studies (Joyce et al., 2014) 
report ΔCKABS to peak to be highest in groups with lower oestrogen levels, despite no differences 
in other markers of EIMD (Friden & Lieber, 2001). The current thesis concludes that ΔCKABS to 
peak is presented with the forewarning that although elevated CK may represent a loss of 
membrane stability and can be seen as an indicator that EIMD has occurred, the inherent 
increase may not reflect the magnitude of EIMD per se (Heled et al., 2007; Friden & Lieber, 
2001; Komulainen et al., 1995; Chrismas et al., 2014). Consequently, the current thesis 
concludes that the severity of EIMD cannot be drawn on the magnitude of CK independently, 
thus although a group differences in CK were reported consistently, taking other markers of 
EIMD into consideration it may not be indicative of an actual group difference in EIMD per se.  
7.4. In vivo fascicle lengthening and MVEKE torque. 
The group comparisons that the current thesis has identified, are all based on the induction of 
damage through MVEKE. Eccentric contractions are proposed to have two main characteristics 
that contribute to the inevitable disruption of the muscle: high force and high strain. The 
remainder of this discussion outlines the evidence for each of these characteristics that 
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results in EIMD. Exercise-induced muscle damage will be discussed predominately using 
MVCKE torque loss and muscle soreness due to the aforementioned issues associated with CK 
as a marker of EIMD.  
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7.4.1. The role of maximal voluntary eccentric knee extension torque on exercise-induced 
muscle damage 
Previously in vitro, eccentric torque has been identified as the main determinant of EIMD 
(Warren et al., 1993a). For example, within rat soleus muscle, Warren et al. (1993a) reported 
force loss to be significantly greater following high eccentric forces compared to low 
eccentric forces (150% and 125% of maximal isometric tetanic tension, respectively). For 
several reasons, including the use of maximal electrical stimulation, the reduction of in series 
MTU compliance (by removing the tendon), and forces being applied directly to the muscle, it 
is difficult to apply the findings from animal studies to in vivo human studies (Crameri et al., 
2007). Although work in vivo is somewhat limited, studies have reported total or peak MVEKE 
torque to have no significant association with isometric torque loss in the elbow flexors 
(Chapman et al., 2008) or with CK in the knee extensors (Hody et al., 2013). The findings of 
chapter four add to the body of in vivo human research supporting that peak MVEKE torque in 
males does not correlate with MVCKE torque loss post EIMD. To the authors’ knowledge 
chapter four is the first to report no correlation between MVEKE torque and MVCKE torque loss in 
the lower limbs. The findings in chapter four appear to contradict the classical eccentric stress 
theory whereby a muscle will fail when an applied tensile strength is greater than its yield 
strength (Warren et al., 1993a). The yield strength of a muscle fibre is predicted to be above 
113% of maximal isometric torque (Warren et al., 1993a; Hasselman et al., 1995) in animals. 
However, Warren et al. (1993a) reported that when MVC eccentric torque is below 113% of 
isometric MVC, the association with MVC torque loss is lost. The eccentric torque recorded in 
chapter four during MVEKE and in previous work during eccentric elbow contractions (Chapman 
et al., 2008) did not approach the suggested yield strength of muscle fibres (96% and 94% 
respectively). Therefore upon closer inspection the findings of chapter four agree with the work 
of Warren et al. (1993a). Although it may be suggested that within chapter four participants 
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were not contracting maximally, using electrical stimulation to elicit higher eccentric torques 
may alter the recruitment pattern (Crameri et al., 2007) and potentially mask any protective 
mechanism of the muscle on EIMD. Therefore, by not using electrical stimulation, the current 
thesis has reported data using an eccentric torque achieved during voluntary maximal effort 
(similar to numerous investigations into EIMD). In agreement with Warren et al. (1993a) 
however the current thesis agrees a potential threshold, whereby beyond this point eccentric 
torque may become a determinant of EIMD. Although it may be deemed a limitation that the 
current thesis did not reach this suggested threshold (>113% above MVCKE isometric torque), 
due to the nature of in vivo recruitment and force transmission, our data remains meaningful 
compared to that of Warren et al. (1993a). Therefore, in males chapter four concludes that 
MVEKE torque in vivo is not associated with indirect markers of EIMD in vivo.  
7.4.2. Maximal voluntary eccentric knee extension torque and group differences in 
exercise-induced muscle damage 
Within chapter five, peak MVEKE torque averaged over six sets was significantly higher in 
males compared to females; this is not surprising considering the significantly higher VLACSA 
and estimated QACSA in males. However, despite significantly higher MVEKE torque in males 
there was no sex difference in MVCKE torque loss. Therefore, higher MVEKE torque was not 
associated with a difference in MVCKE torque loss, as mentioned formerly and in agreement 
with chapter four, no association between eccentric torques and MVC torque loss has 
previously been reported (Hody et al., 2013; Chapman et al., 2008).  
Due to significant sex differences in muscle size within chapter five, MVEKE torque 
was made relative to estimated QACSA (stress). There remained no significant association 
between MVEKE torque / QACSA and MVCKE torque loss. Furthermore, within chapter six there 
was no significant difference in MVEKE torque or MVEKE torque / QACSA between OCP users and 
non-users nor was there a significant difference in MVCKE torque loss between OCP users and 
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non-users. Thus, chapter six concurs with chapter five that when corrected for muscle size, 
MVEKE torque is not associated with MVCKE torque loss.  
Despite higher MVEKE torque in males within chapter five, there was no significant 
difference in MVEKE torque made relative to MVCKE torque pre-damage between males and 
females (96% and 87% respectively). Interestingly, in both males and females MVEKE torque 
remained below the suggested yield strength of muscle fibres (< 113% albeit in animals 
(Warren et al., 1993a)). Therefore, comparable MVCKE torque loss between males and females 
in chapter five may be attributed to a couple of reasons: Firstly, there was no group 
difference in MVEKE torque made relative to pre-damage MVCKE torque; and secondly, MVEKE 
torque made relative to pre-damage MVCKE torque in both males and females was below the 
suggested yield strength of muscle fibres. Intriguingly, within chapter six despite MVEKE torque 
made relative to MVCKE being significantly higher in OCP users compared to non-users (108% 
versus 85% respectively), MVCKE torque loss remained comparable between the two groups. 
Although OCP users approached the suggested threshold of MVEKE torque, it remained below 
113%. Therefore, from the findings of chapter six, the hypothesis that MVEKE torque and group 
differences in MVEKE torque are negligible until they are above a certain yield threshold remains 
plausible, but warrants further investigation during voluntary contractions.  
It has been reported that the eccentric torque to isometric torque ratio is lower when 
lengthening contractions are performed at a low compared to a high velocity (Onambele et 
al., 2004). Therefore, the low MVEKE to MVCKE ratio within chapters four, five and six may be 
attributed to the low lengthening velocity used within the current thesis (30s-1). The low 
velocity of the eccentric damage protocol may thus have allowed for active cross-bridge force 
production thereby adding noise in the data through the involvement of calcium kinetics (i.e. 
muscle activation level variations) rather than passive torque production from the stretch 
response per se. Further investigation is therefore required to establish the yield strength of 
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in vivo human muscle and whether the suggested yield strength can be achieved during 
voluntary contractions of large muscle groups. Ultimately, further research should aim to 
determine whether voluntary activation level is in fact a determinant of EIMD? A study 
design to attempt to answer to the above research question would utilise fast lengthening 
velocities i.e. ≥300 mm/s (so that cross-bridge numbers do not alter during lengthening), so 
as to separate any impact of activation level from those of stretch.  
The findings of chapters five and six therefore suggest that group differences in 
MVEKE torque do not result in differences in MVCKE torque loss until MVEKE torque surpasses 
a certain threshold, however the yield threshold for in vivo human muscle requires further 
investigation. Therefore, consistently throughout chapters four, five and six, and in 
agreement with previous research (Hody et al., 2013; Chapman et al., 2008) the current 
thesis concludes that peak MVEKE torque, even when made relative to QACSA, cannot be used to 
explain differences in indirect markers of EIMD, specifically MVCKE torque loss. 
7.4.3. The role of vastus lateralis fascicle lengthening during maximal voluntary 
eccentric knee extensions 
The findings from chapter three support the classical description of an eccentric contraction, 
whereby VL fascicles were reported to lengthen during MVEKE. Within animal studies the 
magnitude of fascicle strain, denoted as fascicle lengthening, has previously been concluded 
as the main determinant of EIMD (Lieber & Friden, 1993; Talbot & Morgan, 1998). 
Theoretically, the association between fascicle lengthening and EIMD can be explained by the 
popping sarcomere theory (Morgan, 1990). Morgan (1990) reported muscle damage to occur 
when the weakest sarcomeres lengthen onto the descending limb of the length-tension 
relationship thus, increasing the strain on surrounding sarcomeres. Morgan (1990) suggested 
that during subsequent contractions the sarcomeres continue to lengthen onto the 
descending limb, progressively from the weakest to the strongest sarcomere, therefore 
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increasing the area of EIMD. However, it is difficult to extrapolate findings from in vitro and in 
situ animal studies for several reasons. Firstly, electrical stimulation is generally used to 
lengthen the muscle. During electrical stimulation the recruitment of muscle fibres does not 
follow the traditional recruitment pattern described by Henneman et al (Henneman et al., 
1965), furthermore fibres lengthen in a uniformed manner whereas during voluntary 
contractions fibres contract in a non-uniformed manner (Gregory & Bickel, 2005). Therefore, 
using electrical stimulation may prevent the potential protective mechanisms of 
heterozygous sarcomere lengthening and may not be representative of the contractile 
behaviour or physiological response to EIMD in vivo (Crameri et al., 2007). Secondly, to be 
able to investigate the association between strain (denoted by fascicle lengthening) and 
EIMD, in situ and in vitro studies exaggerate strain values (i.e. 125% of fascicle length at peak 
MVC (Lieber & Friden, 1993)) (Butterfield, 2010) and remove the tendon from the MTU. The 
strain values used in situ and in vitro are considerable larger than those attained in vivo (i.e. 
18% of fascicle length at peak MVC (Hoffman et al., 2014)) and even to those reported within 
chapter three of the current thesis (58%). Furthermore, by removing the tendon, in situ and 
in vitro studies do not account for the potentially attenuating role of the tendon on fascicle 
lengthening reported in chapter three and estimated in previous muscle models (Lichtwark & 
Wilson, 2007). Therefore, although in situ and in vitro studies are essential to contribute to 
the understanding of EIMD, due to the complicated mechanical properties of the MTU in vivo, 
findings from these studies they are not necessarily replicable or directly applicable in vivo 
(Butterfield, 2010).  
The association between fascicle lengthening and EIMD in vivo is limited, with the 
recent work of Hoffman et al. (2014) being the first to directly investigate the association in 
vivo. Hoffman et al. (2014) reported no association between MVC plantar flexion torque loss 
and gastrocnemius fascicle lengthening during backwards walking. Hoffman et al. (2014) 
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suggested that in vivo the Achilles tendon accounts for ~90% of MTU lengthening thus 
minimising the magnitude of gastrocnemius fascicle lengthening and thus the extent of EIMD. 
However, the degree of fascicle lengthening investigated by Hoffman et al. (2014) was 
considerably smaller than the magnitude of VL fascicle lengthening measured during MVEKE 
in chapter three (~58%). However, despite a larger magnitude of fascicle lengthening 
compared to the work of Hoffman et al. (2014) (42.0 mm and 10.7 mm respectively), chapter 
four concurs that VL fascicle lengthening was not associated with MVCKE torque loss. 
Although the findings of no association between fascicle lengthening and MVCKE torque loss 
appear to contradict the popping sarcomere theory (Morgan, 1990), chapter four or the work 
of Hoffman et al. (2014), cannot account for heterozygous individual sarcomere lengthening 
(Palmer et al., 2011). Thus individual sarcomeres may have extended onto the descending 
limb of the length-tension relationship but through an increase in fascicle compliance or 
through a lateral transmission of force (Bloch & Gonzalez-Serratos, 2003; Butterfield, 2010) 
the true magnitude of MVC torque loss may be masked. Although the current thesis cannot 
confirm this theory, a significant rightward shift in optimal knee angle in chapter four, five 
and six strengthens the hypothesis that optimal fascicle length may have increased during 
and post MVEKE. Therefore, the findings of chapter four conclude that VL fascicle lengthening 
in males is not associated with markers of EIMD in males.  
7.4.4. Fascicle lengthening and group differences in exercise-induced muscle damage 
The main finding of chapter three concludes that during MVEKE the magnitude of VL fascicle 
lengthening is significantly higher in males compared to females. In agreement with chapter 
three, chapter five reported fascicle lengthening to be significantly higher in males compared 
to females, however no significant sex difference in MVCKE torque loss or muscle soreness 
was reported within chapter five. Furthermore, within chapter six, although there was a 
trend for VL fascicle lengthening to be higher in OCP users, there was no significant difference 
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in MVCKE torque loss or muscle soreness between OCP users and non-users (potentially due 
to no differences in patella tendon stiffness). As previously mentioned the current chapters 
cannot account for potential differences in individual sarcomere lengthening or disruption. 
However, no significant group difference in the magnitude of the rightward shift in the 
optimal MVCKE knee angle within chapters five or six may indicate no significant differences 
in sarcomere disruption. Therefore, chapters four, five and six conclude that VL fascicle 
lengthening is not associated with indirect markers of EIMD (Figure 7. 1). 
7.5. Conclusion 
The findings of the current thesis are summarised in Figure 7. 1. Within the current thesis a 
significant positive association between tendon stiffness and VL fascicle lengthening has been 
reported for the first time in vivo. Furthermore, as a result of higher patella tendons stiffness, 
VL fascicle lengthening was significantly higher in males compared to females. When the 
association with EIMD was investigated within the current thesis however, neither fascicle 
lengthening or tendon properties were reported to have a direct effect on the magnitude of 
EIMD. Moreover, higher tendon stiffness and greater magnitude of fascicle lengthening did 
not cause greater EIMD in males compared to females. It may be concluded that although 
tendon properties do not directly affect the magnitude of EIMD, it may be a contributing 
factor during the eccentric contraction. For example, the greater contribution of tendon 
lengthening during MVEKE may alter the degree of fascicle lengthening thus in-directly 
attenuating EIMD (Hoffman et al., 2014). However, this requires further investigation.   
It appears when using voluntary MVEKE contractions in vivo eccentric torques 
investigated may not surpass fibre yield threshold (>113% (Warren et al., 1993a)). 
Therefore, the current thesis concludes that MVEKE torques below 108% of MVCKE torques are 
not associated with, nor do they result in, group difference in MVCKE torque loss. However, 
further investigation is required to establish whether voluntary MVEKE torques higher than 
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the suggested yield strength of muscle fibres (> 113% (Warren et al., 1993a)) can be achieved 
during voluntary eccentric damaging protocols, and if so, is eccentric torque then associated 
with EIMD.  
Consistently within the current thesis ΔCKABS to peak was highest in groups with 
lower oestrogen levels (males > females < OCP users), despite no differences in any other 
markers of EIMD. The lower CK response in the presence of oestrogen may be attributed to 
oestrogen helping to maintain membrane stability, thus reducing the influx of CK into the 
serum. Although an influx of CK represents a loss of membrane stability and therefore a 
marker of EIMD, the severity of the CK influx may not relate to the magnitude of EIMD per se 
(Heled et al., 2007; Friden & Lieber, 2001; Komulainen et al., 1995). Therefore the current 
thesis concludes that CK is attenuated in groups with higher circulating oestrogen. It is also 
apparent from the current thesis that different groups seem to demonstrate different profiles 
in response to EIMD.   
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7.6. Future directions 
Whilst investigating the aims of the current thesis, several areas for future research have 
been highlighted. The following section will briefly discuss several ideas for further research. 
Recently speculation regarding the association between titin and eccentric 
contractions has increased however, scientific evidence remains in its infancy (Herzog, 2014). 
The current thesis has investigated the role of patella tendon stiffness on VL fascicle 
lengthening, and whether tendon stiffness or fascicle lengthening are determinants of EIMD. 
The current thesis however, could not account for differences in structural properties of the 
sarcomeres, for example titin stiffness. Titin stiffness has recently been suggested to alter 
titin force, degree of sarcomere lengthening and stability of the descending limb of the 
length-tension relationship during eccentric contraction (Herzog, 2014). Although, further 
evidence is required to support the role of titin, Herzog (2014) hypothesised that titin 
stiffness may play a significant role in protecting the muscle from EIMD during eccentric 
contractions. Furthermore, the elastic properties of the muscle depends on the titin isoform 
expressed (Wang et al., 1991). Therefore, although currently based on speculation, it should 
be investigated whether sex or muscle group differences in titin stiffness exist, and if so, do 
different titin isoforms explain variability in EIMD?   
Throughout the current thesis, to investigate an association with EIMD in the knee 
extensors, VL muscle properties (fascicle lengthening, VLACSA, pennation angle and thickness) 
were measured at 50% of VL length. Although, during walking, Lichtwark et al. (2007) 
concluded that fascicle length change at 50% of the gastrocnemius muscle allowed for an 
approximation of fascicle lengthening across the whole muscle, it remains unknown if this 
generalisation is applicable in the VL during MVEKE. Within the VL, fascicle length, pennation 
angle and muscle thickness are heterozygous along the muscle (Blazevich et al., 2006), hence 
magnitudes of strain may vary across the muscle (Finni et al., 2003b). Therefore, due to 
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assuming homozygous muscle properties from 50% of VL muscle length, the current thesis 
may have underestimated the association of muscle properties, specifically fascicle 
lengthening, with EIMD. Consequently future research should investigate the role of muscle 
properties at the proximal and distal regions of the muscle on EIMD. 
It is reported that EIMD is significantly lower in the lower limbs compared to the 
upper limbs (Saka et al., 2009; Chen et al., 2011). These differences have been previously 
attributed to the daily exposure of eccentric contractions being higher in the lower limbs 
compared to the upper limbs (Chen et al., 2011). Furthermore, in light of the current thesis, 
greater EIMD in the upper limbs compared to the lower limbs may be attributed to 
differences in muscle architecture and tendon properties (Chen et al., 2011). For example, 
due to parallel muscle fibres in the bicep femoris, the magnitude of fascicle lengthening may 
be significantly greater than the degree of fascicle lengthening reported in the VL. Although 
within the current thesis, muscle and tendon properties were not concluded as determinates 
of EIMD in the lower limbs, it is required to establish whether the same conclusion can be 
drawn in the upper limbs. Secondly, differences in muscle and tendon properties may explain 
differences in EIMD between muscle groups, especially when the difference in the magnitude 
of EIMD investigated is significantly greater than the group differences reported in the 
current thesis.   
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Abstract 
Aim: Elastic tendons have been suggested to attenuate fascicle lengthening during eccentric 
contractions however there is no in vivo evidence to support this hypothesis. Therefore, the 
aim of this study was to determine whether patella tendon stiffness modulates Vastus 
Lateralis fascicle lengthening during eccentric contractions in males and females. Method: 
Vastus Lateralis and patella tendon properties were measured in males and females owing to 
previously reported intrinsic gender differences in tendon properties. During maximal 
voluntary eccentric knee extensions, Vastus Lateralis fascicle lengthening and torque was 
recorded at every 10 (range of motion 20-90). Results: A significant correlation between 
maximal patella tendon stiffness and change in fascicle length (r=0.476, p=0.023) was 
observed. Similarly, there was a significant correlation between maximal Young’s modulus 
and change in fascicle length (r=0.470, p=0.049). As expected, patella tendon stiffness and 
Young’s modulus were significantly higher in males compared to females (p<0.05). 
Interestingly, change in Vastus Lateralis fascicle length during the eccentric contractions was 
significantly greater in males compared to females (p<0.05). Based on patella tendon moment 
arm measurements, Vastus Lateralis muscle-tendon unit elongation was estimated to be 
significantly greater in males compared to females (5.24cm and 4.84cm respectively) 
Conclusion: The significant difference in fascicle lengthening during eccentric contractions 
may be partly explained by the significantly higher patella tendon moment arm, patella 
tendon stiffness and Young’s modulus found in males compared to females. The current study 
provides in vivo evidence to support the hypothesis that the tendon acts as a ‘mechanical 
buffer’ during eccentric contractions. 
Key words: Fascicle lengthening, tendon stiffness, eccentric exercise, and gender  
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Introduction 
Historically eccentric contractions are considered and often defined as “muscle lengthening” 
(e.g. (Lindstedt et al., 2001)). However, with the advent of the sonomicrometry method 
pioneered by Griffiths (1987) and B-mode ultrasonography (Fukashiro et al., 1995), the 
quantification of muscle lengthening during eccentric contractions has been directly 
investigated. During the stance phase in a freely walking cat, Griffiths (1991) found that 
muscle fascicles were shortening despite an increase in muscle tendon unit (MTU) length. In 
agreement with Griffiths (1991), Spanjaard et al. (2007) reported that during the eccentric 
phase of stair descent, the gastrocnemius medialis fascicles shortened despite a lengthening of 
the MTU. In contrast, Fukunaga et al. (2001) reported gastrocnemius medialis fascicles to 
contract quasi-isometrically during the stance phase of human walking, despite significant 
lengthening of the MTU. Although some of the discrepancy in fascicle lengthening can be 
attributed to differences in gait patterns during flat walking versus stair decent (Spanjaard et 
al., 2007), both Spanjaard et al. (2007) and Fukunaga et al. (2001) suggested that the 
lengthening of the MTU during the eccentric phase, occurs predominately at the tendon 
rather than at the muscle fascicles.  
It is widely accepted that tendons are not inextensible and are in fact a viscoelastic tissue that 
deforms under loading (Magnusson et al., 2008). The degree of deformation (elongation) 
depends on the level of loading and intrinsic stiffness of the tendon (Maganaris & Paul, 1999). 
Non-invasive techniques such as B-mode ultrasonography allows the in-series muscle and 
tendon behaviour to be measured independently, at rest and during locomotion (Fukunaga et 
al., 1996; Cronin & Finni, 2013). Understanding the interaction between the tendon and 
muscle is essential to fully understand the contribution of each to everyday tasks such as 
postural balance (Onambele et al., 2006) and acute stretching (Morse et al., 2008). The 
shortening or quasi-isometric behaviour of fascicles during eccentric contractions has 
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previously been attributed to the tendon lengthening under load (Spanjaard et al., 2007; 
Fukunaga et al., 2001; Reeves & Narici, 2003). The greater proportion of MTU lengthening 
occurring at the tendon, reduces the metabolic cost of muscle contractions (Roberts & Scales, 
2002) and economy of walking is enhanced (Fukunaga et al., 2001). The impact of tendon 
properties on fascicular elongation during eccentric loading is further demonstrated through 
the role that tendon stiffness plays in explaining group differences in fascicular elongation 
(Mian et al., 2007). The gastrocnemius medialis fascicles during the eccentric stance phase of 
gait, in the elderly and young, are indeed reported to behave either quasi-isometrically (in the 
old) or to lengthen (in the young) (Mian et al., 2007). With these differences in fascicle 
behaviour being attributed to tendon stiffness decreasing with age (Onambele et al., 2006) 
thus attenuating fascicle lengthening in the elderly. To explain the interaction between 
tendon stiffness and fascicle displacement under loading, Lichtwark et al. (2007) used a three 
element Hill muscle model. Using the Achilles tendon and the gastrocnemius medialis fascicle 
lengthening during the eccentric stance phase of walking they predicted increasing Achilles 
tendon stiffness increased the required amount of fascicle lengthening (Lichtwark & Wilson, 
2007).  
The interaction between the tendon and muscle fascicles have also reported within the vastus 
lateralis (VL) during eccentric tasks, such as drop jumps and countermovement jumps 
(2001). Finni et al., (2001) reported the magnitude of VL fascicle lengthening during the 
eccentric phase was smaller in the drop jump compared to the countermovement jump. Due 
to similar MTU lengthening, they suggested the difference of fascicle lengthening could be 
attributed to the greater tendon elongation required in the drop jump. These findings suggest 
a modulating role of the patella tendon on the degree of VL fascicle lengthening, which is 
dependent on the movement being performed (Ishikawa et al., 2003). Thus, the above 
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supports the hypothesis that the tendon may act as a ‘mechanical buffer’ (Reeves & Narici, 
2003; Roberts & Azizi, 2010). 
 The role of the tendon in attenuating fascicular loading during eccentric contractions 
is particularly relevant when trying to address the gender differences in response to 
eccentric contractions (Sewright et al., 2008). It is well established that males have higher 
tendon stiffness than females, which is associated with a direct impact of raised oestrogen 
levels on tendon properties (Bryant et al., 2008). For example, Onambélé et al. (2007) 
reported patella tendon stiffness to be 57% higher in males compared to females. Even when 
corrected for tendon length and patella tendon cross-sectional area (PTCSA(Young’s 
modulus)), males’ tendon stiffness remained 12% higher than females’. It is these gender 
differences in tendon properties that have previously been alluded to as the mechanism by 
which males experience greater levels of muscle damage following eccentric exercise 
compared to boys (Marginson et al., 2005). Although a lengthening of VL fascicles during 
eccentric knee extensions has been shown (Guilhem et al., 2011), to the authors’ knowledge, 
it is not known whether a gender difference in the elongation of muscle fascicles during 
eccentric contractions exists.  
Therefore, the aim of the present study was to determine whether patella tendon stiffness 
alters VL fascicle lengthening during eccentric contractions in males and females. In view of 
the evidence that males have stiffer tendons than females, it is hypothesised that fascicular 
lengthening during eccentric contractions would be greater in males compared to females.  
 
Materials and methods 
Subjects 
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Nine males (22 ± 2 years of age, 71.9 ± 13.1 kg and 173 ± 8 cm) and nine females (21 ± 2 
years of age, 62.2 ± 6.9 kg and 165 ± 7 cm) volunteered to participate in this study. All 
participants self-reported as being recreationally active (undertaking no more than 1 hour of 
“moderate” physical activity per week) and not undertaking any structured training regime. 
Due to the effects of the oral contraceptive pill on tendon properties (Bryant et al., 2008), 
females had no history of oral contraceptive pill use. Ethical approval was obtained through 
the Department of Exercise and Sport Science, Manchester Metropolitan University and all 
participants signed informed consent prior to taking part in the study. All procedures 
complied with the Declaration of Helsinki. Exclusion criteria were established through 
participant questionnaire prior to testing. Exclusion criteria included an occupation or 
lifestyle that required regular heavy lifting or carrying, resistance trained in the last six 
months, the use of dietary supplements (e.g. vitamin E), known muscle disorder, and any 
musculoskeletal injury in the last three months. Further exclusion criteria for female 
participants included, irregular menstrual cycles (24-35 days) in the last 12 months, previous 
use of any other forms of hormone based contraception, and been pregnant or breast fed in 
the year preceding their application to participate in the present study.  
 
Testing protocol 
Participants were asked to visit the laboratory on two occasions, separated by two days; the 
first session consisted of anthropometric measures (stature and mass), VL anatomical cross-
sectional area (VLACSA), patella tendon moment arm (PTMA), and dynamometer familiarisation. 
Stature and mass were measured using a wall mounted stadiometer (Harpenden 
stadiometer, Holtain Crymych, UK) and digital scales (Seca model 873, Seca, Germany) 
respectively. Familiarisation included two practice MVCs, at two knee joint angles (90 
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seconds rest). The second laboratory visit consisted of patella tendon stiffness measurements 
followed by measurement of VL fascicle length during eccentric contractions. All testing was 
carried out on the non-dominant leg. The non-dominant leg was defined as the leg that 
provided stability during movements, e.g. kicking. During the tendon properties and eccentric 
test protocols, participants were secured (i.e. inextensible straps around the shoulders and 
hips to reduce any extraneous movement during maximal efforts) in a seated position to an 
isokinetic dynamometer (Cybex Norm, Cybex International, NY, USA), with a hip angle of 85°. 
The dynamometer axis of rotation was visually aligned with the knee joint’s centre of rotation.  
 
VL anatomical cross-sectional area 
A real-time B-mode ultrasound (AU5 Harmonic, Esaote Biomedica, Genoa, Italy) was used to 
measure VLACSA. Participants laid supine with their leg full extended (knee angle 0), an 
ultrasound probe (7.5 MHz linear array probe, 38 mm wide) was used to identify the distal 
and proximal insertion sites of the VL. At 50% of VL muscle length echo-absorptive markers 
were placed in parallel, at intervals of 30 mm, from the medial to the lateral edge of the VL 
muscle. The ultrasound probe was placed perpendicular to the VL muscle in the axial plane. 
The ultrasound probe was moved slowly across the echo-absorptive markers from the medial 
to the lateral edge of the muscle. Consistent minimal pressure was placed on the muscle 
during scanning to avoid compression of the muscle. The images were recorded in real time 
onto a PC at 25 frames per second (Adobe Premier pro Version 6). At each 30 mm interval, 
individual images were acquired using capturing software (Adobe Premier Elements, version 
10). The shadows casted by the echo-absorptive markers allowed the images to be aligned by 
the contour of the muscle and the entire VLACSA to be recreated in a single image (Adobe 
Photoshop Elements, version 10). The VLACSA was then measured using digitising software 
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(ImageJ 1.45, National Institutes of Health, USA). This method for calculating VLACSA has 
previously been accepted as reliable and valid when compared to MRI, with a reported 
interclass correlation between 0.998 and 0.999, for reliability and validity respectively 
(Reeves et al., 2004). Furthermore, chapter demonstrates high reliability for measuring 
VLACSA using the ultrasound.  
 
Tendon length and cross-sectional area 
Patella tendon cross-sectional area and patella tendon length (PTL) were measured with the 
knee fixed at 90o angle. The distance between the tibial tuberosity and the apex of the patella, 
marked using sagittal ultrasound images, was taken as PTL. To measure PTCSA the ultrasound 
probe was placed in the transverse plane and images were captured at 25%, 50%, and 75% 
of PTL. The images were subsequently analysed offline using (ImageJ 1.45, National Institutes 
of Health, USA). A mean of the three images was taken as PTCSA (O’Brien et al., 2010). 
 
Patella tendon moment arm 
In order to calculate patella tendon force PTMA was measured at a knee joint angle of 90o (full 
extension = 0o) in the sagittal plane, from a single energy (frame 23.3 cm x 13.7cm) DEXA 
scan (Hologic Discovery, Vertec Scientific Ltd, UK). A goniometer was used to ensure the knee 
angle was 90. Using OsiriX, (DICOM viewer, ver. 4.0, Pixemo, Switzerland) the perpendicular 
distance from the center of the patella tendon to the tibio–femoral contact point was 
determined as the PTMA length (Baltzopoulos, 1995). Compared to the MRI, the DEXA has 
been reported a reliable and valid technique when measuring moment arm length (Erskine et 
al., 2014).  
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Force- elongation relationship / patella tendon stiffness 
With the knee angle fixed at 90o in the isokinetic dynamometer the participants were 
instructed to perform a ramped maximal voluntary knee extension (MVCKE) lasting ~6 
seconds. Concomitantly, ramped MVCKE torque and displacement of the patella tendon were 
recorded. Patella tendon displacement was measured over two MVCKE, once with the 
ultrasound probe positioned over the tibial tuberosity and on the second contraction over the 
apex of the patella. This is consistent with Onambélé et al. (2007) as a means of obtaining 
total patella tendon displacement. Torque was displayed on a Macintosh G4 computer (Apple 
Computer, Cupertino, CA, USA), via an A/D converter (Biopac Systems, Santa Barbara, CA) 
and subsequently analysed with the accompanying software (Acknowledge, version 3.9.2). 
Patella tendon displacement was measured by positioning the ultrasound probe (7.5 MHz 
linear array probe, 38 mm wide) in the axial-plane on the tibial tuberosity (or the apex of the 
patella during alternate contractions). An echo-absorptive marker was placed on the skin to 
cast a shadow on the ultrasound and act as an external marker. The distance of the shadow 
from an internal marker at the beginning of the contraction, to the position of the shadow at 
the end of the contraction, allows excursion to be measured. An externally generated square 
wave pulse was used to synchronise the ultrasound images with the torque acquisition 
system. Images were captured at ~10% intervals of ramped MVCKE torque (Onambélé et al., 
2007). Total patella tendon displacement was calculated as displacement at the tibial 
tuberosity plus the displacement at the apex of the patella (Onambélé et al., 2007). Patella 
tendon forces were calculated as: (MVCKE torque + antagonist co-activation torque) / PTMA. 
The measurement of antagonist co-activation torque is described below. The force – 
elongation curve stemming from data at every 10% MVCKE was then fitted with a second-
order polynomial function, forced through zero (Onambélé et al., 2007), and the tangential 
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slope at discreet sections of the curve, relative to MVCKE, was computed by differentiating the 
curve at each point of interest (i.e. every 10% force intervals). To account for between subject 
differences in maximal force production, the slope of the tangential line, corresponding to the 
MVCKE of the weakest participant (regardless of gender), was computed for each subject. This 
therefore standardised the comparison of tendon stiffness at an absolute load.  
 
Co-activation 
Electromyogram amplitude of the bicep femoris (BF) was measured to determine co-
activation during the ramped MVCKE. Guided by an axial-plane ultrasound of the BF, two 
bipolar electrodes (Ambu, Neuroline 720, Malaysia) were placed in the mid-sagittal line at 
75% of BF muscle length (distal end = 0%). A reference electrode (Ambu, blue sensor, 
Malaysia) was placed on the lateral tibia condyle. The electrodes were placed in a bipolar 
configuration with a constant inter-electrode distance of 20mm (Hermens et al., 2000). 
Preceding electrode placement; the skin was shaved, abraded and cleansed with an alcohol 
wipe to reduce skin impedance below 5000 Ω (Hermens et al., 2000). The participants were 
asked to contract and relax to ensure correct electrode placement. The raw EMG signal was 
amplified (×2000) and filtered (through low and high pass filters; i.e. 10 and 500 Hz 
respectively) with the sampling frequency set at 2000 Hz. Ramped MVCKE torque and BF EMG 
were recorded in real time and synchronised using an externally generated square wave 
pulse. In the isokinetic dynamometer, participants were asked to perform two maximal 
voluntary knee flexions (MVCKF) at 90 knee angle. Participants were instructed to perform 
MVCKF as quickly and as forcefully as possible against the dynamometer’s lever arm. The 
participants were instructed to stop contracting once a two second plateau had been attained 
(as observed on the dynamometer screen display). The integral of the root mean square of 
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the BF EMG signal, was calculated 500 ms either side of instantaneous MVCKF maximal torque 
from the contraction corresponding to the highest MVCKF torque. Prior to contraction the 
baseline signal noise was calculated as the integral root mean square over 1s and removed 
from the measured EMG during MVCKF and MVCKE. The absolute integral of the BF EMG was 
taken over 250 ms at every 10% of ramped MVCKE torque. Co-activation torque was 
calculated as, (BF EMG during ramped MVCKE / BF EMG during MVCKF) × peak MVCKF torque 
(Onambélé et al., 2007). An assumption that BF EMG is linear with MVCKF was made (Lippold, 
1952) 
 
Stress / strain relationship 
Patella tendon stress was calculated as, patella tendon force / PTCSA. Tendon strain was 
calculated as a ratio of total patella tendon displacement and PTL.  
 
Young’s modulus 
Young’s modulus was calculated as: patella tendon stiffness × (PTL (mm) / PTCSA (mm2)) at 
MVC. Furthermore, young’s modulus was also calculated with patella tendon stiffness 
standardised to the MVCKE force of the weakest participant.  
 
Eccentric exercise 
A warm-up of 10 isokinetic knee extensions and knee flexions, ensuring a progressive 
increase in effort (with the last contraction being maximal), was carried out prior to eccentric 
exercise. For the eccentric exercise, the knee extensor range of motion was set at 20 – 90 (0 
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= full extension). Participants were asked to perform 1 set of 12 maximal voluntary eccentric 
knee extensions (MVEKE) repetitions. During the eccentric phase (knee angle 20 to 90), 
contractions were performed at an isokentic angular velocity of 30s-1 (Saka et al., 2009). 
The concentric phase was performed sub-maximally at an angular velocity of 60s-1 to 
minimise fatigue and enhance eccentric damage (Chapman et al., 2006). Visual and verbal 
encouragement was continuously provided throughout the eccentric exercise (Campenella et 
al., 2000). MVEKE torque was recorded throughout each MVEKE and displayed via the torque 
acquisition system.  
 
Change in VL fascicle length during the eccentric protocol 
To measure VL fascicle length during MVEKE, the ultrasound probe was fixed at 50% of VL 
muscle length in the mid-sagittal plane of the non-dominant leg. A hypo-allergenic ultrasound 
gel (Parker, Park Laboratories Inc., Fairfield) was used to enhance coupling between skin and 
the ultrasound probe.  
During the 12 MVEKE contractions, ultrasound images were recorded onto a PC, in real time, 
at 25 frames per second (Adobe Premier pro Version 6). An externally generated square 
wave pulse was used to synchronise the ultrasound images with the torque acquisition 
system. Three MVEKE contractions were randomly chosen from the 12 repetitions for 
architectural analysis. Using frame capture software (Adobe Premier Elements, version 10), 
an ultrasound image (frame corresponding to every 10 of knee angle, ranging from 20- 90) 
was acquired for offline analysis. To ensure there was no movement artefact included in the 
assessment fascicle length, an echo-absorptive marker was fixed on the skin to provide a 
visual baseline of the internal structures. If movement of the probe was observed relative to 
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the VL, the contraction was discarded and another MVEKE contraction was chosen for 
analysis.  
Using digitising software (ImageJ 1.45, National Institutes of Health, USA), VL fascicle length 
was analysed offline at every 10. Fascicle length was measured from the visible insertion of 
the fibre into either the deep or superficial aponeurosis (Reeves & Narici, 2003). The fascicle 
was only measured if it remained visible across the entire ultrasound image. Where the 
fascicle extended beyond the ultrasound image (frame width 3.50 cm and height 4.15 cm), 
linear continuation of the fascicle and aponeurosis was assumed. Using ultrasound a 2-7% 
error has been associated with assuming linear continuation to calculate VL fascicle length at 
120 knee angle (Finni et al., 2003a). To reduce error associated with the estimation of VL 
fascicle length, an average of three fascicles across the image was taken (Guilhem et al., 
2011). Change in fascicle length was calculated at each angle by subtracting the fascicle 
length reported at knee angle 20. Change in fascicle length at each angle was made relative 
to fascicle length at 20. To normalise change in fascicle length for PTMA length, change in 
fascicle length from 20-90 was divided by PTMA length at 90 knee angle.  
VL excursion 
In order to estimate the total VL MTU elongation, the tendon excursion method was adopted 
(Spoor et al., 1990); whereby the change in knee angle (70, 1.22 rad) was multipliedpoo by 
measured PTMA at 90 knee angle.  
Statistics 
All statistical analyses were carried out using the statistical software package SPSS (v.19, 
Chicago, IL) for Windows and Microsoft Excel. To ensure the data were parametric, the 
Shapiro-Wilk and Levene’s tests were utilized to assess the normality and variance of the 
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data. These statistical assumptions were not breached. For gender differences in 
anthropometric measures, VL fascicle length and patella tendon properties, Independent T-
tests were used. A 2×8 mixed design ANOVA (between factors: gender (2 levels), and knee 
angle (8 levels)) was used for MVEKE torque, MVEKE torque corrected for VLACSA, and change in 
VL fascicle length. Wherever the assumption of sphericity was violated, the Greenhouse-
Geisser correction was used. When a significant group effect was found, post-hoc 
Independent T-tests (planned contrast) with LSD correction were carried out. Pearson’s 
correlations were used to investigate whether significant associations were present at 90 
between 1) MVEKE corrected for VLACSA and change in fascicle length 2) patella tendon 
stiffness, at MVCKE and change in fascicle length and, 3) Young’s modulus, at MVCKE, and 
change in fascicle length. Significance was set at p≤ 0.05. Data are presented as mean ± 
standard deviation.  
Results 
Anthropometric measurements  
There were no significant difference in age (males aged 22 ± 2 years, females aged 21 ± 2 
years, p= 0.449) and mass (males 71.9 ± 13.1 kg, females 62.2 ± 6.9 kg, p= 0.066) in males 
compared with females. Males were significantly taller than the females (173 ± 8 cm and 165 
± 7 cm, respectively, p=0.045).  
Tendon Properties 
PTL (males 5.73 ± 0.50 cm, females 5.16 ± 0.55 cm, p= 0.034), PTCSA (males 0.81 ± 0.16 cm2, 
females 0.62 ± 0.14 cm2, p =0.016) and PTMA (males 4.30 ± 0.27 cm, females 4.0 ± 0.29 cm, 
p=0.023) were significantly greater in males compared to females. Ramped MVCKE torque 
was significantly higher in males compared to females at every 10% MVCKE torque (p< 0.01). 
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Patella tendon force was significantly higher in males compared to females at every 10% 
MVCKE torque ((p<0.05), Table 1.). Patella tendon elongation was not significantly different 
between males and females at any 10% MVCKE torque (Table 1). Patella tendon stiffness, at 
MVC, was significantly higher in males compared to females (> 50% MVCKE p<0.05, < 50% 
MVCKE p< 0.01, (Table 1)). The greater patella tendon stiffness in males was reflected in a 
relative shift to the left (compared to the females’ trend line) in the force-elongation curve. 
<INSERT TABLE 1> 
Young’s modulus at MVCKE was significantly higher (p= 0.014) in males (8131 ± 2447 MPa) 
compared to females (5800 ± 1543 MPa). To account for the significantly higher MVCKE 
torque in males, a patella tendon force of 2330N (corresponding to the highest MVCKE torque 
of the weakest participant (independent of sex)) was used to calculate standardised force 
level patella tendon stiffness and Young’s modulus. Standardised force patella tendon 
stiffness (males 880 ± 293 Nmm1, females 553 ± 179 Nmm1, p=0.013) and standardised 
force Young’s modulus (males 6343 ± 2012 MPa, females 4701 ± 1482 MPa, p=0.033) 
remained significantly higher in males compared to females.  
     <INSERT FIGURE 1> 
Change in VL fascicle length during MVEKE 
A two-way mixed repeated measures ANOVA for change in VL fascicle length, reported a 
significant main effect of angle (p< 0.001) and a significant group effect of gender (p= 0.004), 
with a significant interaction effect (p= 0.001). A planned contrast showed at 30 - 90, change 
in fascicle length was significantly higher in males compared to females (p< 0.05, Figure 1). 
When this change in fascicle length was made relative to fascicle length at 20, male’s fascicles 
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increased by 57.6 ± 10.9 % and females increased by 39.6 ± 9.8 % at 90. Thus, relative fascicle 
length increased significantly further in males compared to females (p= 0.002) 
When change in fascicle length during eccentric contraction was corrected for PTMA length, 
change in fascicle length remained significantly higher in males (0.96 ± 0.26 cm) compared to 
females (0.66 ± 0.14 cm, p= 0.008). 
     <INSERT FIGURE 2> 
MVEKE torque showed a significant main effect of angle (p< 0.001) and a significant group 
effect of gender (p=0.004), with a significant interaction effect (p= 0.020). A planned contrast 
demonstrated that MVEKE torque was significantly higher in males compared to females at 
60 (males 148 ± 33.2 Nm, females 101 ± 30.4 Nm, p= 0.007), 70 (males 160 ± 38.9 Nm, 
females 99.2 ± 29.1 Nm, p= 0.002) and 80 (males 145 ± 33.8 Nm, females 88.9 ± 28.8 Nm, 
p=0.002). Peak MVEKE torque was found at 60 for females (101 ± 30.4 Nm) and 70 for males 
(160 ± 38.9 Nm). Independent T-test showed that peak MVEKE torque in males was 
significantly higher than in females (p< 0.003).  
When MVEKE torque was normalised for VLACSA (i.e. MVEKE torque / VLACSA) a significant main 
effect of angle (p< 0.001) was observed but no effect of gender (p=0.162), with a significant 
interaction (p= 0.047). 
VL excursion 
Based on the tendon moment arm excursion, the estimated increase in VL MTU length from 
20-90 was significantly greater in the males compared to the females (5.25 ± 0.33 cm, 4.84 ± 
0.35 cm, respectively, p =0.023). 
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Correlation 
Pearson’s correlations were conducted at 90 (knee angle), as the change in fascicle length 
was greatest at this angle. There was no correlation between MVEKE corrected for VLACSA and 
change in fascicle length (r=0.010, r2 =1.03 %, p=0.485). A significant, although weak, 
correlation between patella tendon stiffness at MVC and change in fascicle length (r=0.476, r2 
=23%) was reported (p=0.023). A significant correlation between patella tendon Young’s 
modulus at MVC and change in fascicle lengthening (r=0.508, r2 =26%) was reported 
(p=0.016) (Figure 2.).  
Discussion 
The aim of the present study was to determine whether patella tendon stiffness alters VL 
fascicle lengthening during MVEKE in males and females. There were three main findings, 1) 
VL fascicles lengthen during MVEKE, 2) in agreement with our hypothesis, the change in VL 
fascicle length and relative change in fascicle length during eccentric contractions was 
significantly greater in males compared to females, 3) a significantly longer PTMA, higher 
tendon stiffness and Young’s modulus in males compared to females, partially accounts for 
increased fascicle lengthening under loading. 
 Consistent with the classical definition of eccentric contractions and the findings of 
Guilhem et al., (2011) the current study reported a lengthening of VL fascicles during MVEKE. 
A lengthening of VL fascicles has previously been reported during eccentric movements 
(Finni et al., 2001), with greater lengthening during a low intensity countermovement jump 
compared to a drop jump where the fascicle lengthening was minimal. As a result of similar 
MTU lengthening between the two jumps, Finni et al. (2001), attributed the difference in 
fascicle lengthening to the greater elongation of the tendon and higher EMG activity found in 
the drop jump. The difference in fascicle behaviour was further explained by Ishikawa et al., 
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(2003) who reported VL fascicle lengthening to reduce, and patella tendon elongation to 
increase when the rebound intensity of the drop jump was increased. These findings suggest 
the interaction between the fascicles and tendon during the eccentric phase allows for the 
fascicle to operate on the most ‘efficient’ part of the force–lengthening relationship, for 
greater rebound intensities (Ishikawa et al., 2003). Therefore although the previous 
literature and the current study report a lengthening of VL fascicles during eccentric 
movements, it should also be clear that the magnitude of lengthening is regulated by the 
amount of tendon elongation, the type of eccentric task and intensity of the task itself 
(Ishikawa et al., 2003; Finni et al., 2001).  
In the current study, change in VL fascicle length was found to be significantly higher in males 
compared to females during MVEKE. The significant difference remained when change in 
fascicle length was made relative to fascicle length at 20. To the best of the authors’ 
knowledge, gender differences in fascicle behaviour during eccentric contractions have yet to 
be reported. The observed gender difference in fascicle behaviour during eccentric 
contractions can be partially attributed to the observed difference in patella tendon 
compliance. Although gender differences remain unreported, the role of the tendon and 
group differences in fascicle lengthening during eccentric phases of gait have recently been 
considered (Mian et al., 2007). For example, Mian et al. (2007) suggested that the group 
differences in the fascicle behaviour of young and elderly participants might be a result of 
reduced tendon stiffness in the elderly; however this was not confirmed experimentally in 
their study.  
The idea that the tendon acts as a mechanical buffer and attenuates fascicle lengthening 
however is not novel (Fukunaga et al., 2001; Spanjaard et al., 2007; Reeves & Narici, 2003). 
Litchwark et al. (2007) used a three element Hill muscle model to predict the effect of 
different levels of tendon stiffness on the behaviour of fascicle lengthening during gait. They 
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predicted that increasing Achilles tendon stiffness, increased the required amount of 
gastrocnemius medialis fascicle lengthening during the stance phase of gait (Lichtwark & 
Wilson, 2007). Thus further supporting the hypothesis that the tendon may modulate fascicle 
lengthening (Reeves & Narici, 2003; Roberts & Azizi, 2010). The accuracy of the model 
remains in question however, as Litchwark et al. (2007), did not take into account fibre 
pennation angle and used a linear model for tendon stiffness despite tendon being known to 
have a non-linear force-elongation relationship (Maganaris & Paul, 2002). The current study 
however, provides in vivo evidence to demonstrate the association between tendon 
properties and fascicle lengthening. In agreement with previous literature (Onambélé et al., 
2007; Kubo et al., 2003), the current study reported significantly higher tendon stiffness and 
Young’s modulus, at MVCKE, in males compared to females. This significant difference 
remained when patella tendon stiffness and Young’s modulus was calculated at a 
standardized absolute force level of 2330N. Significant correlations were found between 1) 
Tendon stiffness when calculated at MVCKE and change in fascicle length and 2) Young’s 
modulus, when calculated at MVCKE and change in fascicle length. Thus, greater fascicle 
lengthening in males can be partially attributed to, the significantly higher patella tendon 
stiffness and Young’s modulus in males. Although the attenuating role of the tendon on 
fascicle behaviour has been alluded to previously, the current study provides in vivo evidence 
to support previous models (Lichtwark & Wilson, 2007) and hypotheses (Reeves & Narici, 
2003; Spanjaard et al., 2007; Fukunaga et al., 2001).  
In addition to the tendon one of the other contributory factors to greater fascicle elongation 
in males could be the greater MVEKE torque. MVEKE torque was significantly higher at 60, 70 
and 80 in males compared to females. Furthermore, peak MVEKE torque was significantly 
higher in males compared to females. Males however, were reported to have significantly 
larger VLACSA compared to females. When MVEKE torque was corrected for VLACSA (stress), 
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there was no significant difference between males and females. Torque was therefore 
‘distributed evenly’ over VLACSA in both males and females. Furthermore, a significant 
correlation between MVEKE torque and change in fascicle length was not observed in the 
current study. Therefore, although we cannot completely dismiss the contribution of greater 
torque on fascicle lengthening, we observed no difference in relative MVEKE torque, or any 
correlation with change in fascicle length. 
Males had a significantly longer PTMA than females thus, in order to establish whether there 
was a significant contribution of the PTMA to the fascicle elongation MTU elongation was 
estimated based on the tendon excursion method (Spoor et al., 1990). Although this method 
estimates the entire quadriceps MTU elongation, we estimated a significantly greater MTU 
elongation in males compared to females (5.24 cm and 4.84 cm respectively). Therefore the 
difference in PTMA contributes to the difference in fascicle lengthening. Based on measured 
fascicle lengthening of 4.07 cm in males and 2.63 cm in females, we estimated that 89% and 
54% (males and females respectively) of the estimated total change in MTU length, from 20-
90, could be attributed to an increase in the fascicle length. It is therefore likely that the 
remaining portion of the increase in MTU length (11% and 46% in males and females, 
respectively), which is not attributed to this increase in fascicle length, may be due to the in 
series elastic component. As a way of determining the contribution of the PTMA and patella 
tendon stiffness on VL fascicle lengthening, change in VL fascicle length was normalised for 
PTMA length. When corrected for PTMA length, change in VL fascicle length remained 
significantly higher in the males compared to females. Highlighting that although PTMA does 
contribute to VL fascicle lengthening, the gender differences in VL fascicle lengthening can be 
attributed to the gender differences in patella tendon stiffness. Although the current study 
has provided evidence to support the role of patella tendon stiffness on VL fascicle 
lengthening during MVEKE, it is acknowledged that the elastic component also incorporates 
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the aponeurosis. It is however unclear how the distinct contributions of the tendon vs. the 
aponeurosis may interplay since the relative mechanical properties of the aponeurosis are 
indeterminate with reports of significantly higher (Maganaris & Paul, 2000), significantly 
lower (Magnusson et al., 2003) or similar (Arampatzis et al., 2005) strain values to the 
tendon. It should be noted that the apparent variability within these cited studies could be 
attributed to different participant activity levels, the specific anatomical MTU investigated 
and the method used to determine MTU lengthening. Therefore, a limitation of the current 
study is that we are unable to provide a measure of the mechanical properties of the VL 
aponeurosis alongside those of the tendon; hence we cannot determine the contribution of 
the VL aponeurosis to fascicle lengthening behaviour. However, it remains that a longer 
fascicle elongation in males compared to females is attributable to a larger moment arm 
length, and an increase in stiffness of the in series elastic components, that of the patella 
tendon in particular. 
In conclusion the current study demonstrates during eccentric contractions, VL fascicles 
lengthen significantly further in males compared to females. The significant difference in 
lengthening may be partly attributed to the significantly longer PTMA, higher patella tendon 
stiffness and Young’s modulus found in males compared to females. The current study 
provides in vivo evidence to support the hypothesis that the tendon acts as a mechanical 
buffer during eccentric contractions. Future research needs to investigate the contribution of 
the aponeurosis to the lengthening of the fascicles during eccentric contractions.  
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Figure I: Change in VL fascicle length from 20, at each knee angle (20-90) during eccentric 
exercise in males and females. Data is reported as mean and standard deviations. * p <0.05, ** 
p <0.01, *** p < 0.001.  
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Figure II: Correlation between patella tendon Young’s modulus and change in VL fascicle 
length. Note: R2 value is for the entire sample.  
Table 1. Structural and mechanical patella tendon properties in males and females, in vivo. 
 
Note: MVCKE (%), ramped isometric maximal voluntary knee extension. Data is presented as 
means and standard deviations. * p ≤ 0.05, ** p ≤ 0.01 
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A.2. Eccentric strain determines exercise-induced muscle damage 
Chapter four was presented at the 19th annual Congress of the European College of Sport 
Science – Amsterdam 2014. The abstract was entered into the Young Investigators Award 
and published in the congress Book of Abstracts. 
K. M. Hicks1, G. L. Onambele-Pearson1, K. Winwood1, and C. I. Morse1 
1. IPR, Manchester Metropolitan University, Cheshire, CW1 5DU, UK 
Introduction 
Fascicle strain, eccentric torque, muscle and tendon properties, have all been suggested to be 
determinants of exercise-induced muscle damage (EIMD) yet these remain to be assessed in 
vivo (Butterfield, 2010). Therefore, the aim of the present study was to establish the in vivo 
muscle and tendon determinants of EIMD. 
Method 
Vastus Lateralis (VL) structural properties (anatomical cross-sectional area (ACSA), 
architecture), and Patella Tendon (PT) properties (CSA, length) were recorded using B-mode 
ultrasonography in 16 recreationally active males (22±2 years). PT displacement during 
Isometric knee extensions was used to determine PT stiffness, and Young’s modulus. Six sets 
of 12 isokinetic maximal eccentric knee extension contractions (knee angle 20-90degs, 
30degs/s) were performed. During the first 3 reps, VL fascicle length (strain) was recorded 
using ultrasonography. During the eccentric phase, torque and strain were recorded at every 
10deg knee angle. Markers of EIMD (creatine kinase (CK) [from 6mL venous blood sample] 
and isometric MVC torque [to calculate torque loss]) were taken pre, 0, 48, 96 and 168 hours 
post EIMD. Pearson’s correlations were used to establish any associations between markers 
of EIMD and muscle-tendon properties. 
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Results 
Tendon stiffness, normalised for tendon force, did not correlate with change in CK (r=0.131, 
p=0.314) or isometric torque loss (r=-0.221, p=0.205). There was a significant correlation 
between change in CK and strain (r=0.534, p=0.017). Eccentric torque, made relative to VL 
ACSA (stress), did not correlate with markers of EIMD. 
Discussion 
The current study can report that the tendon does not directly attenuate markers of EIMD. 
However, tendon may reduce markers of EIMD indirectly through attenuating strain (Hicks et 
al., 2013). Our data showed change in CK to be associated with VL muscle strain in vivo, thus 
supporting the in vitro findings of Lieber and Friden (1993). Despite eccentric contractions 
generating high torques, when made relative to muscle size, tendon stress was not associated 
MVC torque loss. In conclusion, in vivo, strain is a determinant of EIMD, whereas eccentric 
stress and the viscoelastic tendon properties are not.  
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